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Abstract 
Fungi are prolific sources of structurally novel and biologically active 
compounds. Over the past decades terrestrial fungi have been a major 
source of bioactive metabolites. But often these have been obtained from 
easily accessible and culturable organisms while the apparently rare and 
non-culturable groups remain an untapped resource. With the need for new 
bioactive compounds increasing, the yield of potentially useful new 
bioactive natural products from microbial sources is declining. Part of this 
problem stems from the repeated discovery of known compounds due to 
the heavy reliance on soil actinomycetes and common soil fungi as the 
source of choice.  
A study was made using a range of phenol concentrations as a selective 
method for the isolation of ascomycetes from New Zealand soils. A total of 
407 isolates were obtained. Culture extracts of a number of these isolates 
showed significant activity against the P388 murine leukemia cell line, 
Bacillus subtilis and Candida albicans.  
Chemical characterization of metabolites in active extracts was greatly 
aided by employing dereplication techniques using a combination of 
HPLC-UV/Rt database, MS analysis, the CapNMR technique and the 
AntiMarin Database. A significant advantage was gained by the use of the 
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CapNMR technique that enabled a full NMR characterization on very 
small quantities (<20 µg) of the pure compound. 
Of these active extracts, one from Pseudeurotiom zonatum exhibited P388 
activity with an IC50 value of 1,035 ng/mL and two new cytochalasins; 
F7301-1 (A) and F7301-2 (B) were subsequently isolated.  
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This isolation strategy for the characterisation and exploitation of the less 
readily culturable organisms greatly influences the potential for the 
discovery of novel biotypes and new bioactive compounds. 
As well as exploring biodiversity with the isolation of less culturable fungi 
an attempt was made to maximize metabolite production and induce the 
production of novel metabolites from active selected fungi. This strategy 
was based on the OSMAC (one strain many compounds) and hormetic 
(low-dose stimulation and high-dose inhibition) concept. In the OSMAC 
studies the secondary metabolite production was greatly affected by 
subinhibitory concentrations of elicitors for three out of the seven chosen 
fungal isolates. These were Chaetomium globosum, Xylaria sp. and 
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Bombardia sp. Pseudeurotium zonatum only showed an enhancement in 
metabolite productions but not modulation. The remaining three isolates, 
Chaetomium trigonosporum, Penicillium sp and isolate 9017@20.14, were 
not influenced by manipulation or produced no metabolites at all under the 
range of conditions and elicitors used. 
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Abbreviations 
%   percent
°C  degrees Celsius 
1D  one dimensional 
2D  two dimensional 
δ  chemical shift in ppm (in NMR) 
λmax maximum wavelength in nm 
μg  microgram 
μL microlitre 
μm micrometer 
μM micromolar 
ACN  acetonitrile 
amu Atomic Mass Unit 
Au-Pt Gold Palladium 
B.C. Before Christ 
br broad (in NMR) 
C18  octadecyl phase (chromatography column packing) 
CapNMR  capillary-probe NMR 
CDCl3  deuterated chloroform 
CD3OD  deuterated methanol 
CLY  cycloheximide 
COSY  correlation spectroscopy (in NMR) 
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d  doublet (in NMR) 
DAD  diode array detector 
DCM  dichloromethane 
DEA diethylamine 
DEPT distortionless enhancement by polarization transfer (in 
NMR) 
DMDCS  dimethyldichlorosilane 
DMSO-d6  deuterated dimethyl sulfoxide 
e.g.  example given 
EI  electron ionization 
ELSD  evaporative light scattering detector 
ESI electrospray ionization 
ESIMS  electrospray ionization mass spectrometry 
EtOAc  ethyl acetate 
F-actin  filamentous actin 
g  gram 
h hour 
HDACI II  Histone Deacetylase Inhibitor II  
HDACI IV  Histone Deacetylase Inhibitor IV 
HMBC heteronuclear multiple bond correlation spectroscopy (in 
NMR) 
H2O water 
HPLC  high performance liquid chromatography 
HRESIMS  high resolution electrospray ionization mass spectrometry 
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HRLCMS  high resolution liquid chromatography mass spectrometry 
HSQC  heteronuclear single quantum coherence (in NMR) 
Hz  hertz 
i.e. id est (that is) 
IC50  concentration of sample required to inhibit the growth of 
P388 cellgrowth by 50% 
J  coupling constant in Hz (in NMR) 
JAS  jasplakinolide  
kV  kilovolt 
LB  latrunculin B 
LCMS  liquid chromatography mass spectrometry 
log  logarithmic 
m  multiplet (in NMR) 
mA  milliampere 
MeOH methanol 
mg  milligram 
mL  millilitre 
mm  millimeter 
mM milliMol 
mV  millivolt 
MeOH  methanol 
MHz  megahertz 
min  minute 
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MPA  mycophenolic acid  
MS  mass spectrometry 
MTT  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide 
MYP Malt Yeast Peptone 
MYPA Malt Yeast Peptone Agar 
MYPB  Malt Yeast Peptone Broth 
m/z  mass-to-charge ratio (in MS) 
n number of repeating subunit 
ng nanogram 
NMR  nuclear magnetic resonance 
NOE  nuclear overhauser effect (in NMR) 
No. number 
NYS  nystatin 
OD   Optical density 
OSMAC  one strain-many compounds 
pA  picoampere 
psi   pound per square inch 
P388  cells murine leukaemia cells 
PDA  photodiode array 
PHA  phalloidin 
PHB poly-3-hydroxybutyrate 
ppm  parts per million 
 x 
 
PTFE polytetrafluoroethylene 
q  quartet (in NMR) 
Rt  retention time 
rpm    revolutions per minute 
RPMI-1640 Roswell Park Memorial Institute-1640 medium 
s  singlet (in NMR) 
SDA    Sabouraud Dextrose Agar 
SDA+   Sabouraud Dextrose Agar plus antibiotic solution 
¼SDA-CS ¼ strength sabouraud dextrose agar-
chlortetracycline/streptomycin medium 
SDB    Sabouraud Dextrose Broth 
SEM  scanning electron microscope 
Soln solution 
sp.  species (singular) 
t   triplet (in NMR)  
TCZ    tricyclazole  
Temp   temperatures 
TTC    tetracycline 
TFA   trifluoroacetic acid 
UV   Ultra-Violet 
V   volts 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
 
1.1 NATURAL PRODUCTS OVERVIEW 
 
Natural products are organic compounds that are formed by living organisms. 
These naturally occurring compounds can be divided into three broad 
categories:  
a) Primary metabolites. These compounds play a role 
 in the metabolism and reproduction of the cell and include amino acids, 
nucleic acids and sugars. 
b) Structural components of the cell. For example, cellulose in plant cell 
walls (Hanson, 2003)  
c) Secondary metabolites. Unlike the first two categories which have roles 
essential for life, secondary metabolites are not directly essential for the 
normal growth, development or reproducibility of the organism. The actual 
role of secondary metabolites in cellular systems has been greatly debated in 
recent years. The general consensus is that secondary metabolites serve roles 
related to survival functions in organisms that produce them (Demain and 
Fang, 2000), and that the production of secondary metabolites is affected by 
external stimuli such as environmental stress, competition and infection 
(Strohl, 2000). 
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Secondary metabolites are derived from biosynthetic pathways which branch 
off from the primary metabolic pathways (Benita, 1994). With the exception 
of high molecular mass compounds such as maitotoxin and palylatoxin, 
most of these natural occurring compounds have molecular masses less than 
1,500 amu (Bentley, 1999; Cannell, 1998).  
 
1.2 NATURAL PRODUCTS AS A SOURCE OF MEDICINES 
 
1.2.1 History of natural products discovery 
 
Natural products from plants and fungi have been used by man for thousands 
of years as traditional medicines and as natural poisons and are recognised 
as an important source of therapeutically effective drugs (Larsen et al. 2005). 
In the past, the plant kingdom has served as the main source of natural 
products. The first records were written in on clay tablets in cuneiform from 
Mesopotamia and date from about 2600 B.C. The Ebers papyrus, which is 
the Egyptian pharmaceutical record, date from about 1500 B.C. and 
described around 700 drugs (mostly from plants) including formulae for 
gargles, snuffs, infusion, pills and ointments. Since then the use of natural 
products has been widely recorded across all continents (Cragg and Newman, 
2005). Today natural products still serve a role directly as traditional 
medicines and the largest users are the Chinese. Over 5,000 natural products 
have been recorded in their pharmacopeia (Bensky and Gamble, 1993). 
2 
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These traditional medicines, which again derive mostly from plants, formed 
the basis of most of the early medicines (Butler, 2004).  
The most universally used and the world’s best known drug is aspirin 
(Figure 1.1), which was originally derived from willow trees and other 
salicylate-rich plants. The earliest reference of the use of willow bark extract 
as an antipyretic to reduce fever and act as an anti-inflammatory medication 
comes from the Ebers Papyrus, an Egyptian medical text from 1543 BC 
(Diarmuid, 2005). Other examples of natural products with a long history of 
use include morphine (Figure 1.2), an opioid analgesic which was isolated 
from the opium poppy; Papaver somniferum. Although known for thousands 
of years it has only recently been understood how the opioid analgesic effect 
of morphine operates at the molecular level (Aldrich, 1996). Another 
remarkable medicine of note is the anti-malaria drug quinine (Figure 1.3) 
derived from the cinchona tree, Cinchona officinalis and other Cinchona 
species native to South Africa (Casteel, 1997).  
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Figure 1.1: Aspirin Figure 1.2: Morphine    Figure 1.3: Quinine 
Natural products research and fungal metabolite studies were revolutionized 
by the discovery of penicillin in 1928 by Alexander Fleming from 
Penicillium chrysogenum. This “wonder drug” has literally saved millions of 
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lives and sparked an era of fungal-derived medicines (Tulp and Bohlin, 
2004). Penicillin G (Figure 1.4), the original metabolite isolated, is still a 
front-line antibiotic for some common bacterial infections, although its 
effectiveness is now limited by the development of penicillin-resistant gram-
negative bacteria.  
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Figure 1.4: Penicillin G 
 
The phenomenal success of penicillin led to the intensive search for other 
antibiotic-producing micro-organisms. The search was not limited to fungi, 
but also included bacteria and actinomycetes. For example, tyrothricin, a 
mixture of two antibiotics gramicidin and tyrocidin, was isolated from 
Bacillus brevis in 1939. Actinomycin was the first antibiotic isolated from 
actinomycetes in 1941, followed by streptomycin (Figure 1.5) which was 
isolated from Streptomyces griseus in 1942 (Benita, 1994). The concept of 
fermentation products as a productive source of new antibiotics was 
validated after the discovery of streptomycin in 1943 (Kirst, 1996). 
      
 actinomycin streptomycin 
Figure 1.5: Actionomycin and streptomycin 
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The clinical uses of microbial natural products are not limited to antibiotics, 
and as such antiviral and antifungal agents have also been developed (Strohl, 
2000). Recent, newer developments of natural product-based drugs include 
anti-diabetic, anticancer, immunosuppressive, and anti-malaria drugs 
(Harvey, 2000).  
Most of the natural products that enter pharmaceutical markets today are 
derived from terrestrial micro-organisms. A classic example would be 
“Augmentin” which is a combination of clavulanic acid and amoxicillin 
(Figure 1.6). These natural products are derived from Streptomyces 
clavuligerus and the Penicillium nucleus respectively.  
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  clavulanic acid      amoxicillin  
Figure 1.6: Clavulanic acid and amoxicillin 
Mevastatin (Figure 1.7) and lovastatin (Figure 1.8), which were originally 
isolated from Penicillium citrinum and Aspergillus terreus respectively, 
were the lead compounds for many cholesterol-lowing agents that have 
combined annual sales of more than US$ 16 billion dollars in 1999 (Alberts 
et al. 1980; Butler, 2004; and Malik et al. 2006). 
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       Figure 1.7: Mevastatin  Figure 1.8: Lovastatin 
 
1.2.2 Fungal secondary metabolites 
 
Fungi are prolific producers of secondary metabolites. In 1971 Turner 
determined that there were almost 1,000 fungal products but this had more 
than doubled by the next decade (Turner and Aldridge, 1983). To date more 
than 6,000 different metabolites have been reported from fungi (Zain et al. 
2009). Some of the fungal metabolites that have been known for a long time 
are finding new and unexpected uses in medicine today. A recent example is 
mycophenolic acid, (Figure 1.9) first isolated from the fungus Penicillium 
brevicompactum by Gorsio in 1896, for which the structure was not reported 
until 1952. Mycophenolic acid was developed as an immunosuppressive 
agent in 1995. In addition a synthetic pro-drug, mofetil (Figure 1.10) which 
is based on mycophenolic acid, as it liberates mycophenolic acid under 
physiological conditions, is now commercially available (Pearce, 1995).  
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Figure 1.9: Mycophenolic acid  Figure 1.10: Mofetil 
 
While the need for new bioactive compounds is increasing, the yield of 
potentially useful new bioactive natural products from microbial sources is 
declining (Perric-Concha and Long, 2003). Part of this problem stems from 
the repeated discovery of known compounds due to the heavy reliance on 
soil actinomycetes and common soil fungi as the source of bioactive 
metabolites.  
In terms of biodiversity, fungi are the second largest group of organisms in 
the world after insects. Hawksworth (1991) estimated the actual number of 
fungal species could be up to 1.5 million. This is over five times the 
predicted number of plant species and 50 times the estimated number of 
bacterial species. However, less than 5% of the fungal species have so far 
been described and of this 5% only a fraction have been examined for 
natural product production. Among the fungi, the Ascomycetes represent the 
largest group of fungi, but they remain relatively unexplored (Kendrick, 
1992).  
Soil has been one of the most highly investigated sources of micro-
organisms for the discovery of novel compounds because it carries a higher 
population of micro-organisms than any other habitat (Whitman et al. 1998). 
New Zealand has many diverse soil ecotypes ranging from hot muddy soils 
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in geothermally active regions to icy cold soils of mountains and glaciers. 
The soils of the temperate rain-forests also offer much potential in terms of 
microbial diversity. 
 
 
1.3 ASCOMYCOTA  
 
The phylum Ascomycota is the largest phylum of fungi with over 30,000 
species (Hawksworth and Kalin-Arroyo, 1995). Both the Ascomycota and 
Basidiomycota share a number of important features such as a chitinous cell 
wall, formation of septate hyphae, hyphae fused with one another to 
exchange nuclei, and the presence of a dikaryotic phase (Glass and Nelson, 
1994 and Kendrick, 1992).  
The Ascomycota is distinguished from the Basidiomycota by the production 
of meiospores (ascospores) formed within sac-shaped cells (asci) which may 
or may not be produced within a sporocarp (ascoma). Hence, they are 
commonly known as sac-fungi (Blackwell and Spatafora, 2004).  
 
1.3.1 Classification of Ascomycota 
 
Ascomycetes are divided into three monophyletic subphyla (Lutzoni amd 
Kauff, 2004; James et al.  2006 and Hibbett et al.  2007):-  
Subphylum Taphrinomycotina (formerly Archiascomycetes) is resolved as 
the earliest diverging clade; it includes a diverse group of species that 
exhibit yeast-like and dimorphic forms. 
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Subphylum Saccharomycotina (formerly Hemiascomycetes) is comprised of 
the true yeasts such as Saccharomyces cerevisiae and Candida albicans. 
Subphylum Pezizomycotina (formerly Euascomycetes) is the largest 
subphylum comprising the majority of species that produce hyphae and 
ascocarps (fruiting bodies). All of the fungi presented in this thesis are 
members of this subphylum.  
 
1.3.2 Ecology and significance of Ascomycetes 
 
Some of the Ascomycota are known to be pathogenic causing diseases to 
plants, animals and humans. Some of the most common infections to 
humans are dandruff and athlete’s foot. Some fungi, however, can cause far 
more devastating diseases which have very high associated mortality rates 
such as, invasive aspergillosis (caused by Aspergillus sp.), candidosis 
(caused by Candida sp.) and Pneumocystic pneumonia (caused by 
Pneumocystis jiroveci.) (Sullivan et al.  2005). Furthermore, many plant 
diseases have been noted that are caused by Ascomycetes. For example, 
powdery mildew fungi of many crop plants, Dutch Elm Disease, (caused by 
the closely related species Ophiostoma ulmi and Ophiostoma novo-ulmi) and 
Ergot (caused by Claviceps purpurea) (Deacon, 2006). Nevertheless, 
Ascomycota have been utilized in the food processing and manufacturing 
world. For example, baker’s yeast Saccharomyces cerivisiae is used to make 
bread, beer and wine. Another example is the enzyme of Penicillium species, 
the enzyme from Penicillium camemberti played a role in the manufacture of 
the cheeses Camembert and Brie, while those of Penicillium roqueforti do 
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the same for Gorgonzola, Roquefort and Stilton cheese. Apart from the food 
processing aspect, they also play a role in the production of valuable 
commodities such as antibiotics, enzymes, vitamins and pharmaceutical 
compounds (Murphy and Horgan, 2005). A classic example is the discovery 
of penicillin in 1928. Another example of a commercial medicine isolated 
from Ascomycota is that of the ergot alkaloids and related toxins of the ergot 
fungus, Claviceps purpurea, which have many important pharmacological 
applications. An example includes the antimigraine drug “cafergot” which 
consists of ergotamine and caffeine (Figure 1.11) Diener et al. (2002).  
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  ergotamine    caffeine 
Figure 1.11: Ergotamine and caffeine 
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Various types of antifungal agents are also produced by Ascomycota. For 
example, a glucan synthesis inhibitor such as echinocandin B (Figure 1.12) 
was produced by Aspergillus nidulans. Protein synthesis inhibitors such as 
sodarin (Figure 1.13) and xylarin (Figure 1.14) were derived from Sordaria 
araneosa and Xylaria sp. respectively. 
 
N
NH
N
NH
HN
NH
N
H
O
O
O
O
O
O
O
OH
OH
HO
OH
OH
OH
OH
OH
H
O
H
H
H
 
Figure 1.12 Echinocandin B 
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Figure 1.13 Sordarin                      Figure 1.14 Xylarin 
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1.4 SELECTIVE ISOLATION TECHNIQUES 
 
In the past, routine soil sampling has yielded many natural products, but 
often these have been obtained from easily accessible and culturable 
organisms while the lesser, or non-culturable variants remains an untapped 
resource. One reason for this is that the isolation strategies employed have 
not allowed the less culturable organisms to compete with the more easy 
accessible and culturable organisms. Moreover, most isolation media allows 
for the growth of only a selected group of strains and inhibits the majority of 
the natural population (Knight et al. 2003). Undoubtedly, isolation strategies 
for the less readily culturable organisms would enhance the potential for the 
discovery of novel biotypes and new bioactive compounds.  
 
1.4.1 Isolation techniques for soil fungi 
 
There are various methods used to isolate fungi from soil. The standard 
methods are the ‘suspension plating method’ and the ‘soil dilution method’. 
These methods are simple and rapid, but yield a large number of fungal 
isolates. Another method which has been used in the past and still widely 
used today is the ‘Warcup soil plate method’.  
In this method finely pulverized soils are dispersed into a sterile Petri dish. 
Molten agar is poured over the soils and then quick, but gentle, agitation of 
the plates ensures that the soil is mixed with the agar thoroughly. The yield 
of this method is similar to the suspension plating method, but may also 
12 
Chapter 1: Introduction 
 
yield basidiomycetes which are not recovered by the suspension plating 
method (Warcup, 1950). One disadvantage of the Warcup soil plate method 
is that young colonies which are embedded in agar are difficult to isolate. 
Fungi derived using the methods described above originate either from 
spores, or mycelial fragments. Mycelial derived isolates can be enhanced by 
using a particle filtration technique (Gerald et al. 2004). 
All of the above methods rapidly produce large numbers of isolates over a 
wide range of species that grow readily in culture. Unfortunately, high 
propagule densities of fast growing fungi can interfere with the isolation of 
the rarer and/or slow growing species (Gerald et al. 2004).  
 
1.4.2 Selective isolation methods for soil fungi 
 
Many isolation methods have been introduced for the selection of certain 
groups of fungi. The baiting technique is such a method. In this technique an 
organic substratum is enriched nutritionally and then placed in contact or 
mixed with soil thought to contain target organism(s). This method can be 
biased towards animal or plant pathogenic fungi. For example, using 
cellulose baits tends to be selective for plant pathogenic fungi; keratin baits 
for animal pathogenic fungi and chitin baits are more selective for 
entomopathogenic fungi. 
Several partial pasteurization methods using either physical pasteurization 
factors such as dry heat or steam, or chemical treatments, either singly or in 
combination have been applied for selective recovery of ascomycetes and 
basidiomycetes from soil habitats (Bills and Polishook, 1993).   
13 
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During the 1940s and 1950s studies on chemical activation of dormant 
ascospores were conducted in conjunction with selective isolation methods 
for ascomycetes. Warcup (1951a) proposed that short steam treatment or an 
alcohol wash favoured isolation ascosporic Eurotiales, Sordariales and other 
ascomycetes from soils.  The effectiveness of these methods was confirmed 
by Mahoney (1972). He also found that these treatments decreased the 
frequency of isolation of mucoraceous fungi and fungi with thin-walled 
propagules and increased the population of ascosporic fungi. Many chemical 
compounds have been studied for their influence on ascospore germination. 
For example, sodium acetate was used by Asina et al. (1977) to induce the 
ascospore germination of Sporomiella sp. 
In 1970 Lingappa et al. developed a phenol technique to activate ascospore 
germination. Weber and Hess (1976) also used a phenol technique to study 
the physiology of constitutive dormancy and germination of ascospores. A 
more detailed of study was carried out by Furuya and Naito (1980) on 
stimulation of ascospore germination by phenolic compounds. In total 36 
Phenol derivatives and 26 organic compounds were tested on 37 fungal 
species. In their study, two phenol concentrations were used, (1×10-3 M and 
1×10-4 M), and 14 out of the 37 fungal species were found to respond to 
phenol within this concentration range. Moreover, the stimulating effect of 
phenol was restricted to sordariaceous fungi. For phenol derivatives and 
other organic compounds the results showed that 10 out of 62 compounds 
had an effect on ascospore germination. Of those 10 compounds, one was 
phenol and the rest were para-substituted phenol derivatives. However, 
phenol was shown to be the most effective in activating many dormant 
14 
Chapter 1: Introduction 
 
ascospores to germinate. In this study a modified phenol pasteurization 
technique was used based on the acetic acid treatment method of Furuya and 
Naito (1979a) in an attempt to select Ascomycetes from New Zealand soils 
that would not normally be isolated using other methods. 
 
 
1.5 MANIPULATION OF THE FUNGAL METABOLITE 
PRODUCTIONS  
 
Apart from the attempt to access the biodiversity and explore untapped 
natural resources for discovering novel bioactive compound, another option 
is to elevate metabolite production by influencing the biosynthetic pathways 
for the production of secondary metabolites. It is believed that secondary 
metabolite production is affected by various kind of environmental stress.  
Even minor variations in the environment or nutrition have the potential to 
impact on the quantity and diversity of the secondary metabolites produced 
(Bills et al. 2008; Zain et al. 2009). 
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1.5.1 One Strain Many Compound (OSMAC) approach 
 
Bode et al. (2002) stated that fungi or bacteria that produce secondary 
metabolites have the potential to biosynthesise a wide variety of compounds 
from a single strain. A systematic alteration of cultivation parameters such 
as media composition, aeration, temperature, culture vessel, or addition of 
enzyme inhibitors could possibly increase the range and number of 
secondary metabolites produced by one microbial source. This strategy is 
termed the One Strain-Many Compounds (OSMAC) approach. This 
approach has been applied in many recent studies (Bode et al. 2000a). 
Simplest work using the OSMAC approach was carried out by Paranagama 
et al. (2007). In this study the change from tap water to distilled water 
showed an alteration of metabolite productions in Paraphaeosphaeria 
quadriseptata and Chaetomium chiversii. An alteration of the fermentation 
conditions also has an effect the metabolite productions in fungi, Bode et al. 
(2000a) showed that Sphaeropsidales species produce more metabolites 
simply by changing the culture condition from a shaking fermentation to a 
static fermentation. Another example of an OSMAC approach is by the 
addition of organic and/or inorganic compounds into the media. This 
approach also induced secondary metabolite production in Streptomyces sp. 
(Grond et al. 2002). 
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1.5.2 Hormesis 
 
As a result of the many studies conducted it has been concluded that a 
modulation in cell transcription occurs in the presence of antibiotics or 
inhibitors at low concentration. In this situation they act as signalling rather 
than inhibiting agents (Hoffman et al. 2005; Linares et al. 2006 and Yim et 
al. 2006). The use of subinhibitory concentrations of these elicitors is based 
on the concept of hormesis which was defined as low-dose stimulation and 
high-dose inhibition (Calabrese and Baldwin, 2002). This is an adaptive 
response of organisms to low levels of stress or damage. The use of elicitors 
such as antibiotics and cytoskeleton inhibitors at subinhibitory 
concentrations has been shown to alter secondary metabolite production in 
actinomycetes, bacteria and fungi. For example, the presence of tetracycline 
in the media was found to induce phenazine production in a marine 
Streptomyces sp. (Mitova et al. 2008a). The use of an actin stabilizer such as 
jasplakinolide was found to induce the production of chaetoglobosin in 
Phomospis asparagi (Christian et. al. 2005). The intention of the studies 
carried out in this thesis were to explore and studiy the OSMAC approach 
and hormesis in greater detail. 
 
 
 
 
 
 
17 
Chapter 1: Introduction 
 
1.6 SCOPE OF PRESENT STUDY 
 
The main goals of the present study were:-  
1) The development of a selective isolation technique for less readily 
isolatable fungi from soil, especial Ascomycetes. The phenol 
pasteurization technique was used as a selective isolation technique 
for Ascomycetes in soil samples collected from various locations 
around New Zealand.  
2) Chemical characterization of metabolites from fungal extracts. Small 
scale cultivation of isolates of fungi was undertaken. The fungal 
extracts were screened for biological activity such as cytotoxicity and 
antimicrobial activity. The chemical separation in active extracts was 
aided by HPLC. Chemical characterization of metabolites of after 
separation active extracts was greatly aided by dereplication 
techniques whereby a combination of HPLC-UV/Rt database, MS 
analysis, the CapNMR technique and AntiMarin database were used.   
3) Maximize metabolic production and induce the production of 
metabolites. The effect of culture conditions (both physical and 
chemical) were undertaken based on the OSMAC (One Strain Many 
Compounds) and hormetic (low-dose stimulation and high-dose 
inhibition) approach.  
18 
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Chapter 2 
 
Experimental 
 
2.1   ORIGIN OF SOIL SAMPLES 
 
Soil samples from various locations in New Zealand were collected by Mr. 
Craig Galilee and Nic Cummings of the School of Biological Sciences, 
University of Canterbury. Eleven randomly selected soil samples were used 
for the isolation of fungi using the phenol treatment method as shown in Table 
2.1.  
 
Table 2.1: Origin of soil samples 
 
Soil codes Location Date of isolation 
151 Fox Glacier (submerged soil) 13-Jan-2006 
381 Arthurs Pass (stream edge) 13-Jan-2005 
418 Bay of Plenty (inside cotton log frass) 24-Jan-2006 
456 Bay of Plenty (river edge soil) 31-Jan-2006 
654 Nelson 31-Jan-2006 
701 Tasman walk site 1 24-Jan-2006 
702 Tasman walk site2 19-Jan-2006 
770 Eves Bush, Nelson (inside cotton tree stump) 19-Jan-2006 
901 Tiromoana Bush site 1 05-Oct-2007 
902 Tiromoana Bush site 2 05-Oct-2007 
903 Tiromoana Bush site 3 05-Oct-2007 
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2.2 ISOLATION AND CULTIVATION MEDIA 
 
Malt Yeast Peptone Agar (MYPA) and ¼ strength of Sabouraud Dextrose 
Agar  
( ¼ SDA) were used for the isolation and cultivation of the fungi, see 
Appendix I. 
 
 
2.3 PHENOL PASTEURIZATION OF SOIL 
 
Method 
• 5.0 g of soil sample was placed in each of four sterile 125 mL 
conical-flasks labeled; 0, 2, 3, 4, 5, 6, 7, 8.  
• Soil in flask labeled 0 was treated with 20 mL sterile distilled water 
(control). Soils in flasks 2, 3, 4, 5, 6, 7, 8 were treated with 20 mL 
of 2%, 3%, 4%, 5%, 6%, 7% and 8% phenol solution in sterile 
distilled water respectively. 
• Flasks were agitated on a reciprocal shaker for five minutes and 
followed by 15 minutes settling time.  
• The supernatant was discarded and the soil rinsed twice with 5 mL 
sterile distilled water, and then 5 mL sterile distilled water was 
added to the washed soil to make a soil suspension. 
• Treated soil suspension (0.7 mL) was pipetted into an 85 mm Petri 
dish. 15 mL of Sabouraud Dextrose Agar plus antibiotic solution 
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(SDA+) (section 2.3) was dispensed over the suspension. Seven 
replicate plates were prepared for each sample. 
• Each plate was agitated gently in order to mix the suspension with 
the molten agar. 
• After the agar had set, the plates were incubated at; 5 °C, 10 °C, 15 
°C, 20 °C, 25 °C, 30 °C and 37 °C in the darkness. A flow-chart of 
the method used is given in Figure 2.1.  
For the control (0% phenol treatment without soil suspension), 0.7 mL sterile 
distilled water was pipetted into an 85 mm Petri dish and mixed with 15 mL of 
SDA+; seven replica plates were prepared. When the agar solidified, these 
plates were also incubated at; 5 °C, 10 °C, 15 °C, 20 °C, 25 °C, 30 °C and 37 
°C, in darkness.  
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Add 20ml of 2%, 3%, 4%, 5%, 6%, 7% or 8% 
phenol soln 
Add 20ml sterile distilled 
H2O 
-Agitate flasks on a shaker for 5 minutes 
-Allow the soil to settle for 15 minutes 
Aqueous layer yer Solid la
(Phenol) Rinse twice with 5 mL sterile 
distilled water 
Aqueous layer Solid laDiscard in phenol 
waste container 
yer 
Add 5 mL sterile 
distilled water
Discard in phenol 
waste container
Pipette 0.7 mL of treated soil 
suspension into Petri dish 
Dispense 15 mL of molten SDA+ over 
the soil suspension and agitate to 
disperse soil particles evenly 
Incubate at 5 C°, 10 C°, 15 C°, 20 C°, 25 C°, 30C° 
and 37 C° in the darkness  
Figure 2.1: Phenol pasteurization method 
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2.4 CULTURING METHODS 
 
2.4.1 Selection and culture of fungi 
 
Plates were observed for colonies at 3, 7, 14, 21 and 28 day  intervals. All 
colonies present on the master plates were sub-cultured onto 85 mm Petri dishes 
containing 20 mL of SDA+ and incubated as indicated previously. Colonies 
from 7, 14, 21 and 28 day incubation plates were chosen for sub-culturing to 
SDA plates to obtain axenic cultures. 
 
2.4.2 Storage of fungal cultures 
 
Discs (4 mm in diameter) were cut from the growing margin of seven day old 
fungal colonies grown on malt-yeast-peptone agar plates (MYPA; Appendix I). 
Seven discs were placed into a 1.5 mL microfuge tube containing 10% glycerol 
in distilled water and stored overnight at -20 °C before transferred to -80 °C for 
long-term storage. 
 
2.4.3 Fermentation methods 
 
2.4.3.1 Solid phase fermentation 
 
Seven day pure cultures from growth at 20 °C, 25 °C, 30 °C or 37 °C were 
selected for solid phase fermentation. Inoculum was prepared by cutting agar 
discs, 4 mm in diameter, from the margin of a colony. The inoculum disc was 
inverted onto the centre of an 85 mm Petri dish containing 20 mL of MYPA. 
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Inoculated plates were incubated under the same conditions as their master plate 
for 30 days. For each isolate, three replicate experiments were carried out.  
 
2.4.3.2 Liquid phase fermentation 
 
Two broth media were used; ¼ Sabouraud dextrose broth (SDB; Appendix I) 
and Malt Yeast Peptone Broth (MYPB; Appendix I). Medium (15 mL) was 
dispensed in universal bottles and inoculated with two inoculum discs. The 
universal bottles were either held static or shaken on a reciprocal shaker at 125 
rpm, or a mixture of shake/static (four replicates per condition). For the 
shake/static incubation, the first half of the incubation period was shaken as 
outlined previously and the second half of the incubation period was kept static. 
Incubation was carried out for 20 days and 30 days at  20  °C   and 25  °C   in 
the darkness. A summary of the liquid phase fermentation conditions is given in 
Table 2.2.  
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Table 2.2: Liquid phase fermentation conditions 
Media Temp  ( °C  ) 
Inoculation 
period 
(Day) 
Conditions replicates 
static 4 
shaken 4 20 
½ shaken ½ static  4 
static 4 
shaken 4 
20 
30 
½ shaken ½ static 4 
static 4 
shaken 4 20 
½ shaken ½ static 4 
static 4 
shaken 4 
MYPB
25 
30 
½ shaken ½ static 4 
static 4 
shaken 4 20 
½ shaken ½ static 4 
static 4 
shaken 4 
20 
30 
½ shaken ½ static 4 
static 4 
shaken 4 20 
½ shaken ½ static 4 
static 4 
shaken 4 
SDB 
25 
30 
½ shaken ½ static 4 
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2.5 IDENTIFICATION OF FUNGI 
 
Colonies of isolated fungi were examined under a stereoscopic microscope and 
morphological features of the mycelium and reproductive structures examined 
using a compound microscope with magnification up to 400×. Higher resolution 
images of these features were obtained using a scanning electron microscope 
(SEM). Fungi were identified in consultation with Assoc. Prof. Tony Cole and 
Dr. Nic Cummings. 
For the scanning electron microscope specimen preparation, a mounted stub 
with double sided sticky tape was plunged into the culture area bearing 
reproductive structures. The specimen was then coated with a thin coating of 
gold palladium (Au-Pt) using a Polaron E5000 coater with the following 
conditions: 1.2 KV at 20 mA for 2 minutes. Micrographs were taken by a 
Lieca S440 at 10 kV and 80 pA. The working distance was approximately 10 
mm.  
 
2.6 PREPARATION OF CULTURE EXTRACTS 
 
2.6.1. Solid phase extraction 
 
Agar from plates with fungal cultures were macerated with 30 mL HPLC grade 
ethyl acetate (EtOAc) using an Ultra-turrax®. This extraction process was 
carried out three times. The agar slurry was left sitting overnight for the first 
EtOAc extraction, and eight hours each for the second and third extractions. All 
three EtOAc extracts were combined and transferred to a pre-weighed vial and 
Chapter 2: Experimental 
 
 
 27
air dried to yield a crude extract. Crude extracts were prepared to a 
concentration of 1 mg/mL in HPLC grade methanol for bioassays. The 
procedure for the solid phase extraction process is summarised in Figure 2.2.   
Fungi on Solid media 
Homogenised with 30 mL EtOAc 
Soaked for 8 hours 
Liquid layer (EtOAc extract) Solid layer (Agar + Fungi) 
Decant into a 
pre-weighed 
vial 
Soaked with 30 mL EtOAc 
for 8 hours  
Liquid layer Solid layer 
Liquid layer Solid layer 
 
Figure 2.2: Solid phase extraction method 
 
2.6.2. Liquid phase extraction 
 
Two universal bottle cultures were combined and transferred into a 50 mL 
Pyrex® centrifuge tube with a round bottom and homogenised using an Ultra-
turrax® for three minutes, or until the inoculum agar discs and mycelial mat 
were sufficiently macerated. The mixture was filtered through Whatman® filter 
paper grade No. 1 under suction to separate mycelium and broth. The filtrate 
broth was subsequently extracted three times with EtOAc at a ratio of 3:1 (30 
mL EtOAc per 10 mL filtrate). The mycelial residue was re-suspended in 
EtOAc at a ratio of 1:5  (100 mL EtOAc per 20 g wet weight mycelium) and 
extracted three times. The initial EtOAc extraction was left to settle overnight 
Discard 
Air dry 
Soaked with 30 mL 
EtOAc for 8 hours 
Crude Extract 
Prepared to 1 mg/mL 
concentration in methanol 
for bioassays 
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and the second and third for eight hours. All organic phases were combined and 
air dried to yield a crude extract. Crude extracts were prepared to 1 mg/mL 
concentration in methanol for further bioassays. 
 
2.7 BIOASSAYS 
 
Extracts were initially screened in a preliminary quick screen assay. Crude 
extracts (1 mg/mL concentration in HPLC grade methanol) were used for 
quick screen bioassays. An aliquot of each extract was pipetted into individual 
wells of a 96-well microtitre plate. For the cytotoxicity quick screen, 5 µL per 
sample was assayed against the murine leukaemia cell line P388 (ATCC CCL 
46, P388D1). For the antimicrobial quick screens, 10 µL per sample were used 
to test against Bacillus subtilis and Pseudomonas aeruginosa, while 20 µL per 
sample was used to test against Candida albicans.  
 
2.7.1 Cytotoxicity (P388) assay 
 
2.7.1.1  P388 Quick screen assay 
 
Crude extracts were first subjected to the quick screen assay. In this assay, 
P388 cells (8.4×104 cells/mL) were incubated with each crude extract for 72 h 
at 36 °C. Cell viability was determined colorimetrically by the addition of a 
yellow dye, MTT tetrazolium. Unhealthy or dead cells cannot metabolise this 
dye, thereby, leaving a yellow colour. Healthy cells are able to reduce the dye 
to MTT formazan resulting in an intense purple colour (Figure 2.3). The UV 
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absorption of each sample was measured at 540 nm and compared with the 
UV absorption of a control cell. Results were expressed as the percentage of 
cell growth compared to normal cell growth. Those samples showing good 
activity in the P388 quick screen (<20% cell viability) were subsequently 
subjected to a further assay to determine the concentration required to inhibit 
the growth of P388 cells by 50% (IC50) (Perry et al. 1999). Samples were also 
separated and analysed by high pressure liquid chromatography (HPLC). 
N N
+
N
N
S
N
                               
MTT tetrazolium salt (yellow) MTT formazan (purple) 
N N
N
H
N
S
N
 
Figure 2.3: Reduction of the yellow MTT fetrazolium salt to the purple MTT 
formazan by health P388 cells. 
 
2.7.1.2 IC50 assay 
 
Active crude extracts were prepared at a concentration of 10 mg/mL in HPLC 
grade methanol and assayed. This assay requires a serial dilution of the sample 
of interest followed by incubation for 72 h with P388 cells (Figure 2.4). The 
growth indicator was the same as that used in the P388 quick screen assay. 
The result is expressed as an IC50 in ng/mL.  
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Figure 2.4: P388 assay dilution plate: purple indicates viable cells and yellow 
indicates dead or unhealthy cells. 
 
2.7.2  Antimicrobial assay 
 
Bacterial and fungal suspensions were prepared in Roswell Park Memorial 
Institute-1640 medium (RPMI-1640). The density of cells was measured at 600 
nm and adjusted to an optical density (OD) of 0.04 for B. subtilis, and 0.05 OD 
for P. aeruginosa and C. albicans. 200 µL of the bacterial or fungal 
suspension was incubated with each crude extract for 24 h at 30 °C . The cell 
viability was determined colorimetrically by the addition of the blue dye, 
resazurin. Resazurin is a growth indicator and the presence of bacteria or fungi 
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is indicated by oxygen emission which reacts with resazurin, generating a pink 
colour. The UV absorption of each sample was read at 600 nm and compared 
against the UV absorption of the control media. Results are given as a 
percentage of cell viability (Lang et al. 2006). Crude extracts which had a 
result less than 10%; i.e. 90% of bacterial or fungal cells were killed by the 
crude extract, were noted and analysed by HPLC. 
 
2.7.3 HPLC microtitre plate screening 
 
An aliquot of the crude extract (250 µL) was analysed by reversed phase C18 
HPLC (solvents (A) H2O + 0.05% formic acid, (B) ACN) using the following 
standard gradient solvent system: 2 minutes of 10% ACN/H2O; a linear gradient 
to 75% ACN/H2O for 12 minutes; isocratic at 75% for another 10 minutes; a 
linear gradient to 100% ACN for 4 minutes then returned to 10% ACN/H2O 
over 2 minutes and re-equilibrated for 8 minutes. The flow rate was 1 mL/min at 
40  °C. The eluant from the HPLC column was collected into a master plate, 96-
well polystyrene microtritre plate, with a total of 88 wells being collected and 
each well containing a total of 250 µL. A daughter plate was prepared by 
transferring 50 µL aliquots from each well of the master plate. After complete 
evaporation of the solvent, using a centrifugal evaporator, the plates were 
screened in the P388 assay. In the antimicrobial screens, the master plate was 
used directly after evaporation of the solvent. No daughter plates were made up. 
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2.8 ISOLATION AND IDENTIFICATION OF ACTIVE 
COMPOUNDS 
 
As part of the isolation and identification process all small scale extracts were 
initially examined by HPLC to separate the compounds in the crude extracts. 
Mass spectrometry (MS) analysis was carried out to attempt to determine 
molecular mass of each compound. Pure compounds were subjected to 
Nuclear Magnetic Resonance (NMR) spectroscopy for the structure 
elucidation. 
 
2.8.1 HPLC screening of metabolites 
 
Crude extracts were prepared at a concentration of 1 mg/mL in HPLC grade 
methanol.  All samples were filtered through 0.45 µm polytetrafluoroethylene 
(PTFE) membrane filters immediately prior to injection. An aliquot of the 
crude extract (30 µg) was analysed by analytical HPLC on a reverseed phase 
column (Phenomenex Luna C18, 10×250 mm, 5µm; Solvents: (A) H2O + 
0.05% TFA, (B) ACN) using the standard gradient solvent system (see 
Section 2.7.3). 
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2.8.8.1 Separation of extract F9330  
 
All other extracts were screened using the standard gradient (see Section 
2.7.3) except extract F9330 as in this case the metabolite peaks, which eluted 
over the period Rt 8.0-10.0 min, were not separated by the standard gradient. A 
25-40% gradient was developed for this particular extract: 2 minutes of 10% 
ACN/H2O; a linear gradient to 20% ACN/H2O for 3 minutes; a linear gradient 
to 25% ACN/H2O for 7 min; a linear gradient to 40% ACN/H2O for 8 min; a 
linear gradient to 75% ACN/H2O for 2 min; isocratic at 75% for another 10 
minutes; a linear gradient to 100% ACN for 4 minutes then returned to 10% 
ACN/H2O over 2 minutes and re-equilibrated for 8 minutes. 
 
2.8.2 Electrospray ionization mass spectrometry (ESIMS) 
 
High Resolution Electrospray Ionization Mass Spectra (HRESIMS) were 
obtained on a Kratos MS80RFA spectrometer, operating with a 4 kV 
accelerating potential, 70 eV and a source temperature of 250 °C. HRESIMS 
were recorded on a Micromass LCT spectrometer using a probe voltage of 
3200 V, an operating temperature of 150 °C  and a source temperature of 80 
°C. The carrier solvent was 50:50 ACN/H2O at 20 µL/min (for direct inject 
mode). A 10 µL injection of sample was made from a 10 µg/mL stock solution. 
When obtaining positive ESI mass spectra, some samples were protonated 
with 10 µg/mL formic acid prior to injection. When recording negative ESI 
mass spectra, samples were deprotonated, as required, with 10 µg/mL DEA 
prior to injection. 
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2.8.3 Liquid chromatography mass spectrometry (LCMS) 
 
High Resolution Liquid Chromatography Mass Spectra (HRLCMS) were 
recorded on a Waters 2790 HPLC system equipped with a Waters 996 
photodiode array (PDA) detector coupled to a Micromass LCT spectrometer 
using a probe voltage of 3200 V, an operating temperature of 150 °C and a 
source temperature of 80 °C. The carrier solvent was 50:50 ACN/H2O at 20 
µL/min (for direct inject mode). A 10 µL of a 10 µg/mL solution was injected. 
Leucine enkephalin was used as the internal standard.  
 
2.8.4 Nuclear magnetic resonance (NMR) spectroscopy 
 
Samples used in this analysis were obtained from analytical HPLC microtitre 
plate collection using the standard method given in Section 2.7.3 except that 
the eluant was collected into a polypropylene microtitre plate instead of the 
polystyrene microtitre plate. Master plates were dried using centrifugal 
evaporation; no daughter plates were made. 1H, correlation spectroscopy 
(COSY), heteronuclear single quantum coherence (HSQC), heteronuclear 
multiple bond correlation spectroscopy (HMBC) and nuclear overhuser effect 
(NOE)  NMR experiments were all recorded on a Varian INOVA 500 
spectrometer at 23 °C, operating at 500 MHz. The INOVA was equipped with 
a variable temperature and capillary NMR probe (Figure 2.4). Chemical shifts 
are expressed in part per million (ppm) on the δ scale, and were referenced to 
the appropriated solvent peaks:  
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∑ protons (solvent – A)   
    ∑ protons (solvent) 
CDCl3 referenced to CHCl3 at δH 7.25 ppm (1H) and CHCl3 at δC 77.0 ppm 
(13C); 
CD3OD referenced to CHD2OD at δH 3.30 ppm (1H) and CHD2OD at δC 49.3 
ppm (13C); 
DMSO-d6 referenced to CD3(CHD2)SO at δH 2.50 ppm (1H) and (CD3)2SO at 
δC 39.6 ppm (13C). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Protasis capillary NMR probe. 
 
The pure compound obtained from the method described in Section 2.7.3 was 
dissolved in 6 µL of CD3OD and injected into an inlet capillary via a syringe. 
This was then followed by an injection of 11 µL of deuterated MeOH to 
position the sample in the probe. All samples were retrieved into HPLC vials 
or inserts that were silated as described in Section 2.8.5. The quantity of the 
compound in each well (A) was estimated according to the formula below.  
 
                         A (µg) =     
Molecular weight of A   
                                         ×                                        × 0.35 
                                                           ∑ protons of A 
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2.8.5 Silanization of glassware surface for CapNMR 
 
Due to the low concentration of sample analysed in CapNMR, all glassware 
used in CapNMR analyses were deactivated the surface to minimize 
adsorption in sample. All glassware was immersed into dimethyldichlorosilane 
(DMDCS) solution (5% DMDCS in dichloromethane (DCM)) for 15 min. 
After pouring off the deactivating solution the glassware was immediately 
rinsed with DCM and then immediately immersed in MeOH for 15-30 mins. 
This step was performed immediately in order to minimize exposure to 
moisture in the air. The MeOH was drained off and the glassware was dried in 
a 100 °C oven until completely dry. The DMDCS solution was freshly 
prepared before use. 
 
2.8.6 Solvents 
 
All solvents used in the chromatographic techniques were HPLC grade. 
Analytical grade solvents were used for other analyses.  
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Chapter 3 
 
Development of a selective isolation 
technique for Ascomycetes 
 
 
3.1 INTRODUCTION 
 
Several isolation techniques have been developed and employed for 
isolating slow-growing fungi and eliminating fast-growing fungi. These 
include physical treatments. Steam treatment has been found to be an 
effective method for isolation of Ascomycetes (Warcup, 1951a), however, it 
does not favour the isolation of Chaetomium sp. or Sordariaceae (Warcup, 
1951a). Furthermore, many studies have reported that the soil-steaming 
method only gives an initial depression of the growth of Mucorales and does 
not eliminate them permanently (Tam and Clark, 1943 and Martin, 1950). 
Various chemical agents have also been used in partial sterilization and 
some disadvantages have been reported. Formalin was found to be a very 
effective agent to eliminate fast-growing fungi, but the growth of fungi on 
the isolation plates is very slow and time consuming (Warcup, 1951b). 
Ethanol is another agent that has been used in a partial sterilization method 
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(Bills and Polishook, 1993) but resulted in a lot of sterile strains rather than 
ascosporic fungi being isolated. In the study by Furuya and Naito (1979b), 
ethanol was used as a selective isolation agent with the addition of sodium 
acetate as an ascospore germination stimulator. The effectiveness of the use 
of ethanol as a selective isolation method was therefore somewhat confused. 
Acetic acid, which was shown to stimulate ascospore germination (Butler, 
1956) was found to be effective for the isolation of Ascomycete genera such 
as Chaetomium, Eupenicillium, Gelasinospora, Sordaria and Talaromyces 
(Furuya and Naito, 1979a). This study showed similar results to the present 
phenol study. 
 
 
3.2 ISOLATION OF FUNGI 
 
 
3.1.1 Colony growth  after phenol pasteurization  
 
All 11 soil samples were treated with a range of phenol concentrations (2% 
to 8%) and plated out as described in Chapter 2. Colonies were counted and 
recorded after 3, 7, 14, 21 and 28 days incubation see (Table I-XI, 
Appendix II). Average colony numbers after 3, 7 and 14 days incubation for 
these 11 soil samples after phenol treatment are given in Figures 3.1-3.3.  
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Figure 3.1: Average colony numbers at 3 days 
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Figure 3.2: Average colony numbers at 7 days 
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Figure 3.3: Average colony numbers at 14 days 
 
 
After 3 days incubation the untreated soil plates (0% phenol treatment) were 
overrun by mucoraceous fungi and no ascomycetes could be distinguished. 
At this point, soils treated with 2-8% phenol showed no sign of mucoraceous 
fungi. However, it was seen that after 7 days incubation some plates from 
soils treated with 2% phenol solution were overrun by mucoraceous fungi, 
but not at any higher phenol concentrations. After 14 days incubation some 
plates from soil treated with 3% phenol were overrun by mucoraceous fungi, 
but not with the soils treated with 4% phenol and above. Furthermore, those 
soils treated with 4% phenol and above showed no sign of mucoraceous 
fungi being present at the end of the 28 day observation period.  
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Apart from phenol concentration, temperature also showed a profound effect 
on the growth of the fungi. Figures 3.1- 3.3 clearly show that the optimum 
temperature for growth was 20 °C followed by 25 °C, with little growth 
occurring at 5 °C or 37 °C.   
A comparison of the average colony numbers of the three day (Figure 3.1) 
and seven day incubation (Figure 3.2) showed a dramatic increase in the 
average colony numbers observable with treatment both at 20 °C and 25 °C. 
This was, however, a result of the growth of mucoraceous fungi. This also 
accounted for the large increase of colony numbers after 14 days (Figure 
3.3) with 2% phenol treatment at 25 °C and with the 3% phenol treatment at 
20 °C.  
 
 
3.1.2 Identification of fungal isolates 
 
 
Untreated plates mainly yielded fast growing mucoraceous species. With 2% 
phenol treatment, most of the fungi that were recovered were sterile or 
anamorphic fungi including Aspergillus sp., Aureobasidium sp., 
Cephalosporium sp., Fusarium sp., Gliocladium sp., Isaria farinosa, four 
different strains of Penicillium and Verticillium tenerum.  Several ascosporic 
fungi were also recovered from this treatment and identified as Gymnoascus 
sp. and Talaromyces sp. With 3% phenol treatment and above, a few sterile 
and anamorphic fungi were recovered including Aureobasidium sp., 
Gliocladium sp., Humicola sp., Penicillium sp. and Verticillium tenerum, 
Chapter 3: Development of a sele
                   Ascomycetes 
ctive isolation technique for   
 
 
 42
however, the majority of species were ascomyceteous including 
Chaetomium globosum, C. trigonosporum, Eupenicillium sp., Eurotium sp., 
Gymnoascus sp., Melanospora sp., Sodaria sp., Spherodes sp., Talaromyces 
sp., Thielavia sp. and Xylaria sp. 
A total of 407 isolates were obtained. The number of fungal isolates 
obtained from each phenol concentration is shown in Table 3.1.  
 
Table 3.1: Fungal isolates obtained from soil samples treated with different 
phenol concentrations.  
 
Phenol concentration Isolation medium Number of isolates  
2% MYPA 129 
3% MYPA 101 
4% MYPA 82 
5% MYPA 55 
6% MYPA 19 
7% MYPA 13 
8% MYPA 8 
  Total 407 
 
 
Isolates were initially identified to the genus level where possible based on 
their morphology and colony characteristics. A number were able to be 
identified to the species level by their specific characteristics. A summary of 
identified fungal isolates obtained from each phenol treatment is shown in 
Table 3.2.  
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Phenol 2% Phenol 3% Phenol 4% Phenol 5% Phenol 6% Phenol 7% Phenol 8% 
Aspergillus sp. Aspergillus sp. Bombardia sp. Aureobasidium sp. Cephalosporium sp. Aureobasidium sp. Cephalosporium sp. 
Aureobasidum sp. Chaetomidium sp. 
Chaetomium 
globosum 
Chaetomium 
globosum 
Eurotium sp. Gymnoascus sp.  
Cephalosporium  sp.  Chaetomium globosum 
Chaetomium 
trigonosporum 
Eupenicillium sp. Thielavia sp. Talaromyces sp.  
Fusarium sp. Chaetomium trigonosporum Eupenicillium sp. Eurotium sp.    
Gliocladium sp. Eurotium sp. Eurotium sp. Pseudeurotium sp.    
Gymnoascus sp. Gymnoascus sp. Gliocladium sp. Spherodes sp.    
Isaria farinosa Humicola sp. Gymnoascus sp.     
Paecilomyces sp. Isaria sp. Melanospora sp.     
Penicillium sp. Melanospora sp. Poroconiochaeta sp.     
Talaromyces sp. Paecilomyces sp. Pseudeurotium sp.     
Verticillium tenerum.  Talaromyces sp. Spherodes sp.     
 Verticillium tenerum  Talaromyces sp.     
 Xylaria hypoxylon Verticillium sp.     
    Xylaria sp.         
Table 3.2: Identified fungal isolates from different phenol treatments. 
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3.3 DISCUSSION 
 
The isolation technique in this study was adapted from that of Furuya and 
Naito (1979b) who used 65% etanol as a selective agent for the isolation of 
Ascomycetes. The study of activation of germination of ascospores by 
Furuya and Naito in 1980, showed phenol to be the most effective activating 
agent. Furthermore, Greald et al. (2004) suggested using a 2% phenol 
solution as a standard method for selective recovery of ascomycetes from 
soil. In this study, however, a 2% phenol treatment was not sufficient to 
eliminate overgrowth by mucoraceous fungi and these isolates recovered 
were usually either sterile or anamorphic fungi. Higher concentration of 
phenol; 3% to 8%, (8% being the maximum solubility of phenol in water 
(Carey, 2003)) were consequently used in an attempt to select for 
ascomyceteous fungi.  
In this study an increase in phenol concentration above that used by Furuya 
and Naito (1980) decreased the frequency of isolation of Mucorales and 
fungi with thin-walled propagules and increased the proportion of 
Ascomycetes. Ascosporic fungi often have a thick-walled ascocarp which 
could protect the ascospores within. Furthermore, some of the ascospores 
themselves are thick-walled unlike many common soil fungi which have 
thin-walled propagules and are unlikely to survive higher phenol 
concentrations (Bills and Polishook, 1993). Occasionally, common soil 
fungi also survived at high phenol level, probably because they are situated 
deep within particles and so are protected (Gerald et al. 2004).  
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Treatments with 3% and 4% phenol were found to be the most useful for the 
soil partial pasteurization method since these concentrations yielded a 
greater variety of fungal isolates and Ascomycetes were more frequently 
isolated. At higher phenol treatments (5% to 8%) fewer fungal isolates were 
retrieved and most of these were also retrieved at lower phenol levels. 
Soil texture and organic matter content can affect the results of phenol 
sterilization. Fine-textured soils are sterilized more efficiently than those of 
coarse texture (Gerald et al. 2004).  
Temperature is another major factor affecting the growth of fungi. The 
optimal growth temperature was found to be 20 - 25 °C (Figures 3.1-3.3) 
which is the optimal temperature for the growth of most fungi (Zak and 
Wildman, 2004). At the end of the 28 day observation period, plates from 5 
and 37 °C incubation had less than 10 fungal colonies present but when 
allowed to sit at 25 °C for a week further colonies were observed, indicating 
retardation rather than death of the fungal propagules. 
From the treated soil plates a total of 407 distinguishable isolates were 
grown and extracts subjected to bioassays as discussed in Chapter 4. 
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Chapter 4 
 
Bioactivity and chemical characterization 
of culture extracts 
 
4.1 BIOACTIVITY SCREENING OF CULTURE EXTRACTS 
 
A total of 407 isolates were cultured on MYPA for 30 days and the resultant 
cultures extracted with ethyl acetate (EtOAc) to yield a total of 407 fungal 
extracts. All 407 extracts were assayed in the quick screen against P388 
cells, Bacillus subtilis, Pseudomonas aeruginosa and Candida albicans. 
Extracts that inhibited the growth of P388 cells >80% were considered 
active extracts and were further assayed to determine the concentration 
required to inhibit the growth of P388 cells by 50% (IC50).  
Of the 407 extracts, 123 were active against P388 cells, 40 extracts were 
active against B. subtilis (<20% cell viability) and 19 extracts active against 
C. albicans (<20% cell viability). None of the 407 extracts tested were 
active against P. aeruginosa.  
Of the total of 123 extracts that were active against P388 cell in the quick 
screen assay, 71% of extracts showed IC50 values <12,500 ng/mL. These 
71% were derived from fungal isolates obtained from different phenol 
concentrations see Table 4.1.  
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Table 4.1: Summary of active extracts derived from fungal isolates obtained 
from each phenol concentration.  
 
Phenol concentration  Number of active extracts  
2% 22 (5.4%) 
3% 25 (6.1%) 
4% 16 (3.9%) 
5% 13 (3.1%) 
6% 5 (1.2%) 
7% 4 (1%) 
8% 2 (0.5%) 
Total 87 (71%) 
 
All 87 extracts had been prioritized and investigated. These extracts were 
then subjected to HPLC screening for separation of compounds present in 
the extract. 
 
4.2 HPLC SCREENING OF CULTURE EXTRACTS 
 
HPLC screening for significant peaks provides a basis for selection of 
extracts for further investigation. Detection was by both evaporative light 
scattering detection (ELSD) and UV (DAD), as shown in Figure 4.1. The 
HPLC-ELSD profile was used to assess the relative quantities of each of the 
metabolites present in each of the extracts (Higgs et al. 2001). The UV 
chromophore (Figure 4.2) and retention time (Rt) of the compound was used 
in conjunction with the in-house HPLC-UV/Rt library database to 
distinguish known compounds from unknown compounds. This is based on 
a combination of matching the UV profile and the retention time. If all 
significant peaks resulted in “known hits”, further work on that extract was 
discontinued. This is the first step of the dereplication strategies used in this 
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study. Further details of dereplication strategies are discussed in Section 4.3: 
Dereplication. 
 
Figure 4.1:  HPLC chromatogram of crude extract F8642 showing the two 
main peaks F8642-1 and F8642-2. UV detection 210 nm (blue) with ELSD 
(black) comparison. 
 
 
Figure 4.2: UV absorption (nm) in % of UV-max of peak F8642-1 (a) and 
F8642-2 (b).  
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4.3 DEREPLICATION 
 
Rapid identification of natural products is an important step to distinguish 
known and unknown compounds and allowing the exclusion of known 
compounds at an early stage. The natural products chemistry group at the 
University of Canterbury has focused on natural products of fungal and 
marine origin and the search for new bioactive natural products has been 
aided by the development of new, effective and less time consuming 
methodologies for dereplication.  
The group’s approached to dereplication utilizes a combination of HPLC-
UV and an in-house HPLC-UV/Rt library database for known fungal 
metabolites using the Chromeleon software on a Dionex analytical HPLC. 
MS analysis and capillary NMR probe (capNMR) are also utilised. These 
methods are all used in conjunction with the combined Marinlit/Antibase 
database known as AntiMarin (Lang et al. 2006). 
 
4.3.1 Dereplication using HPLC-UV library database and MS analysis
 
An in-house HPLC-UV/Rt library database was created using the 
Chromeleon software on a Dionex analytical HPLC. Two libraries are 
combined in the database; an “all compound library” and a “known 
compound library”.  
Dereplication of fungal metabolites using the library databases is carried out 
by establishing whether any of the significant peaks in the extract shows a 
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match for both the UV chromophore and retention time (Rt) with any 
compounds present in the library. Peaks which showed a match with a 
known compound are then confirmed by MS analysis. Examples of 
dereplication using the HPLC-UV/Rt library database and MS analysis are 
given below. 
 
Example 1: Extract F7342  
 
Extract F7342 derived from a Eurotium sp. showed one significant bioactive 
peak eluting at 12.7 min in the HPLC screening (Figure 4.3). A search in 
the HPLC-UV/ Rt library database of the UV chromophores and Rt of this 
peak showed matches with several known compounds, with the highest 
match being for brefeldin A (Figure 4.4). The relative Rt window in the 
search profile was set to 13 min. The metabolite in F7342 eluted at 12.7 min 
and the brefeldin reference eluted at 13.1 min. Other compounds, as listed, 
also had close matches to the peak at 12.7 min in F7342. 
 
Figure 4.3: HPLC chromatogram of the crude extract F7342. UV detection 
(blue) with ELSD (black) comparison. 
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Figure 4.4: UV spectra of the peak eluted at 12.7 min (black) and  
brefeldin A (red) with a search in the HPLC- UV/ Rt library database.  
 
Subsequent MS analysis of the peak at 12.7 min showed the presence of a 
dimeric cluster ion [2M+H]+ in the spectrum that assigned the [M+H]+ ion 
as 281.186 amu which matched with the molecular mass of brefeldin A 
(Figure 4.5) - 280.167 amu reported by Nielsen and Smedsgaard, 2003. 
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Figure 4.5: Mass spectrum of compound eluting at 12.7 min in F7342 
(brefeldin A)  
 
Since the main peak resulted in an exact match with a known compound, 
further work on this extract was discontinued.  
 
Example 2:  Extract F6983 
 
Extract F6983 showed one significant peak named F6983-1 eluting at 14.39 
min in the HPLC chromatogram that was subsequently shown to be active 
component in the bioactivity screening (Figure 4.6). A search of the HPLC-
UV/Rt library database for the UV chromophores and Rt of this peak gave 
three probable matches with known compounds in the library; 2-hexylidene-
3-methylsuccinic acid, Sch-642305 and 2-(2-hydroxybutyl)-pent-2-enoic 
acid. All three compounds shared similar UV chromophores with compound 
F6983-1 (Figure 4.7).  
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Figure 4.6: HPLC chromatogram of the crude extract F6983 showing the 
bioactive compound at 14.39 min. UV detection (blue) with ELSD (black) 
comparison. 
 
 
Figure 4.7: UV spectra of the peak F6983-1 (black), 2-hexylidene-3-
methylsuccinic acid (red), Sch-642305 (blue) and 2-(2-hydroxybutyl)-pent-
2-enoic (green) with a search in the HPLC- UV/Rt library database. 
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MS analysis showed that compound F6983-1 had a molecular mass [M+H]+ 
of 215 amu which matched with the reported known compound 2-
hexylidene-3-methylsuccinic acid (Figure 4.8) (Anderson et al. 1985). 
Hence, the main peak of this extract represented a known compound and 
work on this extract was also discontinued. 
 
 
Figure 4.8: Mass spectrum of compound F6983-1 which concluded it to be 
2-hexylidene-3-methylsuccinic acid. 
 
Dereplication using the HPLC-UV library database and MS analysis is a 
primary method to distinguish known from unknown compounds, however, 
this method is not a definitive method for dereplication.  
The UV spectrum only gives definitive structure information for those 
compounds with strong chromophores or for compounds that have 
absorption maxima in the range of 200-800 nm (Anderson et al. 2004). For 
compounds with commonly observed UV profiles an incorrect conclusion cn 
result since similar chromophores give comparable UV spectra. For 
example, some cytochalasin and chaetoglobosin derivatives which contain 
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an indole group as the backbone structure exhibit similar UV profiles 
(Figure 4.9) which correspond to the absorption maxima of indoles (216, 
270 and 286 nm)  (Andonovski and Stojkovlić, 2000).  
 
 
Figure 4.9: A comparison of UV spectra of cytochalasin and chaetoglobosin 
derivatives which correspond to an indole group in their structure.  
 
 
With ESIMS analysis, the mass spectrum can contain, in addition to the 
molecular ion MH+, pseudo-molecular ions such as MNa+, MNH4+ or 
MHCH3CN+. There is also the possibility of interfering ions from minor 
components that ionize more readily than the component of interest. These 
features can lead to confusion over the actual molecular mass of the sample 
(Nielson and Smedsgaard, 2003; Lang et al. 2008). Therefore, additional 
data such as a 1H NMR spectrum is necessary to deliver definitive structural 
information.  
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4.3.2 Dereplication using the CapNMR technique
 
Extracts that were not readily dereplicated using the HPLC-UV library 
database and MS analysis were investigated using CapNMR spectroscopy in 
conjunction with the AntiMarin database.  With the use of a CapNMR 
probe, only 2-10 µg of pure compound is required for dereplication. The 1H 
NMR spectrum can then provide specific structural information such as the 
number and types of a methyl group. For example, the methyl groups could 
be pre-set as singlets, doublets or triplets. The database also includes the 
ability to search on other structural features such as the type of aromatic 
substitution. These features are the most readily interpreted in a search in the 
AntiMarin database. A full account of the use of the AntiMarin database has 
been published (Blunt et al. 2007). An example of dereplication using the 
CapNMR technique is given below.  
 
Example 1: Extract F8767 
 
Extract F8767 was derived from a Penicillium sp. and on the basis of HPLC 
analysis (Figure 4.10) showed a presence of one major compound, denoted 
as F8767-1, eluting at 15.05 min. A search of the in-house UV database 
suggested several known compounds as possible hits with the closest match 
being recorded for griseofulvin and a compound F4656-9 which was 
griseofulvin or griseofulvin-like structure (Figure 4.11). 
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Figure 4.10: HPLC chromatogram of the crude extract F8767 showing the 
bioactive component at 15.05 min. UV detection (blue) with ELSD (black) 
comparison. 
 
 
Figure 4.11: A comparison of UV spectra of compound F8767-1, 
Griseofulvin and F4656-9.  
 
This compound was examined by CapNMR and the 1H spectrum obtained. 
Compound F8767-1 displayed one doublet methyl group, three methoxy 
groups, one olefinic proton and one aromatic proton in the 1H NMR 
spectrum (Figure 4.12).  
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Figure 4.12: The 1H NMR spectrum of 15µg of F8767-1 in 6 µL CD3OD, 
recorded at 500 MHz. 
 
 
These features were entered into the AntiMarin Database (Figure 4.13), 
together with the measured low resolution mass of 352 amu.   
 
 
Figure 4.13: Screen shot of AntiMarin search profile for F8767-1. 
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Two matches were found with the same structure (Figure 4.14). These were 
both griseofulvin. Therefore, compound F8767-1 was identified as a known 
compound and no further work was done on this extract. 
 
Figure 4.14:  A screen shot of the AntiMarin search result for F8767-1 
 
Using the HPLC-UV/Rt library database, MS analysis, and the CapNMR 
technique, 97% of the 87 extracts were eliminated from further study as all 
the significant bioactive peaks could be assigned as known compounds. 
Details of the compounds identified in the active extracts are given in Table 
4.2. The new metabolites discovered are discussed in Chapter 5. 
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Table 4.2: Summary of dereplication of metabolites from fungal extracts. 
Metabolites Isolates Extracts 
1,3,6 trihydroxy-8-methylxanthone 7024@30.2 (unidentified) F7029 
7703@30.8 (Xylaria sp.) F6983 2-hexylidene-3-methylsuccinic 
acid 7623@30.1 (unidentified) F7107 
 3823@25.5 (unidentified) F7152 
 7703@25.14 (Xylaria sp.) F7167 
 6543@25.29 (unidentified) F7236 
 4562@25.2 (Xylaria sp.) F7251 
 4562@20.12 (unidentified) F7446 
4-acetyl-6,8-diOH-5-
methylisocoumarin 7023@30.10 (unidentified) F7008 
 4563@30.5 (unidentified) F7105 
4-ketoclonostachydiol 7023@30.1 (unidentified) F7107 
 6544@20.2 (Gliocladium sp.) F7339 
 6544@20.4 (Gliocladium sp.) F7340 
 6544@20.6 (Gliocladium sp.) F7342 
 6543@20.14 (unidentified) F7403 
5-methyl mellein 3812@25.2 (unidentified) F7169 
bisvertinoid 7025@25.9 (unidentified) F8629 
altenusin 7703@30.7 (Talaromyces sp.) F6982 
andrastatin A 6543@25.33 (Xylaria sp.) F7230 
beauvericin 7702@20.4 (Beauveria sp.) F6881 
 4562@20.11 (Gymnoascus sp.) F7445 
bisdethiodi(methylthio)-aranotin 6543@25.22 (Eurotium sp.) F7234 
 
6544@20.12  
(Gliocladium sp.) F7345 
bisnaphthopyrone 
6543@25.23  
(Chaetomium sp.) F7235 
 7702@20.13 (unidentified) F7471 
 1515@20.9 (unidentified) F8596 
 7027@15.4 (unidentified) F8621 
 7025@15.5 (unidentified) F8622 
 7705@20.8 (unidentified) F8623 
 7025@25.13 (unidentified) F8626 
 7025@25.15 (unidentified) F8628 
 7025@25.9 (unidentified) F8629 
 9023@20.7 (unidentified) F8696 
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Table 4.2: (Continue) 
Metabolites Isolates Extracts 
brefeldin A 7023@25.2 (unidentified) F7186 
 6542@25.6 (Penicillium sp.) F7210 
 6543@25.3 (Gliocladium sp.) F7221  
 
4563@25.4  
(Meranospora sp.) F7223 
 NEL3@25.7 (Telaromyces sp.) F7226 
 6544@20.6 (Eurotium sp.) F7342 
 9014@30.4 (Eurotium sp.) F8678 
brevianamide 7702@30.7 (unidentified) F7038 
 7704@25.2 (Penicillium sp.) F7240 
cephalochromin 
3813@25.4 
(Cephalosporium sp.) F7151 
 7022@25.1 (sterile) F7164 
 
7023@25.3  
(Cephalosporium sp.) F7171 
 7023@25.6 (sterile) F7174 
 7023@25.11 (sterile) F7176 
 7024@25.5 (Cephalosporium sp.) F7178 
 1514@25.5 (sterile) F7179 
 7022@20.10 (sterile) F7319 
 7022@20.14 (sterile) F7321 
 7022@20.15 (sterile) F7322 
 
6542@20.15  
(Gymnoascus sp.) F7387 
 4563@20.5 (sterile) F7448 
 4563@20.11 (sterile) F7452 
 4564@20.6 (sterile) F7456 
 4564@20.9 (sterile) F7457 
 7025@20.9 (sterile) F8596 
 7026@20.10 (sterile) F8598 
 7027@20.5 (sterile) F8601 
chaetoglobosin D 7702@20.2 (Penicillium sp.) F7371 
 
7022@20.43  
(Chaetomium sp.) F7626 
 
7012@20.36  
(Chaetomium sp.) F7680 
chaetoglobosin J 7702@20.2 (Penicillium sp.) F7371 
chaetoglobosin R 7702@25.11 (unidentified) F7212 
 7012@20.2 (Penicillium sp.) F7371 
 6542@20.14 (Penicillium sp.) F7386 
 6543@20.7 (unidentified) F7400 
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Table 4.2: (Continue) 
Metabolites Isolates Extracts 
chaetoglobosin S 7702@25.6 (Penicillium sp.) F7210 
 7702@25.11 (unidentified) F7212 
 
7702@20.35  
(Chaetomium sp.) F8002 
chetomin 6542@30.7 (unidentified) F7038 
citreoviridin 4182@25.7 (Penicillium sp.) F7197 
cladosporin 7014@30.1 (Cladosporium sp.) F6997 
 7023@30.10 (unidentified) F7008 
 4563@30.5 (unidentified) F7105 
 6543@25.22 (Eurotium sp.) F7234 
clonostachydiol 7023@30.11 (unidentified) F7009 
curvularin 7703@30.7 (Talaromyces sp.) F6982 
cycloaspeptide 7022@30.1 (unidentified) F7002 
cycloaspeptide A 4182@25.6 (Aspergillus sp.) F7467 
cytochalasin D 9014@30.1 (unidentified) F8646 
cytochalasin G 3812@25.1 (unidentified) F7147 
 3812@20.6 (unidentified) F7303 
 
3812@20.2  
(Pseudeurotium sp.) F7564 
 9032@15.2 (unidentified) F8713 
 9034@15.1 (unidentified) F8714 
 9033@20.2 (unidentified) F8724 
cytochalasin X 
6542@30.9  
(Pseudeurotium sp.) F6908 
deacetylzygosporin G 7022@30.1 (unidentified) F7002 
dehydrosterigmatocystin 4183@25.1 (unidentified) F7463 
 4183@25.2 (unidentified) F7464 
desmethyl-lasiodiplodin 7023@30.11 (unidentified) F7009 
 7017@15.1 (unidentified) F8619 
 9022@30.6 (unidentified) F8642 
 9022@30.10 (unidentified) F8657 
enniatin B 901_4@37.6 (Fusarium sp.) F8639 
ganoderenic acid C 9034@30.4 (unidentified) F8676 
griseofulvin 4564@20.1 (Xylaria sp.) F8591 
 9024@30.2 (Penicillium sp.) F8684 
 9024@20.2 (Aspergillus sp.) F8722 
  9036@20.8 (Xylaria sp.) F8766 
 9036@20.9 (Penicillium sp.) F8767 
 
 
 
Chapter 4: Bioactivity and chemical characterization of culture extracts 
 
 
 
 64
Table 4.2: (Continue) 
Metabolites Isolates Extracts 
gyroporin 7704@25.1 (unidentified) F7163 
 6542@25.6 (Penicillium sp.) F7210 
harzianolide A 7703@20.4 (Trichoderma sp.) F7398 
hirsutide 7022@25.1 (unidentified) F7164 
meleagrin 4182@25.4 (Penicillium sp.) F7196 
melinacidin IV 6543@25.33 (Xylaria sp.) F7230 
mellein 7012@30.4 (unidentified) F6987 
N-acetyltyramine 7024@30.2 (unidentified) F7029 
paecilosetin 
7702@20.27  
(Paecilomyces sp.) F7389 
 9035@30.4  (Paecilomyces sp.) F8649 
penicillic acid 4562@25.14 (Penicillium sp.) F7256 
 4182@25.6 (Aspergillus sp.) F7467 
phomosine A 7703@25.33 (Xylaria sp.) F7230 
spiro-palmarumicin 7703@25.11 (unidentified) F7229 
sterigmatocystin 7012@30.8 (Aspergillus sp.) F6990 
 7012@25.1 (unidentified) F7180 
 4183@25.55 (unidentified) F7213 
ternatin 654L3@25.29 (unidentified) F7236 
viridicatol 6542@30.6 (Penicillium sp.) F7037 
 
 
4.4 DISCUSSION 
 
The results from the quick screen assays showed that of the 407 extracts, 
123 extracts were active against P388 cells, 40 extracts were active against 
B. subtilis, 19 extracts were active against C. albicans, and none of the 
extracts were active against P. aeruginosa. There is an implication here that 
those 284 extracts which displayed no activity in any assay were inactive, 
but this is incorrect as these extracts might possess other than these activities 
from the few assays that were utilized at the University of Canterbury.  
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The presence of secondary metabolites in extracts can be estimated by ELSD 
HPLC analysis. From the data in Table 4.1, some active metabolites, for 
example brefeldin A, cephalochromin and 2-hexylidene-3-methylsuccinic 
acid, were frequently found in different extracts derived from the same 
fungal type, but derived from different soil samples. Furthermore, it is not 
unusual for some secondary metabolites to be produced by a number of 
different fungal species, which may or may not be phylogenetically related 
(Frisvad, 1989), e.g., griseofulvin is produced by Aspergillus sp., 
Penicillium sp., and Xylaria sp. Some fungal species such as Xylaria sp., 
Chaetomium sp., and Penicillium sp. have the ability to produce a wide 
range of diverse compounds and they are considered good candidates for the 
OSMAC (one strain many compounds) approach which was adopted for 
further work with some fungi and will be discussed in Chapter 5. 
Effective dereplication methods are essential in identifying compounds and 
eliminating known compounds rapidly (Sprogøe et al. 2007). The HPLC-
UV/ R  library database only gives definitive structure information for 
compounds containing strong and unique chromophores. In addition, 
compounds which contain the same sub-structural unit may give similar UV 
spectra (Carey, 2003) and can lead to confusion in identifying compounds. 
In this study, for example, the UV spectra of chaetoglobosin and 
cytochalasin derivatives gave similar UV profiles due to an indole subunit 
(Figure 4.9). A conclusive molecular weight cannot always be obtained 
from a single positive ESIMS experiment. Too often pseudo-molecular ions 
such as 
t
MH+, MNa+, MNH4+ or MHCH3CN+, or the presence of  interfering 
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ions from minor components which ionize more readily than the component 
of interest can lead to confusion over the actual molecular weight of the 
bioactive compound (Lang et al. 2008). This phenomenon was seen for 
compound F6983-1 (Figure 4.8) which was identified as 2-hexylidene-3-
methylsuccinic acid. Therefore, the dereplication approach using HPLC-
UV/R  and MS analysis works efficiently if compounds have a characteristic 
UV spectrum, simple mass and not too many hits in the AntiMarin database. 
t
The limited amount of materials from extracts is another issue in natural 
products studies. With the CapNMR technique only 5-10 µg of pure 
compounds are required to obtain a H NMR spectrum 1 (Gronquist et al. 
2005; and Mitova et al. 2008b). The data from the H NMR spectrum and 
mass spectrometry provided useful information for subsequent AntiMarin 
database searching to determine the identity of the bioactive compounds of 
interested.  
1
The dereplication method develop by the Marine Group not only saves on 
the time taken to determine whether the compounds is known or unknown, 
but it also markedly reduces the amount of extract required. More 
dereplication examples using the CapNMR/database method are described in 
the following chapter, together with examples where the identification of 
new bioactive compounds was achieved.  
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Chapter 5 
 
Effect of culture conditions and elicitors on 
metabolite production 
 
 
5.1 INTRODUCTION 
 
For decades, natural product researchers have been developing strategies to 
discover additional novel bioactive compounds either from animals, plants or 
microorganisms. The first option is to access the biodiversity and explore 
untapped natural resources for discovering novel bioactive compounds. 
Another option, especially for microorganisms, is to elevate metabolite 
production by influencing the biosynthetic pathways for secondary 
metabolites of such organisms. A systematic alteration of cultivation 
parameters; such as media composition, pH value, temperature, addition of 
enzyme inhibitors and oxygen supply, is called an OSMAC (one strain many 
compounds) approach (Bode et al., 2002). This approach represents a 
powerful tool that has potential to yield a variety of metabolites from different 
microbes; bacteria, actinomycetes and fungi either from soil or marine origin 
(Bode et al., 2000a; Christian et al., 2005; Groud et al., 2002; Puder et al., 
2001).  
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Based on the HPLC profiles of the 87 active extracts described in Chapter 4, 
seven fungal isolates were selected for the OSMAC approach. Apart from 
bioactivity and HPLC traces, further criteria were considered for selection of 
these seven fungal isolates. From previous reports of the secondary 
metabolites produced by Chaetomium globosum, Penicillium sp., 
Pseudeurotium zonatum and Xylaria sp. (Ariyo et al., 1997; Whalley and 
Edwards, 1999; Paranagama et al., 2007) these fungi are classified as 
productive genera and hence deemed to have the potential to produce a greater 
variety of metabolites. The rare and unstudied isolates of Chaetomium 
trigonosporum and Bombardia sp. were also selected. Furthermore, an 
unidentified white isolate, which was recovered from a high phenol treated 
soil, was also selected. Selected isolates are shown in Figures 5.1 (a) and (b).  
 
 
Figure 5.1 a) Examples of isolates selected for the OSMAC approach based 
on productive genera 
 
 
Figure 5.1 b) Examples of isolates selected for the OSMAC approach based 
on resistance to phenol and rarity. 
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5.2 EFFECT OF CULTURE CONDITIONS ON METABOLITE 
PRODUCTION 
 
Three out of the seven fungal isolates; P. zonatum, C. globosum and C. 
trigonosporum, were chosen as representatives for a study of the effects of 
culture conditions on metabolite production. The main aim of this study was 
to observe the effects of different culture parameters, such as media 
composition, period of fermentation, state of fermentation (solid or liquid 
phase fermentation) and temperature, on metabolite production and to 
determine optimal conditions for growth and metabolite production. Also the 
aim was to establish a set of standard culture conditions for the selected seven 
fungi for a later study on the effect of elicitors on metabolite production 
(Section 5.3). Results of the effect of these culture conditions on the growth 
of these three isolates is given in Appendix III.  
 
5.2.1 Effect of state of fermentation on production of cytotoxic metabolites 
 
Two media bases were used: - a nutrient rich medium (Malt Yeast Peptone 
(MYP)) and a nutrient deficient medium (¼ strength Sabouraud Dextrose 
(SD)). These were prepared in solid phase; Malt Yeast Peptone Agar (MYPA) 
and ¼ strength Sabouraud Dextrose Agar (SDA), and in liquid phase; Malt 
Yeast Peptone Broth (MYPB) and ¼ strength Sabouraud Dextrose Broth 
(SDB) (see Section 2.4.3 in Chapter 2 for methods).  The effect of solid and 
liquid phase fermentation on the production of cytotoxic compounds was 
ascertained by P388 assay and the results are given in Table 5.1.  
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Table 5.1: P388 activity of extracts from P. zonatum, C. globosum and C. 
trigonosporum cultured under different conditions 
 
P388 IC50 (ng/mL)  
on different Media Fungi 
Cultural 
period 
(days) 
Temp
 (°C) Conditions 
MYP SD 
Agar (85 mm Petri dish)  3,754 5,542 
Broth, static 5,711 >12,500 
Broth, shaken 9,793 >12,500 
20 
Broth, ½ shaken ½ static  8,431 7,916 
Agar (85 mm Petri dish)   4,916 2,954 
Broth, static >12,500 4,361 
Broth, shaken >12,500 11,376 
20 
25 
Broth, ½ shaken ½ static  >12,500 >12,500 
Agar (85 mm Petri dish)   1,239 1,722 
Broth, static >12,500 11,376 
Broth, shaken >12,500 >12,500 
20 
Broth, ½ shaken ½ static  7,494 >12,500 
Agar (85 mm Petri dish) 3,986 2,324 
Broth, static 9,330 10,782 
Broth, shaken >12,500 >12,500 
Ps
eu
de
ur
ot
iu
m
 zo
na
tu
m
 
30 
25 
Broth, ½ shaken ½ static  >12,500 >12,500 
Agar (85 mm Petri dish) 2,479 3,986 
Broth, static 10,258 11,376 
Broth, shaken > 12, 500 > 12, 500 
20 
Broth, ½ shaken ½ static  > 12, 500 > 12, 500 
Agar (85 mm Petri dish)   8,431 2,954 
Broth, static > 12, 500 > 12, 500 
Broth, shaken > 12, 500 > 12, 500 
20 
25 
Broth, ½ shaken ½ static  > 12, 500 12,253 
Agar (85 mm Petri dish)   1,975 3,431 
Broth, static > 12, 500 > 12, 500 
Broth, shaken > 12, 500 > 12, 500 
20 
Broth, ½ shaken ½ static  > 12, 500 > 12, 500 
Agar (85 mm Petri dish) 12,253 1,035 
Broth, static > 12, 500 > 12, 500 
Broth, shaken > 12, 500 > 12, 500 
Ch
ae
to
m
iu
m
 g
lo
bo
su
m
 
30 
25 
Broth, ½ shaken ½ static  > 12, 500 > 12, 500 
* P388 IC50 activities ≥12,500 ng/mL are considered to be inactive. 
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Table 5.1: (Continued) 
 P388 IC50 activities (ng/mL) 
on different Media  Fungi 
Cultural 
period 
 (days) 
Temp
 (°C)  Conditions 
MYP SD 
Agar (85 mm Petri dish)   >12,500 8,951 
Broth, static >12,500 >12,500 
Broth, shaken >12,500 >12,500 
20 
Broth, ½ shaken ½ static  >12,500 >12,500 
Agar (85 mm Petri dish)   10,398 9,224 
Broth, static >12,500 >12,500 
Broth, shaken >12,500 >12,500 
20 
25 
Broth, ½ shaken ½ static  >12,500 4,361 
Agar (85 mm Petri dish)   >12,500 5,220 
Broth, static >12,500 >12,500 
Broth, shaken >12,500 >12,500 
20 
Broth, ½ shaken ½ static  >12,500 >12,500 
Agar (85 mm Petri dish)   >12,500 >12,500 
Broth, static >12,500 >12,500 
Broth, shaken >12,500 >12,500 
Ch
ae
to
m
iu
m
 tr
ig
on
os
po
ru
m
 
30 
25 
Broth, ½ shaken ½ static  >12,500 >12,500 
* P388 IC50 activities ≥12,500 ng/mL are considered as inactive. 
 
Analysis of the results showed that solid phase fermentation favoured 
metabolite production in P. zonatum, C. globosum and C. trigonosporum. 
Agitation, or the combination of static and shaken conditions did not improve 
bioactivity. Nevertheless, the P388 IC50 results of P. zonatum fluctuated and 
no firm conclusions could be drawn. 
The presence of significant amounts of metabolites in the fungal extracts was 
detected by HPLC screening. HPLC traces showed no metabolite peaks from 
liquid media culture (Figure 5.2a-c).  
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(a): HPLC traces of P. zonatum grown at 20 °C for 20 days on differing media 
and conditions. 
 
 
b): HPLC traces of C. globosum grown at 20 °C for 20 days on differing 
media and conditions. 
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c): HPLC traces of C. trigonosporum grown at 20 °C for 20 days on differing 
media and conditions. 
 
Figure 5.2: HPLC traces of extracts from P. zonatum, C. globosum and C. 
trigonosporum. 
 
 
5.2.2 Effect of temperature and cultivation period on bioactive metabolite 
production 
 
The three selected fungi were cultured on solid media (MYPA and SDA) at 
four different temperatures; 10, 20, 25 and 30 °C. Cytotoxic and antimicrobial 
metabolite production were assessed at 10, 20, 30 and 40 days. Results are 
shown in Table 5.2. The effect of temperature and cultivation period on 
growth was also noted results are given in Appendix III. 
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Table 5.2: Bioactivities of P. zonatum, C. globosum and C. trigonosporum 
under different test conditions. 
 
Bioactivity of extracts on different media 
P388 IC50 
activities (ng/mL)  
B. subtilis (% of 
cell growth) 
C. albicans (% 
of cell growth) 
Fungi 
Cultural 
period 
 (days) 
Temp
 (°C) 
MYPA SDA MYPA SDA MYPA SDA 
10 14,458 9,540 >50.0 >50.0 >50.0 >50.0 
20 12,825 3,868 >50.0 >50.0 >50.0 >50.0 
25 >12,500 7,940 >50.0 >50.0 >50.0 >50.0 
10 
30 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
10 4,916 6,063 27.4 38.5 45.8 47.6 
20 3,754 5,542 34.7 31.1 21.8 37.9 
25 4,916 7,760 43.2 48.6 50.3 51.3 
20 
30 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
10 2,324 6,634 44.5 51.9 38.1 48.2 
20 2,324 1,722 27.4 31.5 21.8 23.2 
25 3,986 2,324 49.8 42.8 29.7 48.5 
30 
30 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
10 2,395 3,536 >50.0 >50.0 38.1 48.2 
20 1,574 2,867 31.4 >50.0 >50.0 23.2 
25 4,771 4,771 >50.0 >50.0 29.7 48.5 
Ps
eu
de
ur
ot
iu
m
 zo
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m
 
40 
30 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
10 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
20 >12,500 3,986 >50.0 >50.0 >50.0 >50.0 
25 8,431 2,954 >50.0 >50.0 >50.0 >50.0 
10 
30 >12,500 8,182 >50.0 >50.0 >50.0 >50.0 
10 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
20 1,775 1,167 >50.0 >50.0 >50.0 >50.0 
25 3,643 1,775 >50.0 >50.0 >50.0 >50.0 
20 
30 3,754 1,276 >50.0 >50.0 >50.0 >50.0 
10 8,687 3,431 >50.0 >50.0 >50.0 >50.0 
20 >12,500 3,431 >50.0 >50.0 >50.0 >50.0 
25 >12,500 1,035 >50.0 -17.1 >50.0 >50.0 
30 
30 >12,500 4,107 >50.0 >50.0 >50.0 >50.0 
10 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
20 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
25 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
C
ha
et
om
iu
m
 g
lo
bo
su
m
 
40 
30 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
* P388 IC50 activity >12,500 ng/mL and antimicrobial activity over 50% of cell growth 
were considered to be inactive. 
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Table 5.2: (Continued) 
Activities on different media 
P388 IC50 
activities (ng/mL) 
B. subtilis (% 
of cell growth) 
C. albicans (% 
of cell growth) 
Fungi
Cultural 
period 
 (days) 
Temp
 (°C) 
MYPA SDA MYPA SDA MYPA SDA 
10 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
20 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
25 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
10 
30 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
10 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
20 11,600 >12,500 >50.0 >50.0 >50.0 >50.0 
25 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
20 
30 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
10 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
20 >12,500 12,764 >50.0 >50.0 >50.0 >50.0 
25 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
30 
30 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
10 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
20 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
25 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
C
ha
et
om
iu
m
 tr
ig
on
os
po
ru
m
 
40 
30 >12,500 >12,500 >50.0 >50.0 >50.0 >50.0 
* P388 IC50 activity over 12,500 ng/mL and antimicrobial activity over 50% of cell 
growth were considered to be inactive. 
 
From the data in Table 5.2 it was concluded that the production of bioactive 
compounds from P. zonatum and C. globosum were found to be best at 20 °C 
on both of the media used. In contrast, extracts from C. trigonosporum 
showed no bioactivity except when the fungus was grown at 20 °C on MYPA 
with a 20 day cultivation period. HPLC profiles of the extracts of each fungus 
assessed at each cultivation period at 20 °C were compared and are shown in 
Figures 5.3 – 5.5.  
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Figure 5.3: HPLC profiles of extracts from P. zonatum grown at 20 °C on a) 
MYPA medium and b) SDA medium, accessed at 10, 20, 30 and 40 days of 
cultivation period. 
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Figure 5.4: HPLC profiles of extracts from C. globosum grown at 20 °C on a) 
MYPA medium and b) SDA medium, accessed at 10, 20, 30 and 40 days of 
cultivation period. 
 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 78
 
 
 
 
 
Figure 5.5: HPLC profiles of extracts from C. trigonosporum grown at 20 °C 
on a) MYPA medium and b) SDA medium, accessed at 10, 20, 30 and 40 
days of cultivation period. 
 
 
The HPLC profiles of P. zonatum showed no difference in metabolite 
production between the two media. A significant amount of metabolite 
production was first detected when the fungus was grown for 20 days on 
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MYPA medium and for 10 days on SDA. HPLC profiles and the bioactivity 
results for P. zonatum are shown in Table 5.2. A longer cultivation period 
increased metabolite production with a consequent increase in bioactivity 
(lower IC50 values). Details of the elucidation of compounds present are given 
in Section 5.6.  
HPLC profiles of C. globosum (Figure 5.4a and b) showed that different 
metabolites were produced when the fungus was grown on different media 
(Details of elucidation of compounds are given in Section 5.9). Metabolite 
production was first detected at 20 days when the fungus was grown on 
MYPA medium, and at 10 days on SDA medium.  
No significant amount of compounds was detected from the HPLC profiles of 
C. trigonosporum. Nevertheless, studies on the effects of elicitors on 
metabolite production are continuing for this fungus. 
Metabolite production was found to be best at 20 °C and a 20 day cultivation 
period on both media. This in combination appeared to be an appropriate 
time/temperature selection for further studies on the effect of elicitors on the 
growth and metabolite production of the seven selected fungi. 
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5.3 EFFECT OF ELICITORS ON METABOLITE PRODUCTION 
 
Recent studies have shown that minor variations in the environment or 
nutrition have the potential to impact the quantity and diversity of 
fermentation products of microorganisms (Bills et al. 2008). Furthermore, the 
use of elicitors such as antibiotics and cytoskeleton inhibitors at subinhibitory 
concentration has been shown to alter secondary metabolite production in 
actinomycetes, bacteria and fungi (Goh et al. 2002; Christian et al. 2005; 
Mitova et al. 2008a). The use of subinhibitory concentrations of these elicitors 
is based on the concept of hormesis which was defined as low-dose 
stimulation and high-dose inhibition (Calabrese et al. 2002). This is an 
adaptive response of organisms to low levels of stress or damage. Many 
studies have shown that a modulation in cell transcription occurred in the 
presence of antibiotics or inhibitors at low concentration, as they act as 
signaling rather than inhibitory agents (Hoffman et al. 2005; Linares et al. 
2006; Yim et al. 2006). 
For the next step in the current study, the seven chosen fungi were challenged 
with elicitors such as antibiotics and actin inhibitors to determine if secondary 
metabolite production was affected by subinhibitory concentration of elicitors.  
Elicitors used in this study are summarized in Table 5.3, while media 
preparation is given in Appendix I. 
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Table 5.3: List of elicitors used in OSMAC approach 
Name Amount presence in 1 mL agar Mode of action 
10 mM 
5 mM Cycloheximide (CLY) 
2.5 mM 
Interference with the translocation 
step in protein synthesis thus 
blocking translational elongation. 
0.2 µM 
0.4 µM 
Histone Deacetylase  
Inhibitor II  
(HDACI II)  0.8 µM 
Induces apoptosis (Glick et al. 
1999; Marks et al. 2000) 
0.05 µM 
0.5 µM 
Histone Deacetylase  
Inhibitor IV  
(HDACI IV)  1 µM 
Reverse gene silencing (Herman et 
al. 2006) 
0.01 µM 
Jasplakinolide (JAS) 
0.05  µM 
F-actin stabilizer (Bubb et al. 2000; 
Fenteany and Zhu, 2003) 
0.25 µg 
Latrunculin B (LB) 
0.5 µg 
F-actin destabilizer (Fenteany and 
Zhu, 2003) 
Mycophenolic acid 
(MPA) 1.5 µg 
Enzyme inhibitor (Sweeney et al. 
1972) 
1 U 
10 U Nystatin (NYS) 
100 U 
Interruption of fungal cell 
membranes, that leads to K+ 
leakage and fungal cell death 
Phalloidin (PHA) 0.1 U F-actin stabilizer (Fenteany and Zhu, 2003) 
Tetracycline (TTC) 1.0 µg Protein synthesis inhibitor 
Tricyclazole (TCZ) 1.5 µg DHN biosynthesis inhibitor 
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Part A: Pseudeurotium zonatum 
 
5.4 CULTURE CHARACTERISTICS AND MORPHOLOGY 
 
Fungal strain 3814@20.2 was isolated from a 4% phenol treated soil sample 
that originated from Arthur’s Pass (stream edge), Canterbury. The fungal 
strain was identified as belonging to the family Pseudeurotiaceae. Colonies 
were slow growing, reaching 12-16 mm in diameter after 10 days at 20 °C on 
malt-yeast-peptone agar (MYPA) (Figure 5.6a). The young colony had white 
aerial and submerged mycelium. Colonies became grey or dark brown when 
cleistothecial ascomata developing (Figure 5.6b); ascomata matured within 
20-25 days. Ascomata globose, 70-130 µm in diameter, ostiole and ascomatal 
hairs were absent. Cleistothecial surface was composed of cephalothecoid 
plates (Figure 5.6c). Asci evanescent; ascospores globose, 2.0-4.0 µm in 
diameter (Figure 5.6d-e).  
After comparing the characteristic of this fungal strain with the description 
provided by Malloch and Cain (1970), Domsch et al. (1980) and Sogonov et 
al. (2005), fungal strain 3814@20.2 was identified as Pseudeurotium zonatum. 
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Figure 5.6: Pseudeurotium zonatum. a) 10 days culture at 20 °C on MYPA 
plate; b) 30 days culture at 20 °C on MYPA plate; c) SEM of cleistothecium 
(bar = 10 µm); d) SEM of fractured cleistothecium and ascospores (bar = 10 
µm); e) ascospores (bar = 2 µm). 
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5.5 EFFECT OF ELICITORS ON GROWTH AND METABOLITE 
PRODUCTION 
 
5.5.1 Effect of elicitors on the growth of P. zonatum 
 
P. zonatum was grown on MYPA and SDA media at 20 ° C for 20 days. The 
colony diameter (three replicates) was measured every 5 days for 20 days 
prior to extraction. A comparison of mycelial growth of P. zonatum in the 
presence of elicitors in MYPA and SDA media is shown in Figures 5.7 and 
5.8 respectively. Ascocarp production was observed and presented in Table 
5.4 
 
Table5.4: Observation of ascomata production at 20 days incubation. 
Observation of visible ascomata on plate of each media 
MYPA SDA Elicitors 
appearance on plate appearance on plate 
Control ++ + 
TTC + ++ 
MPA +++ ++ 
TCZ ++ + 
NYS 1 U + + 
PHA 0.1 U +++ + 
LB 0.5 µg + + 
LB 0.25 µg + + 
JAS 0.05 µM ++ + 
JAS 0.01 µM ++ + 
HDACI IV 1 µM N/O N/O 
HDACI IV 0.5 µM N/O N/O 
HDACI IV 0.05 µM N/O N/O 
HDACI II 0.8 µM + N/O 
HDACI II 0.4 µM N/O N/O 
HDACI II 0.2 µM N/O N/O 
* +++ visible ascomata cover entire colony, ++ visible ascomata abundance at 
the edge of the colony, + visible ascomata under dissection microscope, N/O 
no ascomata production. 
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Figure 5.7: Effect of elicitors on growth of P. zonatum on MYPA medium at 20 °C. 
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Figure 5.8: Effect of elicitors on growth of P. zonatum on SDA medium at 20 °C.
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It was noted that no growth was observed in the presence of cycloheximide 
and nystatin (100 U and 10 U concentrations) in either media. Without the 
elicitors the growth of the fungus was greater on MYPA medium than SDA 
medium. The growth rate declined after 15 days incubation. Mycelial growth 
and ascomata production was enhanced with mycophenolic acid (MPA) and 
phalloidin (PHA) present in MYPA medium, but not enhanced when present 
in SDA medium. Growth and ascomata production was suppressed in the 
presence of histone deacetylase inhibitor II (HDACI II) and histone 
deacetylase inhibitor IV (HDACI IV) at any concentration on MYPA 
medium. It was noted that on SDA medium mycelial growth was enhanced by 
HDACI II and HDACI IV with the best mycelial growth seen with HDACI IV 
at 0.05 µM. Development of ascomata, however, was suppressed by HDACI 
II and HDACI IV.  
 
 
5.5.2    The effect of elicitors on metabolite production 
 
5.2.2.1 Cytotoxicity and HPLC screening 
 
The initial extract (F7301) from P. zonatum (isolate 3814@20.2) was screened 
for bioactivity and showed potent activity (>80% cells inhibition) against 
P388, B. subtilis and C. albicans in the quick screens, with subsequent 
determination of a P388 IC50 value of 1,035 ng/mL. The HPLC profile of the 
extract (Figure 5.9) showed two distinct peaks, named F7301-1 and F7301-2, 
which eluted at 16.8 and 19.7 minutes respectively. To determine the 
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bioactivity of each peak, an extract was subjected to HPLC microtitre plate 
screening with P388, B. subtilis and C. albicans (method described in 
Chapter 2 section 2.7.3). Results showed that peak F7301-1 was active 
against P388 cells, B. subtilis and C. albicans, while peak F7301-2 was active 
against P388 cells and B. subtilis, but not C. albicans. P388 IC50 values for 
peak F7301-1 and F7301-2 were determined as 1,837 and 9,837 ng/mL 
respectively. 
 
Figure 5.9: HPLC chromatogram of F7301 showing overlay of ELSD 
detection (solid) and the UV detection (pink-dash). The lines below UV 
detection chromatogram represent bioactive region(s) as tested against P388 
cell (blue), B. subtilis (red) and C. albicans (green). 
 
 
The cytotoxicities of the extracts from each elicitor treatment are given in 
Table 5.5. This isolate showed better IC50 values when it was grown on 
MYPA than SDA. No modulation in metabolite production was observed in 
the presence of elicitors. Nevertheless, an enhancement in metabolite 
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production was seen in the presence of elicitors. The growth of P. zonatum 
was not affected by HDACI II and HDACI IV, but the presence of these 
elicitors in both media at all concentrations suppressed metabolite production. 
 
Table 5.5: Effect of elicitors on cytotoxicity of P. zonatum on MYPA and 
SDA media culture at 20 °C for 20 days.  
 
Cytotoxicity on both media 
MYPA SDA Elicitors 
Extracts IC50 (ng/mL) Extracts IC50 (ng/mL)
Control F9210 1,035 F9225 3,232 
TTC F9211 1,500 F9226 2,954 
MPA F9212 1,035 F9227 >12,500 
TCZ F9213 1,483 F9228 >12,500 
NYS 1 U F9216 1,483 F9231 2,256 
PHA 0.1 U F9220 1,035 F9235 >12,500 
LB 0.5 µg F9221 1,500 F9236 1,622 
LB 0.25 µg F9222 1,066 F9237 1,035 
JAS 0.05 µM F9223 1,355 F9238 1,622 
JAS 0.01 µM F9224 1,622 F9239 >12,500 
HDACI IV 1 µM F9421 5,542 F9428 >12,500 
HDACI IV 0.5 µM F9423 3,959 F9430 >12,500 
HDACI IV 0.05 µM F9425 4,916 F9432 >12,500 
HDACI II 0.8 µM F9518 11,722 F9524 >12,500 
HDACI II 0.4 µM F9520 8,687 F9526 >12,500 
HDACI II 0.2 µM F9522 4,916 F9528 >12,500 
     * P388 IC50 activity >12,500 ng/mL was considered to be inactive. 
 
 
The ELSD traces of all 15 elicitors and control from MYPA (Figure 5.10 a-b) 
and SDA (Figure 5.11 a-b) showed the presence of compoundsF7301-1 and 
F7301-2.  
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Figure 5.10 (a-b): HPLC traces of extracts from P. zonatum cultured on 
MYPA medium at 20°C for 20 days with addition of different elicitors in the 
medium. 
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Figure 5.11 (a-b): HPLC traces of extracts from P. zonatum cultured on SDA 
medium at 20°C for 20 days with addition of different elicitors in the medium. 
 
 
 
 
 
 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 92
5.6 STRUCTURAL ELUCIDATION OF THE COMPOUNDS 
PRODUCED BY P. zonatum 
 
The extracted UV spectra of F7301-1 and F7301-2 exhibited multiple UV 
absorption maxima at 202, 223 and 282 nm (Figure 5.12), suggesting that 
these two compounds were structurally related compounds. A search in the 
HPLC-UV/Rt library database for a compound with similar UV maxima 
showed that F7301-1 and F7301-2 could be related to either the cytochalasin, 
or the chaetoglobosin family of compounds (Figure 5.12). A comparison 
between cytochalasin and chaetoglobosin structures showed that many of the 
compounds in these families share the basic structure of an indole subunit. 
The UV absorption maxima of F7301-1 and F7301-2 have UV chromophores 
similar to those of an indole system, as reported by Andonovski and 
Stojkovtić (2000). 
 
Figure 5.12: A comparison of UV absorption maxima of F7301-1 (black), 
F7301-2 (blue), chaetoglobosin B (green) and cytochalasin Z (pink). 
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The positive ion Electrospray Ionization mass spectrum (ESIMS) of 
compound F7301-1 suggested a molecular mass of 473 amu ([M+H]+) 
(Figure 5.13a) and 457 amu ([M+H]+) for compound F7301-2 (Figure 
5.13b). 
 
 
 
 
 
Figure 5.13: a) ESIMS spectrum of compound F7301-1; b)ESIMS spectrum 
of compound F7301-2 
 
 
A search of the AntiMarin database using these molecular masses and an 
indole group substructure resulted in no hits with any compounds within the 
database for the compound in the range m/z 472-474 amu. However, for the 
compound F7301-2 (m/z 457-458 amu) there were four hits in the AntiMArin 
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database. However, none of these hits were related to either the cytochalasin 
or chaetoglobosin structure class. Both compounds were therefore 
investigated further to establish structures for these metabolites. 
 
5.6.1 Fraction F7301-1 
 
The 1H NMR spectrum of F7301-1 (Figure 5.14) showed the presence of one 
singlet methyl group at δH 1.21 and two doublet methyl groups at δH 0.62 and 
1.15. The aromatic region of the 1H NMR spectrum exhibited two doublets at 
δH 7.34 and 7.63, two triplets at δH 7.04 and 7.09, and one singlet at δH 7.15. 
These two doublets and two triplets are characteristic of 1, 2-disubstitued 
aromatic ring of an indole system while the singlet represents a proton 
adjacent to the NH group in the indole system (H-2′) (Figure 5.15). The 
signals at δH 5.22, 6.21, 6.27 and 7.86 represent olefinic hydrogens in the 
compound. A search in the AntiMarin database using the above criteria 
revealed thirteen hits, but none of them matched with the observed molecular 
weight (472) of the compound. 
 
Figure 5.14: 1H NMR spectrum of F7301-1, 34 µg in 6 µL CD3OD, recorded 
500 MHz, 100sec. 
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Figure 5.15: Indole system 
 
A series of 2D NMR experiments; Homonuclear Correlation Spectroscopy 
(COSY), Heteronuclear Single Quantum Coherence (HSQC) and Heteronuclear 
Multiple Bond Correlation (HMBC) were performed to generate the data for 
structural elucidation.   
The HSQC experiment (Figure 5.16) disclosed the presence of three methylene 
(CH2) groups in the compound at δC 33.5, 43.9 and 47.1. From the COSY and 
HMBC experiments (Figure 5.17 and 5.18) three different fragments were 
deduced.  
 
Figure 5.16: HSQC NMR spectrum of F7301-1 in CD3OD (blue lines represent 
CH2 group). 
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Figure 5.17: COSY NMR spectrum of F7301-1 in CD3OD. 
 
Figure 5.18: HMBC NMR spectrum of F7301-1 in CD3OD. 
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The first fragment consisted of an assignment of protons and carbons in an 
indole system (Figure 5.19). In the COSY NMR spectrum the proton at δH 7.34 
was coupled to δH 7.09, which was in turn was coupled to a signal at δH 7.04. 
This proton was, in turn, coupled to δH 7.63. The carbon assignments for these 
protonated carbons were assigned from the HSQC NMR spectrum (1JCH). From 
the HMBC spectrum, a  proton at δH 7.04, H-6′ was correlated to carbons at δC 
111.3, C-8′ (3JCH) and δC 127.6. The carbon at δC 127.6 was assumed to be a 
carbon at position 4′ because the HSQC experiment suggested the two vicinal 
carbon of C-6′ (C-5′ and C-7′) were assigned different carbon chemical shifts. 
The C-4′ chemical shift was then confirmed by 2JCH coupling from H-5′ and 
3JCH coupling from H-2′ and H-8′ (Figure 5.19). From the long range 
connectivities of H-2′ it was assumed that the carbon chemical shifts at C-3′ and 
C-9′ could be assigned as δC 109.9 and 136.9. Furthermore, H-7′ showed a long 
range connectivity (3JCH) to carbon at δC 136.9, thus suggesting its assignment 
to the C-9′ position. The carbon at δC 109.9 was confirmed to be assigned to C-
3′ by the 3JCH coupling from H-5′. 
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Figure 5.19: Indole spin system of F7301-1 obtained from COSY, HSQC and 
HMBC NMR spectral data.  
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Fragment 2; from the COSY NMR spectrum, protons at δH 0.62 were coupled 
to δH 1.53 which  in turn was coupled to a signal at δH 3.38 (Figure 5.20a). The 
proton resonance at δH 3.83 was coupled to the methylene protons at δH 2.71 
and 2.94 (Figure 5.20b). The proton resonance at δH 2.19 was coupled to 
protons at δH 2.84 and 6.27 while the olefinic proton at δH 6.27 was further 
coupled to another olefinic proton at δH 5.22 which was then in turn coupled to 
methylene protons at δH 2.14 and 2.32 (Figure 5.20c).  
H3C
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0.62
36.1
44.5
3.40
a.)
H H
H
b.)
2.71 2.94
3.83
33.5
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H
H
H H
H
H
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62.6
48.0
2.19
6.27
5.22
2.14 2.30
137.2133.1
43.9
c.)  
Figure 5.20: Spin systems of F7301-1 obtained by COSY (solid line) and 
HSQC. 
 
From the HMBC NMR spectrum, the methyl protons at δH 0.62 showed a 2JCH 
correlation to a methine carbon at δC 36.2, and 3JCH correlations to a methine 
carbon at δC 44.5 and a quaternary carbon at δC 58.4, giving the substructure as 
depicted in Figure 5.21a. A singlet methyl signal at δH 1.21 showed 
correlations to δC 36.2, 58.4 and 62.7. This placed the methyl signal next to the 
quaternary carbon at δC 58.4 (Figure 5.21b). A proton at δH 2.84 (see Figure 
5.20c) showed correlations to carbons at δC 18.5, 48.0, 58.4 and 133.1 thus 
joining fragment 5.20c and 5.21b, to give the substructure depicted in Figure 
5.21c. 
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Figure 5.21: HMBC correlations observed for the proton at a) δH 0.62;  
 b) δH 1.21; and c) δH 2.84. 
 
 
The chemical shift of both the quaternary carbon at δC 58.4 and the tertiary 
carbon at δC 62.7 indicated the presence of an oxygen atom, therefore, the 
presence of a trisubstituted epoxide was suggested (Figure 5.22).  
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Figure 5.22: Trisubstituted epoxide fragment 
 
The proton at δH 2.94 showed a 3JCH correlation to a methine carbon at δC 44.5 
(see Figure 5.22) as well as showed 2JCH and 3JCH correlations to carbons in the 
indole system at δC 109.9 and 123.7 (Figure 5.19) respectively. Thus the indole 
system could be connected the fragment given in Figure 5.22, to give a larger 
fragment as shown in Figure 5.23.  
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Figure 5.23: HMBC correlations observed for the proton at δH 2.94. 
 
The third fragment was assembled from the remaining substructure units as 
revealed in the COSY experiment. This showed that the methyl proton at δH 
1.15 was coupled to a proton at δH 1.72 (Figure 5.24a) and that the olefinic 
protons at δH 6.21 and 7.86 were coupled to each other (Figure5.24b). The 
HSQC NMR experiment showed that the resonances at δH 2.12 and 3.31 were 
part of the same methylene group (Figure 5.24c).  
H3C1.15
H
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H
H6.21
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143.4
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H
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c)  
Figure 5.24:  Spin systems of F7301-1 obtained by COSY (bold line) and 
HSQC. 
 
From the HMBC experiment, the methylene protons at δH 2.12 and 3.31 
showed correlations to the carbonyl carbon at δC 204.9 as well as to the methine 
carbon at δC 32.0 (Figure 5.25a). The proton at δH 7.86 showed correlations to 
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the carbonyl carbons at δC 204.9 and δC 195.0. The proton at δH 6.21 also 
showed a correlation to the carbonyl carbon at 195.0. Therefore, the carbonyl 
carbon at δC 195.0 was assigned as being adjacent to the olefinic carbon at δC 
133.1 (Figure 5.25b) thereby defining the third unit.  
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32.0
1.72
O
204.9
a)
H
H2.12
3.31
47.1
H3C1.15
H
24.6
32.0
1.72
O
204.9
H
H6.21
133.1
143.4
7.86b)
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Figure 5.25: HMBC correlations observed for the protons a) δH 2.12 and 3.31; 
b) δH 6.21 and 7.86 
 
As the methyl protons at δH 1.15 showed a 3JCH correlation to the methylene 
carbon at δC 43.9, and the proton at δH 5.21 showed a 3JCH correlation to the 
carbon at δC 32.0, the structure fragment from Figure 5.23 could be linked with 
the structure fragment given in Figure 5.25b to give the structure fragment 
shown in Figure 5.26.  
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Figure 5.26: HMBC correlations observed for protons at δH 1.15, 5.21 (red 
arrows), 2.19, 3.38 and 3.83 (black arrows) . 
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The protons at δH 2.19, 3.38 and 3.83 all correlated with the third carbonyl 
group at δC 173.3 (Figure 5.26) , while the δH 2.19 proton was also correlated to 
a quaternary carbon at δC 66.9 (see Figure 5.26). The molecular mass of 
compound F7301-1 was found to be 472 amu, while the molecular mass of  the 
structure fragment shown in Figure 5.26 with an additional carbonyl group and 
a quaternary carbon requires 457 amu. This leaves 15 amu unaccounted for in 
the molecular mass, which could be assigned to an NH group. From previous 
searching of the AntiMarin database, compound F7301-1 closely resembled the 
NMR data reported for cytochalasin Z, which is closely related to cytochalasin 
G (Figure 5.27) as reported by Feng et. al. (2002). This suggested that the 
remaining NH, carbonyl carbon and quaternary carbon could be included as a 
lactam ring as seen in both the structures of cytochalasin G and Z. 
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Figure 5.27: cytochalasin G and cytochalasin Z. 
 
A comparision of the NMR data with the literature data of cytochalasin Z 
together with the data derived in the preceeding discussion led to the proposal 
of the planar structure of F7301-1 as shown in Figure 5.28. As the literature 
NMR data for cytochalasin G and Z was obtined in CDCl3 the 1H NMR was 
reacquired for F7301-1 in CDCl3 to permit a direct comparison as shown in 
Table 5.6.  
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Figure 5.28: Planar structure of compound F7301-1 
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Table 5.6: 1H NMR data of F7301-1 and Cytochalasin G and Z (500 MHz in CDCl3) 
F7301-1 run in CD3OD F7301-1 run in CDCl3 Cytochalasin Z Cytochalasin G Position  
δH splitting J Hz δH splitting J Hz δH splitting J Hz δH splitting J Hz 
1 -         - -     - -     - -     
2           5.91 br s     6.65 br s     5.98 br s     
3 3.83 ddd 2.2 5.0 7.5 3.84 m     3.84 m     3.80 t 5.5   
*4 3.38 dd 2.2 5.7   3.34 dd 6.6 12.3 3.21 dd 5.5 2.0 2.87 br d 5.0   
5 1.53 dt 7.3 5.9   1.73 t 6.8   1.77 t 6.5   1.89 br s     
6 -         - -     - -            
7 2.84 d 5.5     2.87 d 5.5   2.81 d 5.5   2.82 d 5.5   
8 2.19 m       2.18 m     2.12 dd 10.0 5.5 2.10 dd 10.5 6.5 
9 -        - -    - -           
10a 2.94 dd 4.9 13.8   2.98 dd 3.3 13.8 2.95 dd 4.0 14.0 2.89 dd 14.0 4.5 
10b 2.71 dd 8.3 14.1   2.73 dd 9.2 14.3 2.72 dd 8.5 14.0 2.64 dd 14.5 6.5 
11 0.62 d 7.3     1.15 d 7.5   1.22 d 7.5   1.09 d 7.0   
12 1.21 s       1.27 s     1.24 s     1.20 s     
13 6.27 dd 11.4 15.6   6.26 dd 11.4 15.6 6.36 dd 15.0 10.0 6.14 dd 15.5 10.0 
14 5.22 ddd 4.0 11.0 15.2 5.18 ddd 3.3 11.0 5.40 dtd 11.5 3.5 5.05 dtd 11.5 3.5 
15a 2.32 d 13.4     2.34 d 14.1   2.33 m     2.25 m     
15b 2.14 m       2.16 m     1.9-2.0 m     1.6-1.7 m     
16 1.72 m       1.64 m     2.25-2.30 m     2.3-2.4 m     
17a 3.31 m       3.47 br s     2.60 dd 15.5 4.0 2.4-2.5 m     
17b 2.12 m       2.14 m     2.36-2.42 m     1.86 t 3.5   
18 -         - -     - - -           
19 7.86 d 16.5     7.96 d 16.5   4.57 d 2.0   2.6-2.7 m     
19b                           2.3-2.4 m     
20 6.21 s       6.30 d 16.3   3.42 d 2.0   3.42 dd 17.0 12.5 
20b                           1.6-1.7 m     
21 -         - -     -   -           
22 1.15 d 7.0     1.18 d 7.0   1.17 d 6.5   0.95 d 6.5   
1'                   8.59 br s     8.31 br s     
2' 7.15 s       7.07 s     7.04 s     6.97 d 2.5   
3' -         - -     -   -           
4' -         - -     -   -           
5' 7.63 d 7.9     7.55 d 7.9   7.53 d 8.0   7.49 d 8.0   
6' 7.04 t 7.2     7.17 t 7.5   7.16 t 6.5   7.15 t 8.0   
7' 7.09 t 7     7.23 t 7.3   7.24 t 7.0   7.20 t 8.0   
8' 7.34 d 81     7.40 d 8.3   7.46 d 8.5   7.35 d 8.5   
9' -         -       -   -           
Note: *4 indicate stereocentre; chemical shifts in red colour indicate the positions used to assign the stereochemistry of F7301-1. 
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The tabulation of the proton chemical shifts of cytochalasin G, cytochalasin Z 
and F7301-1 (Table 5.6) in CDCl3 shows the close structural identity between 
these structures. The major differences in the 1H values for these three 
compounds were centred on H-19 and H-20. In cytochalasin G these protons 
were methylenes, but in cytochalasin Z, H-19 and H20 (δH 4.57 and 3.42 
respectively) were part of an epoxide system. In F7301-1 H-19 and H-20 
appeared at δH 7.96 and 6.30 respectively and were assigned as olefinic protons. 
This comparison supports the proposal that F7301-1 is similar to cytochalasin Z 
except for the replacement of the epoxide with a double bond at positions 19 
and 20. Furthermore, the coupling constant for H-19/H-20 was 16.5 Hz 
indicating a trans disposition of protons across the double bond.  
Previous studies have suggested that the essential elements of the cytochalasin 
skeleton have the same stereochemistry, viz., the cis-sterochemistry across the 
5/6 ring junction and the trans-sterochemistry of the macro cyclic ring (Natori 
and Yahara, 1991). 
The stereochemistry of F7301-1 was determined as shown in Figure 5.29 by 
comparing the proton chemical shifts and coupling constants of F7301-1 with 
the literature data of cytochalasin Z and cytochalasin G as shown in red in 
Table 5.6. 
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Figure 5.29: Structure of F7301-1  
 
This comparison supports the structure proposed in Figure 5.29 except that the 
proton at position 4 of F7301-1 in CDCl3 has different coupling constants 
compared with the reported data. However, the nuclear overhauser effect 
(NOE) NMR experiments which were performed in CD3OD were in agreement 
with a configuration of H-4 as proposed in Figure 5.29 as irradiation of the H-
3, H-4 and H-11 protons gave the expected enhancements of H-3, H-4 and H-11 
as listed in Table 5.7.  
 
Table 5.7: NOEs observed in F7301-1 
Irradiation at NOE enhancement 
H-3 H-11, H-12 
H-4 H-5 
H-11 H-12 
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5.6.2 Fraction F7301-2 
 
The general features of the 1H NMR spectrum of F7301-2 (Figure 5.30) were 
found to closely resemble those of F7301-1, except in the region of the six-
membered ring. A proton resonance at δH 2.84, H-7 in F7301-1 was replaced by 
an olefinic proton at δH 5.40.  
 
Figure 5.30: 1H NMR spectrum of F7301-2, 25 µg in 6 µL CDCl3, recorded at 
500 MHz, 100sec, (crosses indicate impurities). 
 
Furthermore, the difference in the molecular mass of compound F7301-1 
compared to F3301-2 was 16 amu, immediately suggesting the replacement of 
an epoxide with a double bond at positions 6 and 7. A series of 2D NMR 
experiments (COSY, HSQC and HMBC) were conducted and compared with 
the data for compound F7301-1 (showed in Table 5.8) in order to confirm this 
replacement as well to ptovide complete assignment of all protons and carbons. 
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Table 5.8: Summary table of NMR experiments of F7301-1 and F7301-2 
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From comparison of the data in Table 5.8, the proton chemical shifts of both 
compounds are almost identical. The major points of difference are noted in 
red. The main structure features that had been found in compound F7301-1 
such as, one singlet methyl (C-12); two doublet methyl groups( C-11 and 22), 
an indole system, an alkene (Δ19), were also found in compound F7301-2.  
The major diffferences in the 1H δ values for these two compounds were to be 
found centred on C-7. It was established or concluded that the proton at δH 2.84 
in 1 was replaced with an olefinic proton at δH 5.40 in F7301-2. Small 
differences in the proton chemical shifts in the six-membered ring of the two 
compounds were also noted, confirming the change of functional group in this 
region.  
The COSY NMR spectrum of F7301-2 showed that the olefinic proton at δH 
5.40 was coupled to δH 2.52, and vice-versa. Furthermore, the HMBC 
experiment revealed that the methyl protons at δH 1.77 had a 3JCH correlation to 
δC 124.8 (Figure 5.31) once again confirming the interchange of an epoxide 
functionality with an alkene at positions 6 and 7. The planar structure of 
compound F7301-2 is depicted in Figure 5.31. 
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Figure 5.31: Planar structure of compound F7301-2 
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The relative configuration of F7301-2 (Figure 5.32) was assigned by 
comparison of the coupling constants for compound F7301-1 with those for 
cytochalasin Z1 (Evidente et al. 2002) and chaetoglobosin T (Jiao et al. 2004) 
(Figure 5.33). A comparison of the experimental 1H NMR data of F7301-1 and 
2 with the literature data is shown in Table 5.9, with the data displayed in red 
representing the chemical shift values used to assign the relative configuration.   
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Figure 5.32: Structure of F7301-2 
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Figure 5.33: Cytochalasin Z1 and Chaetoglobosin T. 
 
To date, more than 50 cytochalasins have been isolated from a range of fungi. 
Their diverse biological activity especially the cytoplasmic cleavage 
inhibition in mammalian cells was unprecedented in any other class of 
chemical compounds (Natori and Yahara, 1991). The two new cytochalasins 
(F7301-1 and F 7301-2) isolated in this study showed moderate cytotoxicity 
against murine P388 leukemia cells.  
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Table 5.9: 1H NMR data of F7301-2, F7301-1, Cytochalasin Z1 and Chaetoglobosin T (500 MHz in CDCl3) 
F7301-2 F7301-1 Cytochalasin Z1 Chaetoglobosin T Position  
δH  splitting J Hz δH  splitting J Hz δH  splitting J Hz δH  splitting J Hz 
1 -     -     -         
2 5.58 s    5.91 br s    5.53 br s    5.67 br s   
3 3.34 q 7.1 4.8 11.8 3.84 m    3.06 ddd    3.30 m   
4 3.51 t 4.5   3.34 dd 6.6 12.3  2.70 dd 4.0 3.9  2.99 t 5.0 4.0 
5 2.35 d 2.4   1.73 m    2.81 m    2.50 dd 7.5  
6 -     -     -         
7 5.40 d    2.87 d 5.5   5.38 br s    5.34 br s   
8 2.52 d 10.5   2.18 m    3.20 br d 10.2   2.67 m   
9           -         
10a 3.15 dd 3.1 14.4  2.98 dd 3.3 13.8  2.92 ddd 13.4 3.6  3.03 dd 14.0 10.5 
10b 2.66 q 10.5 3.7 14.3 2.73 dd 9.2 14.3  2.81 dd 13.4 10.4  2.58 dd 13.5 10.0 
11 1.39 d 7.3   1.15 d 7.5   1.22 d 6.6   1.34 d 7.5  
12 1.77 s    1.27 s    1.77 br s    1.75 s   
13 6.08 m    6.26 m    5.87 ddd 14.4 10.2 1.8 5.96 m   
14 5.09 m 3.3 11.5 14.8 5.18 ddd 3.3 11.0 15.2 5.35 ddd 14.4 10.9 3.7 5.10 m   
15a 2.32 d 2.4   2.34 d 14.1   2.12 br d 13.8 1.8  2.21 m   
15b 2.13 d    2.16 m    177 m    1.90 m   
16 1.81 m    1.64 m    1.41 m    2.47 br m   
16' †           0.87 d 6.6   0.95 d 7.0  
17a 3.34 q 7.1 4.8 11.8 3.47 br s    1.60 m    5.22 d 8.0  
17b 2.11 m    2.14 m    0.93 m        
18 -     -     1.19 m        
18'           0.78 m    1.52 d 1.0  
19 8.18 d 16.5   7.96 d 16.5   1.73 m    4.38 m   
19'           1.35 m        
20 6.29 d 16.7   6.30 d 16.3   2.28 m    2.48 m   
21 -     -     7.17 ddd 15.6 9.0 6.5 6.80 m   
22 1.16 d 6.9   1.18 d 7.0   5.69 d 15.6   6.89 d 16.0  
23                    
1'                8.22 br s   
2' 7.03 s    7.07 s    7.05 d 8.4   6.99 d 2.5  
3' -     -     6.77 d 8.4       
4' -     -              
5' 7.39 d 8.1   7.55 d 7.89   6.77 d 8.4   7.51 d 7.5  
6' 7.22 t 7.3   7.17 t 7.52   7.05 d 8.4   7.12 t 7.5  
7' 7.16 t 7.2   7.23 t 7.3        7.19 t 7.5  
8' 7.54 d 8.0   7.40 d 8.26        7.36 d 75  
9' -     -              
† H-16′ in cytochalasin Z1 and chaetoglobosin T is equivalent to H-22 in F7301-2. 
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Part B: Chaetomium globosum 
 
5.7 CULTURE CHARACTERISTICS AND MORPHOLOGY 
 
Fungal strain 6544@20.34, identified as belonging to the genus Chaetomium, 
originated from soil obtained from Nelson and was isolated from a 4% phenol 
plate. Colonies on MYPA reached 85 mm in diameter in 10 days at 20 °C and 
showed a pale yellow aerial mycelium; Figure 5.34a. Colonies on SDA reached 
48 mm in diameter after 10 days at 20 °C; Figure 5.34b, with buff aerial 
mycelium with a yellow exudate.  
Perithecia matured within 10-12 days, olivaceous, spherical or ovate, ostiolate, 
75-145 × 173-205 µm (Figure 5.34c); ascomatal hairs were numerous, wavy or 
very loosely coiled and intertwined at tips.  Evanescent asci containing 8 
ascospores (Figure 5.34d); ascospore ovate 6-7 × 8-9 µm, with an apical germ 
pore (Figure 5.34e and f).  
A comparison of the colony and morphology features with that of the description 
provided by Arx et al. (1984, 1986) and Guarro and Figueras (1989) enabled 
strain 6544@20.34 to be identified as Chaetomium globosum Kunze.  
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Figure 5.34:  Chaetomium globosum; a) 10 days colony on MYPA plate; b) 10 
days colony on SDA plate; c) SEM of ascocarp (bar = 20 µm); d) 
SEM of asci with an immature ascospores (bar =10 µm); e) SEM of 
cross secion of perithecium (bar = 1 µm); f) SEM of ascospores (bar 
= 1 µm). 
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5.8 EFFECT OF ELICITORS ON GROWTH AND METABOLITE 
PRODUCTION 
 
5.8.1 Effect of elicitors on growth of C. globosum 
 
C. globosum was grown on MYPA and SDA media at 20 °C for 20 days. The 
colony diameter (three replicates) was measured every 5 days for 20 days prior 
to extraction. A comparison of mycelial growth of C. globosum in the presence 
of elicitors in MYPA and SDA media is shown in Figures 5.35 and 5.36 
respectively. Ascocarp production was observed, in the presence of some 
elicitors and is presented in Table 5.10 
 
Table 5.10: Observation of ascomata production at 20 days incubation. 
Observation of visible ascocarps  Elicitors MYPA SDA 
Control ++ ++ 
TTC + + 
MPA +++ ++ 
TCZ + + 
NYS 100 U ++ + 
NYS 10 U + + 
NYS 1 U + ++ 
CLY 10 µM + + 
CLY 5 µM +++ + 
CLY 2.5 µM ++ + 
PHA 0.1 U +++ ++ 
LB 0.5 µg N/O N/O 
LB 0.25 µg + ++ 
JAS 0.05 µM + ++ 
JAS 0.01 µM ++ ++ 
HDACI IV 1 µM N/O N/O 
HDACI IV 0.5 µM + N/O 
HDACI IV 0.05 µM + + 
HDACI II 0.8 µM N/O N/O 
HDACI II 0.4 µM N/O N/O 
HDACI II 0.2µM N/O N/O 
* +++ visible ascomata covering entire colony, ++ visible ascomata abundance 
at the edge of the colony, + visible ascomata under dissection microscope, N/O 
no ascomata production. 
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Figure 5.35: Effect of elicitors on growth of C.globosum on MYPA medium at 20 °C. 
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Figure 5.35: (Continued) 
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Figure 5.36: Effect of elicitors on growth of C.globosum on SDA medium at 20 °C. 
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Figure 5.36: (Continued) 
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The growth of C. globosum was greater on MYPA medium than on SDA 
medium. On MYPA medium, colonies reached the edge of an agar plate (85 
mm) after 10-15 days of incubation while on SDA medium, growth of the 
fungus reached stationary phase after 10-15 days of incubation. Growth of the 
fungus on both media was not affected by elicitors, except for latrunculin B 
(LB) 0.25 µg and cycloheximide (CLY) 10 µM on MYPA medium and LB 
0.5 µg in both media. Ascomata development was affected when HDACI II, 
HDACI IV or LB 0.5 µg was present in the media, but they did not affect 
mycelial growth.  
 
5.8.2 Effect of elicitors on cytotoxic and metabolite production 
 
5.8.2.1 Cytotoxicity 
 
There were no differences in IC50 values when this fungus was grown on 
MYPA or SDA media. Extracts from each elicitor treatment showed good 
activity against P388 cells except extract F9246 (yield from fungus grown on 
MYPA medium in the presence of nystatin (NYS) 10U) and extract F9536 
(yield from fungus grown on SDA medium in the presence of HDACI II 0.8 
µM) see Table 5.11 for details.  
 
 
 
 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 120
Table 5.11: Effect of elicitors on cytotoxicity of C.globosum on MYPA and 
SDA media culture at 20 °C for 20 days. 
 
Cytotoxicity  
MYPA SDA Elicitors 
Extracts IC50 (ng/mL) Extracts IC50 (ng/mL) 
Control F9240 2,775 F9255 2,667 
TTC F9241 3,020 F9256 2,996 
MPA F9242 1,484 F9257 3,020 
TCZ F9243 6,971 F9258 2,579 
NYS 100 U F9244 6,971 F9259 1,484 
NYS 10 U F9245 6,715 F9260 3,020 
NYS 1 U F9246 >12,500 F9261 7,100 
CLY 10 µM F9247 2,290 F9262 2,579 
CLY 5 µM F9248 2,157 F9263 5,431 
CLY 2.5 µM F9249 5,559 F9264 2,994 
PHA 0.1U F9250 6,971 F9265 3,020 
LB 0.5 µg F9251 8,431 F9266 9,793 
LB 0.25 µg F9252 3,232 F9267 8,687 
JAS 0.05 µM F9253 4,916 F9268 5,542 
JAS 0.01 µM F9254 3,330 F9269 7,290 
HDACI IV 1 µM F9435 9,504 F9442 8,687 
HDACI IV 0.5 µM F9437 9,054 F9444 9,054 
HDACI IV 005 µM F9439 8,687 F9446 6,971 
HDACI II 0.8 µM F9530 8,182 F9536 >12,500 
HDACI II 0.4 µM F9532 6,971 F9538 7,100 
HDACI II 0.2 µM F9534 6,063 F9540 6,971 
 
 
 5.8.2.2  HPLC screening 
 
A comparison of ELSD traces (Figure 5.38 and 5.39) showed that C. 
globosum produced different metabolites when grown on different media. 
Without elicitors, tetrahydrofuran B (Figure 5.37a) was the main compound 
produced when grown on MYPA, while aureonitol (tetrahydrofuran A) 
(Figure 5.37b) was the main compound produced when the fungus was 
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grown on SDA. The HPLC traces in Figures 5.38 and 5.39 revealed that in the 
presence of certain elicitors, as listed in Table 5.12, tetrahydrofuran A and B 
were produced together on both media. An inducement of peak F9242-2, 
which was later identified as chaetoviridin A (Figure 5.37c), occurred in the 
MYPA extracts when certain elicitors (as listed in Table 5.12) were added to 
the medium.  
A production of peak F9245-2 (later identified as chaetoglobosin A (Figure: 
5.37d) by C. globosum was also induced when some elicitors as listed in 
Table 5.12 were added to both media. Structural elucidation of these four 
compounds is given in section 5.9.  
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Figure 5.37: Compounds produced by C. globosum 
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Figure 5.38: HPLC traces of extracts from C. globosum on MYPA medium at 
20°C for 20 days with addition of different elicitors. 
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Figure 5.39: HPLC traces of extracts from C. globosum on SDA medium at 
20°C for 20 days with addition of different elicitors. 
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Table 5.12: Summary of metabolite peaks enhanced by elicitors 
Summary of metabolite peaks 
Metabolites Peak name Elution (min) Media Elicitors Note 
SDA none Original peak 
CLY 5 µM 
JAS 0.05 µM 
JAS 0.01 µM 
MPA 
NYS 100 U 
Tetrahydrofuran A F7392-E8 16.34 
MYPA 
PHA 0.1 U 
Induced 
peak 
MYPA None Original peak 
CLY 10, 5, 2.5 µM 
JAS 0.05, 0.01 µM 
LB 0.5 µg 
MPA 
NYS 100, 10, 1 U 
PHA 0.1 U 
TTC 
Tetrahydrofuran B F9240-1 15.94 
SDA 
TCZ 
Induced 
peak 
MPA 
NYS 100 U Chaetoviridin A F9242-2 19.64 MYPA 
PHA 0.1 U 
Induced 
peak 
NYS 10 U 
NYS 1 U MYPA 
LB 0.25 µg 
Induced 
peak 
CLY 10 µM 
Chaetoglobosin A F9245-2 17.36 
SDA 
CLY 5 µM 
Induced 
peak 
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5.9 STRUCTURAL ELUCIDATION OF COMPOUNDS PRODUCED 
BY C. globosum 
 
5.9.1 Peak F7392-E8 
 
The crude extract (F7392) from SDA;  20 °C for 30 days was screened for 
bioactivity and showed potent activity (>80% cells inhibition) in both the P388 
and B. subtilis quick screens, with subsequent determination of the P388 IC50 
value of 2,667 ng/mL. The HPLC profile (Figure 5.40) showed a distinct peak, 
F7392-E8, which eluted over the bioactive region at 16.34 minutes. 
 
 
Figure 5.40: HPLC chromatogram of extract F7392 showing overlay of ELSD 
detection (black) and the UV detection (blue) of peak F7392-E8. 
 
Results of HPLC microtitre screening showed that peak F7392-E8 was active 
against P388 cells, but inactive against B. subtilis. The extracted UV spectrum 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 126
of F7392-E8 (Figure 5.40) showed no exact match to any compounds in the 
HPLC-UV/Rt library database. ESIMS of compound F7392-E8 suggested the 
molecular weight to be 415 amu ([M+H+]) (Figure 5.42). Peak F7392-E8 was 
further investigated using the CapNMR technique. 
 
 
Figure 5.41: UV absorption (nm) in % of UV-max of compound F7392-E8 
 
 
Figure 5.42: ESIMS spectrum of compound F7392-E8 
 
The 1H NMR spectrum of F7392-E8 (Figure 5.43) revealed the presence of one 
doublet methyl group at δH 1.72. The signals at δH 5.09, 5.21, 5.46, 5.64, 5.72, 
6.03, 6.12, 6.29 and 6.35 all represented olefinic protons in the compound. The 
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integral in the 1H NMR spectrum ibdicated that the resonances at δH 3.68 and 
4.05 were each two protons. 
 
Figure 5.43: 1H NMR spectrum of F7392-E8; 44 µg in 6 µL of CD3OD, 
recorded 500 MHz, 64 sec. 
 
From the COSY NMR experiment (Figure 5.44) two different fragments were 
deduced.  
 
Figure 5.44: COSY spectrum of F7392-E8 in CD3OD. 
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The first fragment was assembled from units revealed in the COSY experiment, 
showing that the methyl protons at δH 1.72 were coupled to an olefinic proton at 
δH 5.64, which was in turn coupled to an olefinic proton at δH 6.03. Following 
through the correlation in the COSY experiment it was possible to trace a 
sequence of coupled protons from the methyl doublet at δH 1.72 to 5.64, 6.03, 
6.12, 5.46, 2.79 to the methylene at δH  3.68/4.05 (see Figure 5.45).  
H3C
H H
H
H
H
H
H
1.72
5.64
6.03
6.12
5.46
2.79
3.68 4.05
 
Figure 5.45: Spin system in fragment 1 of F7392-E8 obtained by COSY (solid 
line).  
 
 
A second fragment was also deduced from units defined in the COSY 
experiment. The proton resonance at δH 4.05, part of the first system, was 
coupled to protons at δH 3.68 and 5.72, while the olefinic proton at δH 5.72 was 
coupled to the δH 6.29 proton, which was in turn was coupled to δH 6.35, and 
finally to a methylene group at δH 5.09 and 5.21 (Figure 5.46).  
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Figure 5.46: Spin system in fragment 2 of F7392-E8 obtained by COSY (solid 
line).  
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A search of the AntiMarin database using these two substructures and 
restricting the search to the presence of one doublet methyl group resulted in 
only one hit. This was aureonitol (Tetrahydrofuran A) (mw: 206.28) (Figure 
5.47) which had been derived from Chaetomium cochiliodes (Abraham and 
Arfman, 1992).  
O
HO H
HH
 
Figure 5.47: Aureonitol  
 
 
The 1H NMR spectrum of F7392-E8 was reacquired  in CDCl3 in order to 
direclty compare the experimental NMR data with the literature data. The 
details are summarised in Table 5.13. 
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Table 5.13: 1H NMR data for aureonitol† and F7392-E8‡  
  F7392-E8 in CD3OD F7392-E8 in CDCl3 aureonitol in CDCl3 
Position  δH splitting J Hz COSY δH  splitting J Hz δH  splitting J Hz 
1 1.72 d 6.3   5.64     1.74 d 6.6   1.74 dd 6.5 1.5   
2 5.64 m 6.8 14.6 1.72 6.03   5.67 dd 7.5 14.7 5.65 dq 6.5 14.5   
3 6.03 t 14.8 10.7 5.64 6.12   6.02 t 14.9 10.5 6.00 ddq 1.5 14.5 10.0
4 6.12 dd 10.3 14.9 5.46 6.03   6.12 dd 10.5 14.9 6.12 dd 10.0 15.0   
5 5.46 dd 8.4 14.9 2.79 6.12   5.44 dd 8.6 15.0 5.40 dd 15.0 9.0   
6 2.79 m 8.0 7.8 3.68 4.05 5.46 2.84 m     2.84 dddd 9.0 7.5   
7 3.68 t 8.3   2.79 4.05   3.72 m     3.72 dd 7.5     
8 4.05 m     3.68 5.72  4.13 m     4.12 dd 7.5 8.5   
9 5.72 dd 7.0 15.1 4.05 6.29   5.72 dd 7.2 14.3 5.68 dd 7.5 14.5   
10 6.29 m     5.72     6.32 m     6.32 m 10.0 14.5   
11 6.35 m     5.09 5.21   6.37 m     6.32 m 10.0 17.0   
12a 5.21 d 17.2   6.35     5.11 d 16.1   5.10 d 17.0     
12b 5.09 d 10.5   6.35     5.23 d 9.4   5.22 d 10.0     
13a 3.68 t 8.3   2.79 3.68   3.72 m     3.61 dd 8.5    
13b 4.05 m     2.79 4.05   4.13 m     4.10 dd 8.5     
 
† Specrtrum was recorded at 400 MHz for 1H. 
‡ Spectra were recorded at 500 MHz for 1H. 
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Compound F7392-E8 did not readily ionise in the mass spectrometer, therefore, the 
accurate molecular mass for this compound could not be obtained. Nevertheless the 
proton chemical shifts and coupling constants of compound F7392-E8 aureonitol as 
shown in Table 5.13 were and were found to be almost identical. As such it was 
concluded that F7392-E8 was aureonitol. 
 
5.9.2 Peak F9240-1 
 
Extract F9240 was obtained from a culture on MYPA at 20 °C for 20 days. The 
HPLC profile (Figure 5.48) showed a distinct peak, F9240-1, with UV absorption 
maxima at 227.1 and 263.9 nm (Figure 5.49) which eluted at 15.99 minutes. 
 
 
Figure 5.48: HPLC chromatogram of extract F7392 showing overlay of ELSD 
detection (black) and the UV detection (blue) of peak F7392-E8. 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite production 
 
 
 132
 
Figure 5.49: UV absorption (nm) in % of UV-max of compound F9240-1 
 
The 1H NMR spectrum of peak F9240-1 (Figure 5.50) showed that it was 
identical to that of tetrahydrofuran B (Figure 5.51) previously identified by Ms 
Francine Smith (BSc, Hons) project; University of Canterbury, 2007. Thus peak 
F9240-1 could be assigned as being tetrahydrofuran B. 
 
Figure 5.50: 1H NMR spectrum of F9240-1; 36 µg in 6 µL of CD3OD, recorded at 
500 MHz, 240 sec. 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite production 
 
 
 133
O
HO H
HH
O
OH
 
Figure 5.51: Tetrahydrofuran B 
 
5.9.3 Peak F9242-2 
 
Peak F9242-2 was obtained from a culture on MYPA medium containing 
mycophenolic acid. The HPLC profile (Figure 5.52) showed two distinct peaks 
on the ELSD trace; F9242-1 (which was identified as aureonitol) and the peak at 
F9242-2, which eluted at 19.6 min. The extracted UV spectrum of F9242-2 
(Figure 5.53) showed an exact match with chaetoviridin A (Rt = 18.8 min) in the 
HPLC-UV/Rt library database.  
 
Figure 5.52: HPLC chromatogram of extract F9242 showing overlay of ELSD 
detection (black) and the UV detection (blue). 
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Figure 5.53: UV absorption (nm) in % of UV-max of compound F9242-2 (black) 
and chaetoviridin A (red) 
 
ESIMS data for this compound (Figure 5.54) indicated that the mass was 433 
amu ([M+H+]) which is identical to the reported mass for chaetoviridin A 
(Takahashi et al. 1990). 
 
 
Figure 5.54: ESIMS spectrum of compound F9242-2. 
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The 1H NMR spectrum of F9242-2 (Figure 5.55) clearly showed the presence of 
one singlet, three doublet and one triplet methyls (δH 0.8 – 1.8). A search of the 
AntiMarin database based on these five methyl groups and a molecular weight of 
431-433 amu (Figure 5.56a) resulted in a match with chaetoviridin A (Figure 
5.56b). A comparison of proton chemical shifts of F9242-2 with the reported data 
of chaetoviridin A (Takahashi et al. 1990) confirmed the assignment of F9242-2 
as being chaetoviridin A (Figure 5.57).  
 
 
Figure 5.55: 1H NMR spectrum of F9242-2; 24 µg in 6 µL of CD3OD, recorded at 
500 MHz, 240 sec. Inset: enlargement of five methyl groups. 
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Figure 5.56: a) AntiMarin search profile for F9242-2; b)AntiMarin search result 
for F9242-2 
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Figure 5.57: Chaetoviridin A 
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5.9.4 Peak F9245-2 
 
The HPLC profile of the extract obtained from F9245 cultured on MYPA 
containing nystatin (10 U) revealed the presence of two major components; 
tetrahydrofuran B and F9245-2, which appeared at Rt 15.94 and 17.36 min 
respectively (Figure 5.58). The extracted UV spectrum of F9245-2 (Figure 5.59) 
showed no match in the HPLC-UV/Rt library database.  
 
Figure 5.58: HPLC chromatogram of extract F9245 showing overlay of ELSD 
detection (black) and the UV detection (blue). 
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Figure 5.59: UV absorption (nm) in % of UV-max of compound F9245-2 (black) 
and chaetoviridin A (red) 
 
This compound was shown to have a molecular mass of 529 amu ([M+H+]) in the 
positive ESI MS (Figure 5.60). The 1H NMR spectral data for compound F9245-
2 clearly showed the presence of two singlet methlys at δH 1.27 and 1.30, two 
doublet methyls at δH 0.98 and 1.05 and an indole system at the chemical shift 
region δH 6.92-7.45 (Figure 5.61).  
 
 
Figure 5.60: ESIMS spectrum of compound F9245-2. 
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Figure 5.61: 1H NMR spectrum of F9245-2; 24 µg in 6 µL of CD3OD, recorded 
at 500 MHz, 360 sec.  
 
 
A search of the AntiMarin database based on a total of four methyls (two singlets 
and two doublets), a 1,2-substituted benzene and a molecular weight of 527-529 
amu (Figure 5.62) resulted in matches with two known compounds; 
chaetoglobosin A and chaetoglobosin C (Figure 5.63). 
 
Figure 5.62: AntiMarin search profile for F9245-2 
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Figure 5.63: Chaetoglobosin A and chaetoglobosin C 
 
Chaetoglobosin A and chaetoglobosin C have the same mass and resemble each 
other except in the region between C19 and C22 where the olefinic protons at 
position H-21 and H-22 in chaetoglobosin A are replaced by methylene protons in 
chaetoglobosin C and a hydroxyl moiety at position C-19 in chaetoglobosin A is 
now a carbonyl group in chaetoglobosin C.  
To resolve the structure of F9245-2 the COSY NMR spectrum of F9245-2 was 
recorded (Figure 5.64). This showed that the olefinic proton at δH 5.01 was 
coupled to another olefinic proton at δH 6.02 (Figure 5.65a) and that two other 
olefinic protons at δH 6.10 and 7.23 were also coupled (Figure 5.65b) 
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Figure 5.64: COSY NMR spectrum of F9245-2 in CD3OD. 
 
H
H 5.01
6.02
H
H 7.23
6.10
a) b)  
Figure 5.65: Spin systems of F9245-2 obtained by COSY (solid line). 
 
The presence of these four olefinic protons was consistent with the Δ13 and Δ21 
alkene in chaetoglobosin A. A comparison of proton chemical shifts of F9245-2 
with the reported data for chaetoglobosin A (Sekita et al. 1973) and 
chaetoglobosin C (Sekita et al. 1976) confirmed the structure assignment of 
F9242-2 as being chaetoglobosin A. 
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Part C: Xylaria sp. 
 
5.10 CULTURE CHARACTERISTICS AND MORPHOLOGY 
 
Fungal strain 7703@30.8 originating from a soil sample obtained from inside a 
cotton tree stump, Eves bush, Nelson and isolated from a 3% phenol plate was 
identified as belonging to the family Xylariaceae. The colony reached 40 mm 
diameter after 10 days incubation at 20 °C on MYPA medium. The young colony 
was initially white with a regular margin (Figure 5.66a), slowly turning dark 
green to black around at the centre after 20 days incubation (Figure 5.66b).  
Stromata initiated in 30 day old culture (Figure 5.66c), clavate to cylindrical, 
mostly unbranched, reaching height of 2 cm or more (Figure 5.66d), grayish 
black with white apices, bearing conidiophores and conidia except at apices. 
Conidiophores arising as short branch, swollen 5-6 x 3 µm, conidia ellipsoidal 5-6 
x 2-3 µm (Figures 5.66e and 5.66f). 
As these features correlated very closely with the description of Xylaria sp., as 
provided by Chacko and Rogers (1981), Roger (1986), Callan and Rogers (1993) 
and Liu et. al (2008), fungal strain 7703@30.8 was identified as Xylaria sp. 
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Figure 5.66): Xylaria sp. at 20 °C on MYPA plate a) 10 days culture; b) 20 days culture, center area turning dark green; c) 30 days culture 
with stromata visible on plate; d) enlargement of stromata with clear exudates observed; e-f) mycelia and conidiophores.  
 
Chapter 5: Effect of culture conditions and elicitors on metabolite production 
 
 
 144
5.11 EFFECT OF ELICITORS ON GROWTH AND METABOLITE 
PRODUCTION 
 
5.11.1 Effect of elicitors on the growth of Xylaria sp. 
 
Xylaria sp. was grown on MYPA and SDA at 20 °C for 20 days. The colony 
diameter (three replicates) was measured every 5 days for 20 days prior to 
extraction. A comparison of the mycelial growth in the presence of elicitors in 
MYPA and SDA media is shown in Figures 5.67 and 5.68 respectively. Stromata 
development was observed and is presented in Table 5.14 
 
Table 5.14: Observation of ascomata production at 20 days incubation. 
Development of stromata Elicitors MYPA SDA 
Control ++ ++ 
TTC ++ +++ 
MPA ++ +++ 
TCZ + ++ 
NYS 10 U + + 
NYS 1 U ++ ++ 
CLY 10 µM N/O N/O 
CLY 5 µM + + 
CLY 2.5 µM + + 
PHA 0.1U ++ ++ 
LB 0.5 µg +++ +++ 
LB 0.25 µg +++ +++ 
JAS 0.05 µM ++ + 
JAS 0.01 µM ++ + 
HDACI IV 1 µM + + 
HDACI IV 0.5 µM N/O N/O 
HDACI IV 0.05 µM N/O N/O 
HDACI II 0.8 µM N/O N/O 
HDACI II 0.4 µM N/O N/O 
HDACI II 0.2 µM N/O N/O 
* +++ visible stromata observed on plate, ++ entire centre area of colony turned 
grey indication for developing of ascomata, + centre area of colony partially 
turned grey, N/O no sign of stromata development. 
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Figure 5.67:  Effect of elicitors on growth of Xylaria sp. on MYPA at 20 °C 
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Figure 5.67:  (Continued) 
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Figure 5.68:  Effect of elicitors on growth of Xylaria sp. on SDA at 20 °C 
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Figure 5.68:  (Continued) 
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It was noted that no growth was observed in the presence of nystatin (NYS) 
(100 U) in either medium. Without elicitors, growth of the fungus was greater 
on MYPA than SDA. Due to a slow development of stromata, which appeared 
on the plate in 30-40 day old cultures, most of the observation of ascomata 
production (Table 5.14) was based on the dark green area at the centre of 
colony. This is an indication of an initiation of stromata. Nevertheless, 
stromata were visible on plates in the presence of latrunculin B (LB) at both 
of the concentrations used. Growth of the fungus was not significantly 
affected by elicitors except in the presence of cycloheximide (CLY) (10 µM) 
where the growth was suppressed. Stromata development of this fungus was 
suppressed in the presence of CLY (10 µM), HADCI IV (0.5 and 0.05 µM), 
and for all concentrations of HADCI II used in the media.   
 
5.11.2 Effect of the elicitors on metabolite production 
 
 
5.11.2.1 Effect of the elicitors on the cytotoxicity of extracts 
 
Greater cytotoxicity was shown from extracts obtained from the SDA culture 
than those obtained on MYPA. Details of the IC50 results are shown in Table 
5.15.  
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Table 5.15: Effect of elicitors on the cytotoxicity of the extracts from Xylaria 
sp. on MYPA and SDA (20 °C for 20 days). 
Cytotoxicity on both media 
MYPA SDA Elicitors 
Extracts IC50 (ng/mL) Extracts 
IC50 
(ng/mL) 
Control F9300 10,713 F9315 5,384 
TTC F9301 >12,500 F9316 1,500 
MPA F9302 >12,500 F9317 1,035 
TCZ F9303 >12,500 F9318 11,376 
NYS 10 U F9305 >12,500 F9320 8,431 
NYS 1 U F9306 >12,500 F9321 9,224 
CLY 10 µM F9307 <975 F9322 <975 
CLY 5 µM F9308 >12,500 F9323 <975 
CLY 2.5 µM F9309 >12,500 F9324 <975 
PHA 0.1 U F9310 >12,500 F9325 <975 
LB 0.5 µg F9311 >12,500 F9326 <975 
LB 0.25 µg F9312 >12,500 F9327 4,916 
JAS 0.05 µM F9313 >12,500 F9328 4,172 
JAS 0.01 µM F9314 >12,500 F9329 5,220 
HDACI IV 1 µM F9463 >12,500 F9470 8,834 
HDACI IV 0.5 µM F9465 9,054 F9472 >12,500 
HDACI IV 0.05 µM F9467 4,916 F9474 9,054 
HDACI II 0.8 µM F9554 >12,500 F9560 >12,500 
HDACI II 0.4 µM F9556 >12,500 F9562 >12,500 
HDACI II 0.2 µM F9558 >12,500 F9564 >12,500 
 
 
5.11.2.2 HPLC screening of extracts 
 
A comparison of ELSD traces (Figures 5.69 and 5.70) showed that Xylaria 
sp. produced more metabolites when grown on SDA than on MYPA medium. 
Compound F9307-1 was induced in the presence of CLY (10 µM), HDACI 
IV (0.5 µM) and HDACI IV (0.05 µM) in MYPA.  
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Figure 5.69:  HPLC traces of extracts from Xylaria sp. on MYPA (20°C for 
20 days) with various elicitors. 
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Figure 5.70:  HPLC traces of extracts from Xylaria sp. on SDA (20°C for 20 
days) with various elicitors. 
 
 
Compound F9315-1 was the main compound produced when the fungus was 
grown on SDA medium. The production of F9315-1 was suppressed by all 
elicitors except LB (0.5 µg) (see Figure 5.70).  
Four metabolite peaks in the region 13.0-17.0 min were enhanced when 
certain elicitors were present in the medium as summarized in Table 5.16. 
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Metabolite production was totally suppressed in the presence of HDACI IV 
(1µM). The main metabolites are shown in Table 5.16 and the structural 
elucidation is discussed in Section 5.12. 
 
Table 5.16: Metabolites produced in presence of elicitors. 
Summary of metabolite peaks 
Metabolites Peak name 
Elution 
(min) Media Elicitors Note 
none Original peak 
Ternatin F9315-1 16.34 SDA 
LB 0.5 µg Enhanced peak 
CLY 10 µM 
HDACI IV 0.5 µM MYPA 
HDACI IV 0.05 µM 
Induced peak 
TTC 
NYS 10, 1U 
CLY 10, 5, 2.5 µM 
PHA 0.1 U 
LB 0.5 µg 
2-hexylidene-3-
methlysuccinic acid F9307-1 14.37 
SDA 
HDACI IV 0.05 µM 
Enhanced peak 
TTC 
MPA 
TCZ 
NYS 1U 
CLY 5, 2.5 µM 
PHA 0.1 U 
LB 0.5, 0.25 µg 
Dechlorogriseofulvin F9325-1 13.99 SDA 
JAS 0.05, 0.01 µM 
Enhanced peak 
TTC 
MPA 
TCZ 
NYS 1U 
CLY 10, 5, 2.5 µM 
PHA 0.1 U 
LB 0.5, 0.25 µg 
Griseofulvin F9325-3 14.83 SDA 
JAS 0.05, 0.01 µM 
Enhanced peak 
TTC 
MPA 
TCZ 
CLY 10, 5, 2.5 µM 
Chaetoglobosin E F9325-4 16.02 SDA 
PHA 0.1 U 
Induced peak 
 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 154
5.12 STRUCTURAL ELUCIDATION OF COMPOUNDS PRODUCED 
BY Xylaria sp. 
 
5.12.1 Peak F9315-1 
 
The crude extract of F9315 was screened by HPLC microtitre plate collection 
and the ELSD HPLC chromatogram showed the presence of only one main 
peak which eluted at 16.3 min, F9315-1 (Figure 5.71).  
 
 
Figure 5.71: HPLC chromatogram of crude extract F9315. UV detection 
(blue) with ELSD (black) comparison. 
 
A search of the HPLC-UV/Rt library database for the UV chromorphores and 
Rt of this peak showed matches with ternatin (Figure 5.72).  
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Figure 5.72: Extracted UV spectra of peak F9315-1 (black) and ternatin (red) 
from search in the HPLC-UV/Rt library database. 
 
ESIMS analysis showed that compound F9315-1 had a molecular mass 
([M+H+]) of 738.9 (Figure 5.73) which matched that of ternatin (Shimokawa 
et al. 2006). Ternatin was reported to exhibit an antiviral activity as well as a 
moderate cytotoxicity (Simōes et al. 1990).  
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Figure 5.73: ESIMS spectrum of compound F9315-1 assigned as ternatin. 
 
 
5.12.2 Peak F9307-1 
 
The HPLC profile of the extract F9307 obtained from MYPA containing 
cycloheximide showed the presence of cycloheximide in the extract (Rt 12.0 
min) and one other metabolite peak on ELSD trace, F9307-1 (Figure 5.74).  
 
Figure 5.74: HPLC chromatograms of cycloheximide (pink) and crude extract 
F9307 UV detection (blue) with ELSD (black) comparison. 
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The UV chromophore of the peak that eluted at 12.0 min from F9307 was 
synchronized with the UV chromophore of cycloheximide (Figure 5.75), and 
thereby confirmed the identity of the peak eluting at 12.0 min as being 
cycloheximide. 
 
Figure 5.75: Extracted UV spectra of peak at 12.0 min from F9307 (black) 
cycloheximide (pink). 
 
A search of the HPLC-UV/Rt library database and the UV profile of the peak 
at Rt = 14.37 min showed a match with 2-hexylidene-3-methylsuccinic acid 
(Figure 5.76).  
 
Figure 5.76: Extracted UV spectra of peak F9307-1 (black) and 2-hexylidene-
3-methylsuccinic acid (red). 
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ESIMS showed that this peak has a molecular mass of 215 amu ([M+H+]) 
(Figure 5.77) matching that of 2-hexylidene-3-methylsuccinic acid (Anderson 
et al. 1985; Liu et al. 2006). 
 
 
Figure 5.77: ESIMS spectrum of F9307-1.  
 
 
5.12.3 Extract F9325 
 
HPLC analysis of the F9325 extract revealed the presence of five main 
compounds in the ELSD trace; F9325-1, F9325-2, F9325-3, F9325-4 and 
F9325-5 appearing at Rt 13.0-16.5 min (Figure 5.78). Peaks F9325-2 and 
F9325-5 were identified as 2-hexylidene-3-methylsuccinic acid and ternatin 
respectively (see Sections 5.12.1 and 5.12.2 for details).  
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Figure 5.78: HPLC chromatogram of crude extract F9325. UV detection 
(blue) with ELSD (black) comparison. 
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5.12.3.1 Peak F9325-1 
 
The UV profile of peak F9325-1 (Figure 5.79) showed an exact match with 
dechlorogriseofulvin in the HPLC-UV/Rt library database.  
 
Figure 5.79: Extracted UV spectra of peak F9325-1 (black) and ternatin (red) 
with a search in the HPLC-UV/Rt library database.  
 
ESIMS data for this compound (Figure 5.80) indicated that the mass was 319 
amu ([M+H+]), identical to that reported mass for dechlorogriseofulvin 
isolated from Penicillium urticae (Cole et. al, 1970). 
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Figure 5.80: ESIMS spectrum of compound F9325-1 determined as 
dechlorogriseofulvin. 
 
 
5.12.3.2 Peak F9325-3 
 
The extracted UV spectrum of F9325-3 is shown in Figure 5.81. A search in 
the in-house UV database showed that it was likely to be griseofulvin.  
 
Figure 5.81: Extracted UV spectra of peak F9325-3 (black) and griseofulvin 
(red) with a search in the HPLC-UV/Rt library database. 
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ESIMS data for this compound (Figure 5.82) indicated the mass to be 
353/355 amu (3:1) ([M+H+]). Consistent with griseofulvin (Oxford et al., 
1939). 
 
 
Figure 5.82: ESIMS spectrum of compound F9325-3 
 
The 1H NMR spectrum of F9325-3 was also obtained and it revealed the 
presence of one doublet methyl, three methoxy protons, a singlet aromatic 
proton (δH 6.4) and one olefinic proton (δH 5.6) (Figure 5.83).  
 
 
Figure 5.83: 1H NMR spectrum of F7325-3; 15 µg in 6 µL of CD3OD, 
recorded at 500 MHz, 167 sec. 
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These features were identical with those from the 1H NMR spectrum of 
F8767-1 (see Chapter 4, Section 4.3.2) which was identified as griseofulvin 
(Figure 5.84).  
O
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Figure 5.84: Griseofulvin 
 
 
 
5.12.3.3  Peak F9325-4 
 
The UV profile of compound F9325-4 (Figure 5.85) showed no exact match 
to any compounds in the HLPC-UV/Rt library database and the ESIMS 
spectrum indicated the molecular mass was 495 amu ([M+H+]) (Figure 5.86). 
 
 
Figure 5.85: Extracted UV spectra of peak F9325-4. 
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Figure 5.86: ESIMS spectrum of compound F9325-4 
 
The 1H NMR spectrum of F9325-4 revealed the presence of two singlet and 
two doublet methyls, and one monosubstituted benzene moiety (Figure 5.87).  
 
Figure 5.87: 1H NMR spectrum of F7325-3; 15 µg in 6 µL of CD3OD, 
recorded at 500 MHz, 191 sec. 
 
A search of the AntiMarin database using a search profile of four methyl 
groups assigned as two singlets and two doublets, one monosubstituted 
benzene and a molecular weight of 494-496 amu (Figure 5.88a) resulted in a 
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match with cytochalasin E (Figure 5.88e). This cytochalasin had previously 
been isolated from Rosellinia necatrix (Aldridge et. al, 1972).  
 
Figure 5.88a: AntiMarin search profile for F9325-4 
 
Figure 5.88b: AntiMarin search result for F9325-4 
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A comparison of the proton chemical shifts of F9325-4 with the reported 
NMR data of being cytochalasin E (Takamatsu et. al, 2002) confirmed F9325-
4 as cytochalasin E (Figure 5.89). 
HN
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O
O
O O
OH
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Figure 5.89: Cytochalasin E 
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Part D: Bombardia sp. 
 
5.13 CULTURE CHARACTERISTICS AND MORPHOLOGY 
 
Fungal strain 9024@20.5 originated from soil collected from Tiromoana Bush, 
North Canterbury, and isolated from a 4% phenol plate. This strain was 
identified as belonging to the family Lasiosphaeriaceae. Colonies on MYPA 
reached 85 mm in diameter in 10 days at 20 °C. The young colony showed a 
whitish grey aerial mycelium with light brown gelatinized hyphae adpressed 
to the agar surface (Figure 5.90a). Perithecia are superficial, scattered or 
aggregated in a loose cluster, dark brown in colour and are produced in 
abundance on the culture within 15-20 days, (Figure 5.90b), spherical or 
ovate, ostiolate, measuring 450-500 x 250-300 µm (Figure 5.90c). 
Ascospores ovate, 20-35 x 10 µm (Figure 5.90d). A hyaline tail of ascospores 
was observed under a compound microscope, but was evanescent under SEM.  
A comparison of colony and morphological features with the descriptions 
provided by Verma (1939), Jensen (1985), Hyde (1993) and Huhndorf et al. 
(2004) enabled strain 9024@20.5 to be identified as a Bombardia sp. 
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Figure 5.90: Bombardia sp. a) 10 day colony on MYPA plate; b) 20 day 
colony on MYPA plate with perithecia; c) SEM of perithecium d) SEM of 
ascospores. 
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5.14 EFFECT OF ELICITORS ON GROWTH AND METABOLITE 
PRODUCTION 
 
5.14.1 Effect of elicitors on the growth of Bombardia sp. 
 
Bombardia sp. was grown on MYPA and SDA at 20 °C for 20 days. The 
colony diameter (three replicates) was measured every 5 days for 20 days 
prior to extraction. A comparison of the mycelial growth in the presence of 
elicitors in MYPA and SDA is shown in Figures 5.91 and Figure 5.92 
respectively. Ascocarp production was observed and the data is presented in 
Table 5.17 
 
Table 5.17: Observation of ascomata production at 20 days incubation. 
Observation of visible ascocarps Elicitors MYPA SDA 
Control ++ +++ 
TTC +++ ++ 
MPA +++ ++ 
TCZ ++ ++ 
NYS 1 U ++ + 
PHA 0.1U +++ ++ 
LB 0.5 µg + + 
LB 0.25 µg + + 
JAS 0.05 µM ++ ++ 
JAS 0.01 µM +++ ++ 
HDACI IV 1 µM + + 
HDACI IV 0.5 µM ++ ++ 
HDACI IV 0.05 µM ++ ++ 
HDACI II 0.8 µM ++ + 
HDACI II 0.4 µM +++ ++ 
HDACI II 0.2 µM +++ +++ 
* +++ visible ascomata cover entire colony, ++ visible ascomata abundance at 
the edge of the colony, + sparse ascomata observed. 
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Figure 5.91: Effect of elicitors on the growth of Bombardia sp. on MYPA at 20 °C 
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Figure 5.92: Effect of elicitors on the growth of Bombardia sp. on SDA at 20 °C 
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No growth was observed with cycloheximide and nystatin (100 U and 10 U 
concentrations) in the media. Interestingly, no differences were seen between 
the two media used. Furthermore, growth on both media was enhanced in the 
presence of HDACI II (at all concentrations), but was suppressed in the 
presence of LB at both concentrations (Figures 5.91 and 5.92). Ascomata 
production was not affected by elicitors except in the presence of LB and 
HDACI IV (1 µM) where perithecial production was reduced.  
 
 
5.14.2 Effect of the elicitors on cytotoxic and metabolite production 
 
5.14.2.1 Effect of the elicitors on cytotoxicity of extracts 
 
The cytotoxicity of the extracts from each elicitor treatment is shown in Table 
5.18. Greater cytotoxicity was seen with extracts from MYPA rather than 
SDA plates and the best activity was seen using MPA as the elicitor.  
 
 
 
 
 
 
Table 5.18: Effect of elicitors on the cytotoxicity of extracts from Bombardia 
sp. on MYPA and SDA (20 °C for 20 days). 
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Cytotoxicity 
MYPA SDA Elicitors 
Extracts IC50 (ng/mL) Extracts IC50 (ng/mL) 
Control F9330 11,713 F9345 12,395 
TTC F9331 11,892 F9346 >12,500 
MPA F9332 9,772 F9347 >12,500 
TCZ F9333 9,224 F9348 11,376 
NYS 1 U F9336 11,376 F9351 >12,500 
PHA 0.1 U F9340 9,054 F9355 >12,500 
LB 0.5 µg F9341 11,376 F9356 >12,500 
LB 0.25 µg F9342 11,376 F9357 >12,500 
JAS 0.05 µM F9343 8,639 F9358 >12,500 
JAS 0.01 µM F9344 7,432 F9359 >12,500 
HDACI IV 1 µM F9477 8,431 F9484 >12,500 
HDACI IV 0.5 µM F9479 9,054 F9486 >12,500 
HDACI IV 0.05 µM F9481 8,687 F9488 >12,500 
HDACI II 0.8 µM F9566 9,224 F9572 >12,500 
HDACI II 0.4 µM F9568 8,666 F9574 >12,500 
HDACI II 0.2 µM F9570 7,432 F9576 >12,500 
 
 
5.14.2.2 HPLC screening of the extracts 
 
A comparison of the ELSD traces (Figures 5.94 and 5.95) showed that 
Bombardia sp. produced a range of metabolites when grown on MYPA but 
none with SDA. On MYPA, eight metabolite peaks; F9332-1 to F9332-8, 
were induced by all elicitors except LB at both concentrations (see Figure 
5.93). An enhancement of peaks in the region 8.0-9.5 min was observed in the 
presence of certain elicitors; TTC, MPA, JAS (0.01 µM), HDACI IV (1 and 
0.05 µM) and HDACI II (0.4 and 0.2 µM) (Figure 5.93).  
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Figure 5.93: HPLC traces of extracts from Bombardia sp. cultured on MYPA 
at 20°C for 20 days with addition of different elicitors. 
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Figure 5.94: HPLC traces of extracts from Bombardia sp. cultured on SDA at 
20°C for 20 days with addition of different elicitors. 
 
 
The structural elucidation of the compounds produced by Bombardia sp. is 
discussed in Section 5.14.  
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5.15 STRUCTURAL ELUCIDATION OF THE COMPOUNDS 
PRODUCED BY Bombardia sp. 
 
5.15.1 Extract F9330 
 
The crude extract (F9330) from MYPA was first analysed on a reverseed-
phase C18 column using the standard gradient (see Chapter 2; section 2.7.3) 
and indicated the presence of three to four compounds appearing at Rt 8.0-
10.0 min as shown in Figure 5.95.  
 
Figure 5.95: HPLC chromatogram of extract F9330 showing overlay of 
ELSD detection (black) and the UV detection (blue). 
 
The separation of peaks was not adequate so the sample was re-analysed using 
a modified gradient system (see Chapter 2; Section 2.8.1.1). The HPLC 
chromatogram revealed the presence of four separated peaks which were 
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designated F9330-A1 to A4 and which eluted over the period Rt 8.5 – 11.0 
min (see Figure 5.96).  
 
 
Figure 5.96: HPLC chromatogram of extract F9330 showing overlay of 
ELSD detection (black) and the UV detection (blue) with a modified gradient 
system (purple) number indicated percentage of acetronitrile run in solvent 
system.  
 
 
5.15.1.1 Peak F9330-A1 
 
A search of the UV profile of peak F9330-A1 in the HPLC-UV/Rt library 
database resulted in a good match with cycloaspeptide (Figure 5.97) 
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Figure 5.97:  UV spectrum of peak F9330-A1 (black) and cycloaspeptide 
(red) with a search in the HPLC-UV/Rt library database. 
 
The low yield of the F9330 extract was not sufficient for capNMR analysis of 
F9330-A1 and further culturing will be necessary to confirm the structure 
using NMR spectroscopy. 
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5.15.1.2 Peak F9330-A2 
 
The ESIMS data for this compound (Figure 5.98) was of low intensity and 
dominated by multiple ions. No sensible conclusion could be drawn as to a 
likely molecular mass for F9330-A2 and therefore a possible identity.  
 
 
Figure 5.98: ESIMS spectrum of compound F9330-A2 
 
However, the NMR data obtained using the CapNMR probe was adequate for 
interpretation. From the acquired 1H NMR, HSQC and COSY NMR data for 
F9330-2 (see Figures 5.99 - 5.101) several structural features could be 
recognized: two doublet methyls, three methylenes, four methines and what 
could be assigned as either a 1,4-disubstituted, or a 1,2,3,4-tetrasubstituted 
benzene.  
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Figure 5.99: 1H NMR spectrum of F9330-A2 with intregral values; 20 µg in 
5.5 µL of CD3OD, recorded at 500 MHz, 180 sec. 
 
 
 
Figure 5.100: COSY NMR spectrum of F9330-A2 in CD3OD 
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Figure 5.101: HSQC NMR spectrum of F9330-A2 in CD3OD (blue lines 
represent CH2 group).  
 
However, when the integral values were examined a 1,4-disubstituted 
aromatic system seemed unlikely (should have integral values of ~2), and 
even a 1,2,3,4-tetrasubstituted aromatic was also a little doubtful as the 
integral values for the aromatic protons (δH 6.7 and 7.15) were less than 1H 
each.  
It was possible to unambiguously delineate a leucine substructure from the 
1H/COSY NMR data (see Figure 5.102).  
O
N
H3C
CH3
H
H
0.95 0.97
1.91
1.52
H 4.17
H 1.86  
Figure 5.102: Leucine 
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A search was then undertaken in AntiMarin with the following search profile: 
two doublet methyls, three methylenes and four methines. This returned just 
21 matches. Of these 9 contained a leucyl substructure. The data that had been 
obtained matched quite well with either Leu-4-hydroxy-Pro dipeptide (2 
examples), or cyclo[(4-hydroxyprolinyl)-leucine]  (6 examples) (see Figure 
5.103).  
N
N
H
O
O
OH
b) cyclo[(4-hydroxyprolinyl)-leucine]
N
H
H
N
O
OHO
HO
a) Leu-4-hydroxy-Pro dipeptide  
Figure 5.103: a) Leu-4-hydroxy-Pro dipeptide; b) cyclo[(4-hydroxyprolinyl)-  
leucine]. 
 
These two possibilities differ by 18 amu. The molecular mass of the dipeptide 
would be 244 amu and that for the cyclo[(4-hydroxyprolinyl)-leucine] would 
be 226 amu. Reexamination of the MS data showed an ion at m/z 226.92 (see 
Figure 5.98) and no distinctive ion at m/z 244. On this basis F9330-A2 was 
tentatively assigned as cyclo[(4-hydroxyprolinyl)-leucine]. The assignment of 
the NMR structural data for this tentative structure for F9330-A2 is shown in 
Figure 5.104 and was based on 1H NMR, HSQC and HMBC NMR data. The 
HMBC NMR data is included in Figure 5.105.  
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 183
N
N
H
O
O
OH
H3C
CH3
1
2
5
7
9
10
H
H
H
H
H H
H
H
57.5
53.4
H
36.8
68.0
54.0
38.4
24.1
H
20.9
22.3
0.95
0.97
1.86
1.52
1.91
3.66
3.44
4.47
2.10
2.28
4.16
4.54
 
Figure 5.104: Structure of F9330-2 
 
 
Figure 5.105: HMBC NMR spectrum of F9330-A2 in CD3OD.  
 
Both the cis- and trans- isomers of cyclo[L-(4-hydroxyprolinyl)-L-leucine]  
have been previously isolated (Cronan et al. 1998 and Shigemori et al. 1998). 
The 1H NMR data reported by Shigemori had been acquired in CDCl3 while 
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the data from Cronan and F9330-A2 had been acquired in CD3OD. Solvent 
differences have a greater effect on 1H NMR data than 13C NMR data. Table 
5.19 lists the published data (in CD3OD and CDCl3) for the cis- and trans- 
isomers along with the comparable data for F9330-A2 in CD3OD.  
 
Table 5.19: 1H NMR and 13C NMR data of F9330-A1 and cis- and trans- 
isomers of cyclo-4-hydroxyprolinyl-leucine 
 
run in 
CD3OD  
(500 MHz) 
1H NMR in CD3OD, 
13C NMR in D2O (300 MHz) 
run in CDCl3  
(500 MHz) 
F9330-A2 
cyclo[L-trans-4-
hydroxyprolinyl-
L-leucine] 
cyclo[L-cis-4-
hydroxyprolinyl-
D-leucine] 
cyclo[D-cis-4-
hydroxyprolinyl-
L-leucine] 
Po
si
tio
n 
 
δH  δC  δH  δC  δH  δC  δH  δC  
2   167.7    169.0   169.4   167.7 
3 4.18 53.4 4.15 55.2 3.84 57 3.95 56.2 
4     7.56       7.56   
5   171.9    173.0   171.2   169.8 
6 4.52 57.5 4.51 58.7 4.33 57.6 4.16 56.1 
7a 2.10 2.08 2.24 2.45 
7b 2.28 
36.8 
2.27 
37.7 
2.47 
37.7 
2.45 
36.8 
8 4.47 68.0 4.45 68.9 4.40 68.9 4.45 68.1 
9a 3.44 3.42 3.43 3.34 
9b 3.66 54.0 3.65 54.6 3.65 54.3 3.95 54.0 
10 1.52 1.50 1.61 1.63 
10b 1.91 
38.4 
1.90 
39.4 
1.61  
43.4 
1.63 
42.2 
11 1.86 24.1 1.88 25.8 1.74 25.6 1.75 24.6 
12 0.95 20.9 0.95 22.2 0.95 22 0.95 21.5 
13 0.97 22.3 0.98 23.3 0.98 23.3 0.98 23.0 
 
A careful comparison of the data, especially the 13C NMR data (extracted 
from the HSQC and HMBC NMR spectra) suggested that F9330-A2 was the 
trans isomer. The absolute configuration as L/L or D/D could not be assigned, 
although the L/L is shown in Figure 5.106.  
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Figure 5.106: cyclo[L-trans-4-hydroxyprolinyl-L-leucine] 
 
Unfortunately, this can only be a tentative assignment even though a potential 
structure had been obtained. This is because the presence of aromatic protons 
in this sample cannot be considered spurious.  I am grateful to the Internal 
Examiner, Dr. Sylvia Urban, for pointing out this anomaly. She has suggested 
some alternative, more complex structures that could account for these 
aromatic resonance (see Figure 5.107). Until more definitive NMR and 
ESIMS can be obtained the actual structure for F9330-A2 remains unassigned. 
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Structure 1: MW= 526 amu Structure 2: MW= 524 amu
 
Figure 5.107: Suggested possible structures for fraction F9330-A2 
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5.15.1.3 Peak F9330-A3 
 
A search of UV profile of peak F9330-A3 in the HPLC-UV/Rt library 
database resulted in a close match with pseurotin A3 (Figure 5.108). 
 
 
Figure 5.108: UV spectrum of peak F9330-A3 (black) and cycloaspeptide 
(red) with a search in the HPLC-UV/Rt library database. 
 
The 1H NMR spectrum revealed the fraction F9330-A3 contained impurities 
and could be a mixture of compounds. A greater amount of F9330-A3 is 
required for structural elucidation. 
 
 
5.15.1.4 Peak F9330-A4 
 
The extracted UV spectrum of peak F9330-A4, given below in Figure 5.109 
showed no matches in the HPLC-UV/Rt library database.  
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Figure 5.109: Extracted UV profile for compound F9330-A4. 
 
As was observed for F9330-A2 the ESIMS data for this compound (Figure 
5.110) was inconclusive. Again it was of low intensity and dominated by 
multiple ions. No sensible conclusion could be drawn as to a likely molecular 
mass for F9330-A4.  
 
 
Figure 5.110: ESIMS spectrum of compound F9330-A4 
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As for F9330-A2, the CapProbe 1H NMR spectrum of F9330-4 was 
instructive in revealing the presence of three methylenes, three methines and 
one monosubstituted benzene ring as shown in Figure 5.111  
 
 
Figure 5.111: 1H NMR spectrum of F9330-A4; 15 µg in 5.5 µL of CD3OD, 
recorded at 500 MHz, 180 sec. 
 
A search of the AntiMarin database using the following search profile: zero 
methyl groups, three methylenes, three methines, one monosubstituted 
benzene (Figure 5.112a) returned eight matches of which seven were 
diketopiperazines (Figure 5.112b). Of that seven, six were cyclo[4-hydroxyl-
prolynyl)-phenylalanyl] isomers. The molecular mass of that compound was 
260.288 amu. Reexamination of the ESIMS confirmed that there was an ion at 
m/z 261 amu (see Figure 5.110). 
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Figure 5.112: a) AntiMarin search profile for F9330-A4; b) AntiMarin search 
result for F9330-A4. 
 
 
1H and 13C NMR data previously reported for cyclo[(4-hydroxylprolyl)-
phenylalanyl] (Fdhila, 2003; Furtado, 2005) suggested that the data were 
consistent with that obtained for cyclo[D-cis-4-hydroxylprolyl-D-
phenylalanyl] (Figure 5.113).  
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Figure 5.113: cyclo[D-cis-4-hydroxylprolyl-D-phenylalanyl] 
 
5.15.2 Extract F9332 
 
The crude extract F9332 was obtained from MYPA + MPA culture. HPLC 
analysis revealed the presence of eight peaks appearing across the region Rt 
12-18 min as shown in Figure 5.114. 
 
Figure 5.114: HPLC chromatogram of extract F9332 showing overlay of 
ELSD detection (black) and the UV detection (blue).  
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An interesting preliminary observation of fraction F9332-1 to F9332-8 was 
that none of these compounds displayed a UV chromophore with one 
exception in the UV trace. (see Figure 5.115). 
After fractionation of 700 mg of the extract F9332 followed by HPLC 
microtitre plate collection, the 1H NMR spectra of each of the eight fractions 
were acquired using the CapNMR probe. The 1H NMR spectrum of fraction 
F9332-8 is shown in Figure 5.115. The 1H NMR spectra of fractions F9332-1 
and F9332-4 were identical to that of F9332-8 (Figure 5.116). This suggested 
that F9332-1 to F9332-8 were based on a common repeating subunit.  
 
 
Figure 5.115: 1H NMR spectrum of F9332-8; 29 µg in 5.5 µL of CD3OD, 
recorded at 500 MHz, 240 sec 
 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 192
 
Figure 5.116: 1H NMR spectrum of F9332-4; 10 µg in 5.5 µL of CD3OD, 500 
recorded at MHz, 240 sec. 
 
LCMS (see method in Chapter 2; Section 2.8.3) was used to identify the 
molecular masses and relationships among the fractions (Figure 117). The 
positive ESIMS of fraction F9332-1 to 8 showed that each differed from the 
next by 86 amu (Figure 5.118).   
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Figure 5.117: LCMS of F9332 and fraction F9332-1 to F9332-8. 
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Figure 5.118: A comparison of ESIMS of fraction F9332-1 to 8.
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The 1H NMR and LCMS data allowed the assignment of the repeating 
substructure unit as 3-hydroxybutanoic acid (Figures 5.119a and 5.119b).  
 
HO OH
CH3O
a) 3-hydroxybutanoic acid MW= 104
O
CH3O
b) subunit MW = 86 amu  
Figure 5.119: 3-hydroxybutanoic acid and the repeating subunit. 
 
From ESIMS the molecular mass of peak F9332-1 was 277 amu ([M+H+]) 
corresponding to the esterification of three molecules of 3-hydroxybutanoic 
acid (Figure 5.120). 
 
HO OH
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HO OH
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HO O
O O
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+ O
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HO OH
O
 
Figure 5.120: Esterification of 3-hydroxybutanoic acid 
 
With an increase of 86 amu from fraction to fraction, structures could be 
suggested for the series culminating in the structure of F9332-8 as a polymer 
of 10 molecules of 3-hydroxybutanoic acid (C40H62O21); poly-3-
hydroxybutyrate (Figure 5.121). This compound had previously been found 
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in various bacteria such as Alcaligenes eutrophus or Bacillus megaterium 
(Lόpez et al., 1998; Rueping et al., 2001; and Fukui et al., 2009). 
HO O
O
H
10
Fraction F9332-8  
Figure 5.121: Structure of Fraction F9332-8 
 
The calculated molecular weight of fraction F9332-8 is 878 amu in agreement 
with the observed molecular mass from ESIMS of 879 amu ([M+H+]). Thus 
compounds F9332-1 to F9332-8 are poly-3-hydroxybutyrates (Figure 5.122). 
 
HO O
O
H
n = 3-10
 Fraction F9332-1 to 8  
Figure 5.122: Poly-3-hydroxybutyrates
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Part E: Chaetomium trigonosporum 
 
5.16 CULTURE CHARACTERISTIC AND MORPHOLOGY 
 
Fungal strain 7023@20.1 was isolated from soil collected from Tasman Bay 
(3% phenol plate). This culture shared the characteristic features of the 
ascomyceteous genus Chaetomium. The presence of perithecia with perithecial 
hairs and a Scopulariopsis-like conidial state (Figure 5.123a) was consistent 
with this identification. Colonies on MYPA at 20 °C showed a daily growth rate 
of 2.5-3.3 mm. Ascomata are produced in abundance on the culture and reached 
maturity within 10 days (Figure 5.123b). 
Perithecia were ovate, ostiolate, 200-250 µm × 133-155 µm and bear setae-like 
hairs. Hairs were straight, 3.0-5.5 µm diameter at the base, 100-300 µm length. 
Asci contained 8 ascospores (Figure 5.123c) and are evanesence. Ascospores 
are triangular in front view, ellipsoidal in side view and dark brown when 
mature, 4.5-5.0 × 6.6-7.0 × 1.0-1.2 µm (hight × width × depth) (Figure 
5.123d). 
These very characteristic feaures were consistent with the isolate being 
Chaetomium trigonosporum (Arx et al.;1986 and Corlett; 1966).  
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Figure 5.123: Chaetomium trigonosporum; a) 20 day culture at 25 °C on MYPA plate; b) SEM of conidiospores; c) ascus contained 8 immature 
ascospores; d) SEM of cross section of perithecium; e) ascospores. 
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5.17 EFFECT OF ELICITORS ON THE GROWTH AND THE 
METABOLITE PRODUCTION 
 
5.17.1 Effect of elicitors on the growth of C. trigonosporum 
 
C. trigonosporum was grown on MYPA and SDA at 20 °C for 20 days. The 
colony diameter (three replicates) was measured every 5 days for 20 days 
prior to extraction. A comparison of mycelial growth in the presence of 
elicitors in MYPA and SDA media is shown in Figures 5.124 and 5.125 
respectively. Ascocarp production was observed and is presented in Table 
5.20 
 
Table 5.20: Observation of ascomata production at 20 days incubation. 
Observation of visible ascocarps Elicitors MYPA SDA 
Control ++ +++ 
TTC +++ ++ 
MPA +++ ++ 
TCZ ++ ++ 
NYS 1 U ++ ++ 
PHA 0.1 U +++ ++ 
LB 0.5 µg + + 
LB 0.25 µg ++ ++ 
JAS 0.05 µM ++ ++ 
JAS 0.01 µM +++ ++ 
HDACI IV 1 µM N/O + 
HDACI IV 0.5 µM ++ ++ 
HDACI IV 0.05 µM ++ ++ 
HDACI II 0.8 µM ++ ++ 
HDACI II 0.4 µM +++ ++ 
HDACI II 0.2 µM +++ +++ 
* +++ visible ascomata covering entire colony, ++ visible ascomata 
abundance at the edge of the colony, + visible ascomata under dissection 
microscope, N/O no ascomata production. 
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Figure5.124: Effect of elicitors on the growth of C.trigonosporum. on MYPA medium at 20 °C 
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Figure5.125: Effect of elicitors on the growth of C.trigonosporum. on SDA medium at 20 °C 
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Growth of the fungus was better on MYPA as the media than SDA. No 
growth was observed in the presence of NYS (100 U). All other elicitors 
showed suppression of growth on both media. The greatest inhibition was 
seen in the presence of CLY (10 µM), but several elicitors showed moderate 
suppression; NYS (10 U), CLY (5 and 2.5 µM) and LB (0.5 and 0.25 µg). 
Ascocarp production was greatly effected by the presence of HDACI IV (1 
µM) and LB (0.5 µg) in the media. 
 
5.17.2 Effect of the elicitors on the cytotoxicity of the extracts and the 
metabolite production  
 
5.17.2.1 Effect of elicitors on cytotoxicity of extracts 
 
The cytotoxicity of the extracts from each treatment is shown in Table 5.21. 
The extracts from MYPA and SDA without any addition of elicitor were 
considered as being active against P388 cells (IC50 <12,500), while the rest 
showed no cytotoxicity. 
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Table 5.21: Effect of elicitors on cytotoxicity of extracts from C. 
trigonosporum on MYPA and SDA media (20 °C for 20 days). 
 
Cytotoxicity on both media 
MYPA SDA Elicitors 
Extracts IC50 (ng/mL) Extracts IC50 (ng/mL) 
Control F9270 11,760  F9285 11,713 
TTC F9271  >12,500  F9286  >12,500  
MPA F9272  >12,500  F9287  >12,500  
TCZ F9273  >12,500  F9288  >12,500  
NYS 10 U F9275  >12,500  F9290  >12,500  
NYS 1 U F9276  >12,500  F9291  >12,500  
CLY 10 µM F9277 >12,500  F9292 >12,500  
CLY 5 µM F9278  >12,500  F9293  >12,500  
CLY 2.5 µM F9279  >12,500  F9294  >12,500  
PHA 0.1U F9280  >12,500  F9295  >12,500  
LB 0.5 µg F9281  >12,500  F9296  >12,500  
LB 0.25 µg F9282  >12,500  F9297  >12,500  
JAS 0.05 µM F9283  >12,500  F9298  >12,500  
JAS 0.01 µM F9284  >12,500  F9299  >12,500  
HDACI IV 1 µM F9449  >12,500  F9456  >12,500  
HDACI IV 0.5 µM F9451  >12,500  F9458  >12,500  
HDACI IV 0.05 µM F9453  >12,500  F9460  >12,500  
HDACI II 0.8 µM F9542  >12,500  F9548  >12,500  
HDACI II 0.4 µM F9544  >12,500  F9550  >12,500  
HDACI II 0.2 µM F9546  >12,500  F9552  >12,500  
 
 
5.17.2.2 HPLC screening of the extracts 
 
A comparison of ELSD traces showed no differences in metabolite production 
on either MYPA or SDA with any elicitor (Figures 5.126 and 5.127)  
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Figure 5.126: HPLC traces of extracts from C. trigonosporum cultured on 
MYPA at 20°C for 20 days with addition of different elicitors. 
 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 205
 
Figure 5.127: HPLC traces of extracts from C. trigonosporum cultured on 
SDA at 20°C for 20 days with addition of different elicitors. 
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Part F: Penicillium sp. 
 
5.18 CULTURE CHARACTERISTICS AND MORPHOLOGY 
 
Fungal strain 9045@30.2 was also isolated from soil collected from 
Tiromoana Bush after treatment with 5% phenol. Morphological 
characteristics of the isolate 9045@30.2 are shown in Figure 5.128. Colonies 
on MYPA medium attained 30-35 mm diameter in ten days at 20 °C and 60-
65 mm diameter in 20 days. Mycelia were pale yellow to light brown, 
conidiogenesis abundant, greenish grey, reverse brown (Figure 5.128a) 
Culture on SDA led to a colony 20-25 mm diameter after ten days at 20 °C 
and 40-45 mm in 20 days, mycelium were white, conidiogenesis moderate, 
dark green, reverse pale brown (Figure 5.128b). Conidiophores were borne 
from aerial hyphae, stipes 20-150 x 2.0-2.5 µm, smooth walled, 
monoveriticillate. Phialides in verticils of four, ampulliform, 4-6 x 2.0-2.5 µm 
(Figure 5.128c); conidia subspheroidal to ellipsoidal, 1.5-2.0 µm diameter 
with smooth walls, borne in irregular chains (Figure 5.128d). A comparison 
of colony and morphological features with the description by Pitt (1979) 
enabled strain 9045@30.2 to be identified as a Penicillium sp. 
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Figure 5.128: Penicillium sp. a) 20 day colony on MYPA plate at 20 °C; b) 
20 day colony on SDA plate at 20 °C; c) SEM of conidiophores and conidia; 
d) conidia.  
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5.19 EFFECT OF THE ELICITORS ON GROWTH AND 
METABOLITE PRODUCTION 
 
5.19.1 Effect of the elicitors on growth of Penicillium sp. 
 
Penicillium sp. was grown on MYPA and SDA media at 20 °C for 20 days. 
Colony diameter (three replicates) was measured every 5 days for 20 days 
prior to extraction. A comparison of mycelial growth of Penicillium sp. in the 
presence of elicitors in MYPA and SDA media is shown in Figures 5.129 and 
5.130 respectively. 
It was noted that no growth was observed in the presence of cycloheximide 
and nystatin (100 U and 10 U concentrations) in the media. Growth of the 
fungus was greater on MYPA than SDA and that the growth rate declined 
after 15 days incubation. In the presence of elicitors, growth on MYPA was 
suppressed by LB (0.5 and 0.25 µg), while growth on SDA was suppressed by 
LB (0.5 and 0.25 µg) and MPA. A small enhancement of growth was found 
when TCZ and Jas (0.01 µM) were present in the media.  
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Figure 5.129: Effect of elicitors on the growth of Penicillium sp. on MYPA at 20 °C 
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Figure 5.130: Effect of elicitors on the growth of Penicillium sp. on SDA at 20 °C 
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5.19.2 Effect of elicitors on cytotoxicity and metabolite production  
 
5.19.2.1 Effect of the elicitors on the cytotoxicity of extracts 
 
The P388 cytotoxicity of the extracts from each treatment is shown in Table 
5.22. The extract from MYPA without any addition of elicitor was considered 
as being active (IC50 <12,500), while the rest showed no cytotoxicity. 
 
Table 5.22: Effect of the elicitors on the cytotoxicity of the extracts from 
Penicillium sp on MYPA and SDA media (20 °C for 20 days). 
 
Cytotoxicity on both media 
MYPA SDA Elicitors 
Extracts IC50 (ng/mL) Extracts IC50 (ng/mL) 
Control F9270 9,802  F9285 >12,500 
TTC F9271  >12,500  F9286  >12,500  
MPA F9272  >12,500  F9287  >12,500  
TCZ F9273  >12,500  F9288  >12,500  
NYS 1 U F9276  >12,500  F9291  >12,500  
PHA 0.1 U F9280  >12,500  F9295  >12,500  
LB 0.5 µg F9281  >12,500  F9296  >12,500  
LB 0.25 µg F9282  >12,500  F9297  >12,500  
JAS 0.05 µM F9283  >12,500  F9298  >12,500  
JAS 0.01 µM F9284  >12,500  F9299  >12,500  
HDACI IV 1 µM F9449  >12,500  F9456  >12,500  
HDACI IV 0.5 µM F9451  >12,500  F9458  >12,500  
HDACI IV 0.05 µM F9453  >12,500  F9460  >12,500  
HDACI II 0.8 µM F9542  >12,500  F9548  >12,500  
HDACI II 0.4 µM F9544  >12,500  F9550  >12,500  
HDACI II 0.2 µM F9546  >12,500  F9552  >12,500  
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5.19.2.2 HPLC screening of the extracts 
 
A comparison of ELSD traces showed no significant metabolite peaks present 
in extracts from Penicillium sp. when grown on MYPA and SDA with any 
elicitor (Figures 5.131 and 5.132)  
 
 
Figure 5.131: HPLC traces of extracts from Penicillium sp. cultured on 
MYPA at 20°C for 20 days with addition of different elicitors. 
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Figure 5.132: HPLC traces of extracts from Penicillium sp. cultured on SDA 
at 20°C for 20 days with addition of different elicitors. 
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Part G: Unidentified culture 9017@20.14. 
 
5.20 CULTURE CHARACTERISTICS AND MORPHOLOGY 
 
Fungal strain 9017@20.14 was isolated from soil collected from Tiromoana 
Bush after treatment with 7% phenol. Culture on SDA medium: 30-35 mm 
diameter in 10 days at 20 °C; mycelium white, reverse creamy (Figure 
5.133a), culture reaching 70-75 mm diameter in 20 days (Figure 5.133b). The 
culture remained sterile during studies and hence a positive identification 
could not be made using cultural characteristics. 
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Figure 5.133: Isolate 9017@20.14. a) 10 d colony on SDA at 20 °C; b) 20 
day colony on SDA at 20 °C; c-d) SEM of hyphae. 
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5.21 EFFECT OF ELICITORS ON GROWTH AND METABOLITE 
PRODUCTION 
 
5.21.1 Effect of elicitors on growth of 9017@20.14 
 
Fungal isolate 9017@20.14 was grown on MYPA and SDA media at 20 °C for 
20 days. Colony diameter (three replicates) was measured every 5 days for 20 
days prior to extraction. A comparison of mycelial growth of the fungus in the 
presence of elicitors in MYPA and SDA is shown in Figures 5.134 and 5.135 
respectively. 
No growth was observed in the presence of cycloheximide and nystatin (100 
U and 10 U concentrations). No difference between the growth on MYPA and 
SDA was observed.  Suppression of growth was found in the presence of LB 
(0.5 and 0.25 µg) and MPA in both media.  
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Figure 5.134: Effect of elicitors on growth of isolate 9017@20.14 on MYPA at 20 °C 
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Figure 5.135: Effect of elicitors on growth of isolate 9017@20.14 on SDA at 20 °C 
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5.21.2 Effect of the elicitors on cytotoxic and metabolite production  
 
5.21.2.1 Effect of the elicitors on cytotoxicity of extracts 
 
P388 cytotoxicity of extracts from each treatment is shown in Table 5.23. The 
extracts from MYPA and SDA without addition of elicitor were considered as 
being active against P388 cells (IC50 <12,500), while the remainder showed 
no cytotoxicity. 
 
Table 5.23: Effect of elicitors on cytotoxicity of extracts from isolate 
9017@20.14 on MYPA and SDA media (20 °C for 20 days). 
 
Cytotoxicity on both media 
MYPA SDA Elicitors 
Extracts IC50 (ng/mL) Extracts IC50 (ng/mL) 
Control F9270 11,032 F9285 9,014  
TTC F9271  >12,500  F9286  >12,500  
MPA F9272  >12,500  F9287  >12,500  
TCZ F9273  >12,500  F9288  >12,500  
NYS 1 U F9276  >12,500  F9291  >12,500  
PHA 0.1 U F9280  >12,500  F9295  >12,500  
LB 0.5 µg F9281  >12,500  F9296  >12,500  
LB 0.25 µg F9282  >12,500  F9297  >12,500  
JAS 0.05 µM F9283  >12,500  F9298  >12,500  
JAS 0.01 µM F9284  >12,500  F9299  >12,500  
HDACI IV 1 µM F9449  >12,500  F9456  >12,500  
HDACI IV 0.5 µM F9451  >12,500  F9458  >12,500  
HDACI IV 0.05 µM F9453  >12,500  F9460  >12,500  
HDACI II 0.8 µM F9542  >12,500  F9548  >12,500  
HDACI II 0.4 µM F9544  >12,500  F9550  >12,500  
HDACI II 0.2 µM F9546  >12,500  F9552  >12,500  
 
 
 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 220
5.21.2.2 HPLC screening of the extracts 
 
An examination of the ELSD HPLC traces showed that no significant 
metabolite peaks present in the extracts from 9017@20.14 when grown on 
MYPA and SDA with any elicitor (Figures 5.136 and 5.137)  
 
 
Figure 5.136: HPLC traces of extracts from isolate 9017@20.14 cultured on 
MYPA at 20°C for 20 days with addition of different elicitors. 
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Figure 5.137: HPLC traces of extracts from isolate 9017@20.14 cultured on 
SDA at 20°C for 20 days with addition of different elicitors. 
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5.22 DISCUSSION 
 
In the study of the effect of culture conditions on metabolite production with 
P. zonatum and C. globosum it was established that the optimum temperature 
for cytotoxic metabolite production was 20 °C (see Table 5.2), which was 
lower than the optimum temperature for growth (25 °C) (see Figures I and II 
in Appendix III). This was consistent with the previous studies of Weinberg 
(1974) and Votruba and Vanek (1989) who found that the optimal temperature 
for secondary metabolites was often lower than that for growth of the 
producing microorganism. This phenomenon was explained by Farrell and 
Rose (1967) and Demian (1968) who commented that cultivation of 
microorganisms at sub-optimal temperature reduced the metabolic process of 
the microorganisms and hence the demand for the substrate supporting 
primary metabolism was also decreased. Therefore, this rapid growth rate will 
result in a low secondary metabolite yield.  
The phase of fermentation was also another important factor for metabolite 
productions. Liquid fermentation is favoured by many researchers, especially 
for those who work in large-scale fermentation, or work with bacteria and 
actinomycete cultures. The fact that the control of fermentation in liquid 
culture is simpler than for solid culture and less labour is required probably 
accounts for this preference (Espinosa and Webb, 2003). In this study, 
however, the cytotoxicity of P. zonatum, C. globosum and C. trigonosporum 
was dominant when grown on solid media.  These results conform with those 
reported by Ooijkaas et al. (2000), Robinson et al. (2001), Hölker et al. 2004 
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and Barrios et al. (2005) who found that  fungal metabolite production was 
better on solid state than liquid state fermentation. Hölker et al. (2004) also 
pointed out that Ascomycetes and Basidiomycetes spent their evolutionary 
history as terrestrial organisms, therefore enzymes, secondary metabolites and 
spores were developed to be optimized to a moist solid substrate and not a 
liquid. Consequently, the cultivation of Ascomycetes in aqueous suspension 
may in fact impair their metabolic efficiency. Furthermore, Robinson et al. 
(2001) and Barrios et al. (2005) also stated that the oxygen transfer in liquid 
medium is very low due to the viscosity of the media and hence interferes 
with the yield of the metabolite production of the fungi.  
During the study of the effect of elicitors on metabolite production a 
correlation between ascomata development and production of metabolites 
from the fungi was observed. Observations on ascomata production on P. 
zonatum. C. globosum and Xylaria sp. showed that in the presence of elicitors 
(such as HDACI II and HDACI IV) ascomata production was suppressed. 
These were the cultures that showed poor cytotoxicity and low metabolite 
production compared with cultures where ascomata production was not 
effected by elicitors. This phenomenon has been explained by Bennett and 
Cegler (1983) and Deacon (2006) as both the process of morphogenesis and 
the production of secondary metabolites starts at the end of exponential 
growth phase. Many other studies have also found that secondary metabolites 
in fungi are frequently associated with differentiation and sporulation and in 
most cases the secondary metabolites are not produced during log phase 
growth, but rather occur during the stationary phase (Adams and Yu, 1998, 
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Barrios et al. (2005) and Zain et al., 2009). For future studies in this area a 
definite consideration might be to allow a longer cultivation period for those 
cultures for which ascomata production had been suppressed by elicitors. This 
longer cultivation period might allow ascomata production to occur and with 
it possible metabolite production. Nevertheless, it would also be time 
consuming and would lead to unpredictable observations in those cases where 
the production of ascomata was permanently suppressed by elicitors.  
It is believed that the production of secondary metabolites is affected by 
external stimuli such as environmental stress, competition and infection 
(Strohl, 2000). In this study, the production of poly-3-hydroxybutyrate (PHB) 
in Bombardia sp. was observed in the presence of elicitors in MYPA. PHB is 
produced by microorganisms, especially bacteria, for use as an intracellular 
carbon source, as an energy storage material and as storage of reductase 
equivalents (Rueping et al. 1998 and Wendlandt et al. 2001). In this case the 
production of PHB could have been a response to conditions of physiological 
stress (Lόpez et al. 1998).  
Many studies in the past clearly showed that the presence of elicitors in the 
medium at subinhibitory concentration were found to enhance and modulate 
the production of secondary metabolites. For example, tetracycline was used 
to induce the production of phenazine in Streptomyces sp. (Mitova et al. 
2008a), or the use of jasplakinolide to induce a production of chaetoglobosin 
from Phomospis asparagi (Christian et al. 2005). These studies were 
performed in liquid culture media. Nevertheless, the effect of these elicitors 
was also observed in the solid media in this study.  
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Four out of the seven selected fungi in this study clearly showed that 
metabolite production was effected by either media composition, elicitors or 
both in combination. The HPLC traces for P. zonatum (see Figures 5.10 and 
5.11) showed that no modulation in metabolite productions had occurred, but 
an enhancement of metabolite production was observed in the presence of 
elicitors on both media. As for C. globosum, modulation and enhancement 
were observed in the presence of elicitors in both media (Figures 5.38 and 
5.39). The media compositions were found to play a major role in the 
metabolite production for Xylaria sp. and Bombardia sp. Metabolite 
production was maximised when Xylaria sp. was grown on SDA rather than 
MYPA media (Figures 5.69 and 5.70), while in Bombardia sp. the metabolite 
production was maximised on MYPA, not SDA media (Figures 5.93 and 
5.94). This could have been a result of the differences in the carbon and 
nitrogen sources in the media. In MYPA the main carbon source is the malt 
extract and the main nitrogen sources are peptone and the yeast extract, while 
in SDA the carbon source is dextrose and the main nitrogen source is the yeast 
extract (Atlast, 1993). This assumption was perhaps confirmed by the early 
study of Olutiola and Cole (1977) who found that differences in carbon and 
nitrogen sources could effect the growth and differentiation of fungi.  
The careful selection of fungal strains should not be neglected for OSMAC 
studies. As stated earlier by Bode et al. (2000b) fungi or bacteria that produce 
secondary metabolites often have the potential to biosynthesise many 
alternative compounds from a single strain. This tendency was clearly 
demonstrated by C. globosum and Xylaria sp. in this study as they showed a 
 
Chapter 5: Effect of culture conditions and elicitors on metabolite 
production 
 
 
 226
modulation in metabolite production in the presence of elicitors. These two 
fungal strains were recognized as the reproductive strain for biologically 
active secondary metabolite production. For example, metabolites such as 
azaphilones, chaetoglobosins and chaetoviridins are produced by C. globosum 
(Probst and Tamn, 1981; Takahashi et al. 1990; Jiao et al. 2004; Ding et al. 
2005 and Park et al. 2005). For Xylaria sp. the bioactive metabolites would 
include the xyloketal derivatives, the antimalarial benzoquinones, the 
antifungal multipolides, and the cytotoxic metabolites such as the 
cytochalasins and tetralone derivatives (Boonphong et al. 2001; Wu et al. 
2005; Tansuwan et al. 2007; Gu and Ding, 2008 and Pongcharoen et al. 
2008). Surprisingly Penicillium sp., which was also recognized as a 
productive species (Ariyo et al. 1996) did not produce any metabolites at all 
in this study. This could have been due to strain selection up to the species 
level.  
In most cases, the presence of LB (0.5 µg) or HDACI II and HDACI IV at all 
concentrations was found to suppress metabolite production. Despite the 
association between metabolite production and ascomata production 
mentioned above, another possibility could be that the concentrations of the 
elicitors used in this study were too high and beyond the subinhibitory point. 
For future studies the focus would be to obtain a single strain of a fungus and 
this strain would be treated with a wider variation of elicitor concentrations.  
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Chapter 6 
 
Conclusions and future work 
 
As part of the investigation into means of culturing less readily isolatable 
fungi from soil, especially Ascomycetes, a series of experiments were 
performed with the aim of increasing the opportunity to discover novel 
bioactive metabolites. These experiments were guided by a set of aims. 
The first aim was to develop a selective isolation technique for 
Ascomycetes. Once developed the technique would be used on soil samples 
selected from around New Zealand. A phenol pasteurization technique was 
successfully developed and a total of 407 isolates were obtained from 2-8% 
phenol treatments. Analysis of results indicated that treatment with 3% and 
4% phenol were the most useful concentration for partial pasteurization of 
the soil. At these concentrations a greater variety of fungal isolates and 
Ascomycetes were more frequently isolated. A 2% phenol elimination of the 
fast growing mucoraceous fungi was not successful. As for higher phenol 
treatments (5% to 8%), fewer fungal isolates were retrieved and of those that 
were, most had also been retrieved at lower phenol levels.  
The second aim was to discover which of the isolates was producing 
bioactive compounds. This could be either cytotoxicity, antifungal or 
antimicrobial activity. Of the 407 isolates, 123 were active against P388 
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cells and 40 extracts were active against B. subtilis (<20% cell viability) and 
19 active against C. albicans (<20% cell viability). None of the extracts 
were active against P. aeruginosa. Of the total of 123 extracts that were 
active against P388 cell in the quick screen assay, 87 extracts showed IC50 
values <12,500 ng/mL. These were selected for further investigation. 
Thirdly, a chemical characterization of metabolites in active extracts was 
undertaken. The structural elucidation of the metabolites of interest was 
greatly aided by the in-house dereplication techniques consisting of a 
combination of HPLC-UV/Rt database, MS analysis, the CapNMR technique 
and the AntiMarin Database. A significant advantage was gained by the use 
of the CapNMR technique which enabled full NMR characterization on very 
small quantities of pure compounds (<20 µg). From the dereplication 
studies, 48 known compounds were identified from the active extracts. For a 
summary of the compounds identified from the active extracts see Table 
4.2. Two new metabolites, F7301-1 (Figure 5.28) and F7301-2 (Figure 
5.31) were isolated and identified from Pseudeurotium zonatum. This was a 
fungal isolate that had been retrieved from a soil sample treated with 4% 
phenol.  
Finally, manipulation of the metabolite profile of seven selected fungi was 
undertaken. This work was based on the OSMAC (one strain many 
compounds) and hormetic (low-dose stimulation and high-dose inhibition) 
concept. Of these seven chosen fungi, three isolates (Chaetomium globosum. 
Xylaria sp. and Bombardia sp.) could have their secondary metabolite 
production altered by use of subinhibitory concentrations of elicitors. In the 
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case of C. globosum, tetrahydrofuran A and tetrahydrofuran B were the main 
compounds produced when the fungus was grown on media without 
elicitors. Production of chaetoviridin A and chaetoglobosin A were induced 
when this isolate was treated with certain elicitors (summary in Table 5.2).  
Xylaria sp. was found to produce more metabolites when it was grown on 
SDA than MYPA indicating the importance of the growth medium for 
metabolite studies in addition to elicitors. The known compound ternatin 
was the main compound isolated from this strain on SDA without elicitors. 
With elicitors (as listed in Table 5.16), an enhancement in the production of 
2-hexylidene-3-methylsuccinic acid, dechlorogriseofulvin and griseofulvin 
was observed and production of chaetoglobosin E also induced. Compounds 
cyclo[L-trans-4-hydroxyprolinyl-L-leucine] and cyclo[D-cis-4-
hydroxylprolyl-D-phenylalanyl] were isolated from Bombardia sp. when it 
was grown on MYPA without elicitors. Eight metabolite peaks, which were 
subsequently identified to be a series of poly-3-hydroxybutyrates (n=3-10), 
were induced by all elicitors except LB. No metabolites were observed on 
SDA.  
Enhancement of metabolite productions in P. zonatum was observed in the 
presence of certain elicitors, but there was no induction of new metabolite 
production. Finally, neither enhancement nor inducement were observed in 
C. trigonosporum, Penicillium sp. and isolate 9017@20.14 when they were 
treated with elicitors.  
The original aims, as outlined in the Introduction, were accomplished. It was 
perhaps disappointing that a greater range of new bioactive compounds were 
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not discovered and that it was difficult to accomplish the induction of new 
metabolites in the OSMAC experiments. The work conducted in this thesis 
was confined to a study of Ascomycetes species. The study has made a 
significant contribution in understanding how to better produce and 
manipulate secondary metabolites of the Ascomycetes species. The 
successful OSMAC studies that have been reported have mainly focused on 
the Actinomycetes not Ascomycetes. It is possible that Ascomycetes are not 
as easily manipulated under OSMAC conditions as are the Actinomycetes. 
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Media for Isolation and Cultivation 
 
MEDIA FOR ISOLATION METHOD 
 
Chlortetracycline/streptomycin antibacterial solution 
 
2.5 g streptomycin sulfate (Sigma) and 0.5 g chlortetracycline hydrochloride 
(sigma) were dissolved in 100 mL distilled water. The solution was sterile filtered 
and stored frozen at -20 °C.   
 
¼ strength Sabouraud dextrose agar-chlortetracycline/streptomycin medium 
(¼SDA+) 
 
3.9 g Sabouraud dextrose agar (Oxoid), 0.6 g yeast extract (Oxoid), and 9.0 g  
bacteriological agar (Oxoid) were dissolved in 600 mL distilled water. The 
medium pH of 5.7 (±0.1) was measured and recorded prior to sterilization. 
Addition of 6.0 mL antibacterial solution was made to the media prior to plate 
preparation. 
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MEDIA FOR CULTIVATION METHOD 
 
Malt yeast peptone agar (MYPA)  
12.0 g malt extract (Oxoid), 1.8 g peptone (Oxoid), 0.6 g yeast extract (Oxoid) 
and 9.0 g bacteriological agar (Oxoid) were dissolved in 600 mL distilled water. 
The medium pH was measured and recorded as pH 6.1 (±0.1) prior to sterilization  
  
¼ strength Sabouraud dextrose agar (¼ SDA) 
3.9 g Sabouraud dextrose agar (Oxoid), 0.6 g yeast extract (Oxoid) and 9.0 g  
bacteriological agar (Oxoid) were dissolved in 600 mL distilled water. The 
medium pH was measured and recorded as pH 5.7 (±0.1) prior to sterilization.  
 
 
MEDIA FOR ONE STRAIN MANY COMPOUNDS (OSMAC) APPROACH 
 
Base media used in this experiment were MYPA and ¼ SDA. The elicitors, as 
outlined below, were added to the base media.  
 
Tetracycline 
A 25 mg/mL tetracycline (Sigma) stock solution was prepared in sterile distilled 
water. 24 µL was then added to 600 mL of base media to give a final concentration 
of 1 µg/mL of tetracycline in each agar plate. 
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Mycophenolic acid  
A 25 mg/mL mycophenolic acid (Sigma) stock solution was prepared in methanol. 
36 µL of stock solution was then added to 600 mL of based media to give a final 
concentration of 1.5 µg/mL of mycophenolic acid in each agar plate. 
 
Tricyclazole 
A 5 mg/mL tricyclazole (Sigma) stock solution was prepared in methanol. 180 µL 
of stock solution was then added to 600 mL of base media to give a final 
concentration of 1.5 µg/mL of tricyclazole in each agar plate. 
 
Nystatin 
A nystatin stock solution of 10000 U/mL (Sigma) was diluted to give a final 
concentration of 100 , 10 and 1U/mL of nystatin in each agar plate. 
 
Cycloheximide 
A 0.5 mM cycloheximide (Sigma) stock solution was prepared in sterile distilled 
water and diluted to give final concentrations of 10, 5 and 2.5 µM of cycloheximide 
in each agar plate. 
 
Phalloidin 
A stock phalloidin solution of 200 U/mL (Sigma) was diluted to give a final 
concentration of 0.1 U/mL of phalloidin in each agar plate. 
 
Latrunculin B  
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A 1 mg/mL latrunculin B (Sigma)  stock solution was prepared in methanol and 
diluted to give final concentrations of 0.5 and 0.25 µg/mL of latrunculin B in each  
agar plate. 
 
Jasplakinolide  
A 1 mM jasplakinolide (CALBIOCHEM) stock solution was prepared in methanol 
and diluted to give final concentrations of 0.05 and 0.01 µM of jasplakinolide in 
each agar plate.   
 
Histone Deacetylase Inhibitor II 
A 22 mM Histone Deacetylase Inhibitor II (CALBIOCHEM) stock solution was 
prepared in methanol and diluted to give final concentrations of 0.8, 0.4 and 0.2 
µM of Histone Deacetylase Inhibitor II in each agar plate. 
 
Histone Deacetylase Inhibitor IV 
A 500 µM Histone Deacetylase Inhibitor IV (CALBIOCHEM) stock solution was 
prepared in methanol and diluted to give final concentrations of 1, 0.5 and 0.05 
µM of Histone Deacetylase Inhibitor IV in each agar plate. 
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Appendix II 
 
Colony count from each soil sample 
 
Table I: Colony count from soil site 151.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 0 9 250 250 250 5 0 0 0 0 0 
10 0 500 500 500 500 10 0 0 0 0 0 
15 500 500 500 500 500 15 0 0 0 0 0 
20 500 500 500 500 500 20 0 0 0 0 0 
25 500 500 500 500 500 25 0 0 0 0 0 
30 300 500 500 500 500 30 0 0 0 0 0 
0% 
37 0 300 500 500 500 
5% 
37 0 0 0 0 0 
5 0 0 0 2 6 5 0 0 0 0 0 
10 0 4 4 4 4 10 0 0 0 0 0 
15 1 5 55 55 55 15 0 0 0 0 0 
20 2 9 10 10 10 20 0 0 0 0 0 
25 4 5 5 5 5 25 0 0 0 0 0 
30 1 7 7 7 7 30 0 0 0 0 0 
2% 
37 0 0 0 0 0 
6% 
37 0 0 0 0 0 
5 0 0 0 1 1 5 0 0 0 0 0 
10 0 1 1 1 5 10 0 0 0 0 0 
15 0 5 5 5 5 15 0 0 0 0 0 
20 1 10 11 11 11 20 0 0 0 0 0 
25 2 4 4 4 4 25 0 0 0 0 0 
30 0 1 1 1 1 30 0 0 0 0 0 
3% 
37 0 0 0 0 0 
7% 
37 0 0 0 0 0 
5 0 0 0 1 3 5 0 0 0 0 0 
10 0 0 0 1 2 10 0 0 0 0 0 
15 0 0 0 3 3 15 0 0 0 0 0 
20 0 1 1 5 5 20 0 0 0 0 0 
25 0 3 3 3 4 25 0 0 0 0 0 
30 0 2 2 4 4 30 0 0 0 0 0 
4% 
37 0 0 0 0 0 
8% 
37 0 0 0 0 0 
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Table II: Colony count from soil site 381.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 0 9 250 250 250 5 0 0 0 0 0 
10 0 500 500 500 500 10 0 0 0 0 0 
15 500 500 500 500 500 15 0 0 0 0 11 
20 500 500 500 500 500 20 0 0 5 10 11 
25 500 500 500 500 500 25 0 0 0 0 0 
30 300 500 500 500 500 30 0 0 0 0 0 
0% 
37 0 300 500 500 500 
5% 
37 0 0 0 0 0 
5 0 0 2 2 2 5 0 0 0 0 0 
10 0 1 3 3 3 10 0 0 0 0 0 
15 0 3 3 5 5 15 0 0 0 0 18 
20 4 10 17 19 19 20 0 0 0 0 1 
25 2 5 8 9 9 25 0 0 0 0 0 
30 0 2 3 5 5 30 0 0 0 0 0 
2% 
37 2 2 2 2 2 
6% 
37 0 0 0 0 0 
5 0 0 1 1 1 5 0 0 0 0 0 
10 0 0 1 1 1 10 0 0 0 0 0 
15 0 0 1 3 3 15 0 0 0 0 6 
20 1 7 9 11 11 20 0 0 0 0 0 
25 0 1 5 8 8 25 0 0 0 0 0 
30 0 0 1 1 1 30 0 0 0 0 0 
3% 
37 0 0 0 0 0 
7% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 0 0 0 10 0 0 0 0 0 
15 0 2 2 2 2 15 0 0 0 0 0 
20 0 2 6 8 8 20 0 0 0 0 0 
25 0 1 4 8 8 25 0 0 0 0 0 
30 0 0 0 0 0 30 0 0 0 0 0 
4% 
37 0 0 0 0 0 
8% 
37 0 0 0 0 0 
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Table III: Colony count from soil site 418.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 0 0 101 101 101 5 0 0 0 0 0 
10 0 36 243 243 245 10 0 0 0 0 0 
15 67 107 284 300 500 15 0 0 0 0 0 
20 100 203 300 500 500 20 0 0 0 0 0 
25 83 100 500 500 500 25 0 0 0 0 0 
30 52 70 84 100 100 30 0 0 0 0 0 
0% 
37 0 0 0 0 0 
5% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 0 0 0 10 0 0 0 0 0 
15 0 0 0 0 0 15 0 0 0 0 0 
20 0 0 0 0 0 20 0 0 0 0 0 
25 0 0 0 0 0 25 0 0 0 0 0 
30 0 0 0 0 0 30 0 0 0 0 0 
2% 
37 0 0 0 0 0 
6% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 0 0 0 10 0 0 0 0 0 
15 0 0 0 0 0 15 0 0 0 0 0 
20 0 0 0 0 0 20 0 0 0 0 0 
25 0 0 0 0 0 25 0 0 0 0 0 
30 0 0 0 0 0 30 0 0 0 0 0 
3% 
37 0 0 0 0 0 
7% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 0 0 0 10 0 0 0 0 0 
15 0 0 0 0 0 15 0 0 0 0 0 
20 0 0 0 0 0 20 0 0 0 0 0 
25 0 0 0 0 0 25 0 0 0 0 0 
30 0 0 0 0 0 30 0 0 0 0 0 
4% 
37 0 0 0 0 0 
8% 
37 0 0 0 0 0 
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Table IV: Colony count from soil site 456.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 500 500 500 500 500 5 0 0 0 0 0 
10 500 500 500 500 500 10 0 0 0 0 0 
15 500 500 500 500 500 15 0 0 0 1 1 
20 500 500 500 500 500 20 0 0 0 0 0 
25 500 500 500 500 500 25 0 3 4 6 6 
30 500 500 500 500 500 30 0 0 0 0 0 
0% 
37 500 500 500 500 500 
5% 
37 0 0 0 0 0 
5 0 0 0 8 8 5 0 0 0 0 0 
10 0 9 9 15 15 10 0 0 0 0 0 
15 4 21 21 24 24 15 0 2 2 5 5 
20 2 29 32 32 32 20 0 4 4 5 5 
25 2 32 500 500 500 25 0 2 5 5 5 
30 1 5 500 500 500 30 0 2 3 3 3 
2% 
37 0 0 0 0 0 
6% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 0 26 26 10 0 0 0 1 1 
15 0 72 72 72 72 15 0 2 3 5 5 
20 0 46 63 63 63 20 0 0 0 0 0 
25 0 7 13 16 16 25 0 0 3 3 3 
30 0 2 2 2 2 30 0 0 0 0 0 
3% 
37 0 0 0 0 0 
7% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 0 7 7 10 0 0 0 0 0 
15 0 13 13 13 13 15 0 0 0 0 0 
20 0 10 12 12 12 20 0 0 0 0 0 
25 0 12 12 12 12 25 0 0 0 0 0 
30 0 4 6 6 6 30 0 0 0 0 0 
4% 
37 0 0 0 0 0 
8% 
37 0 0 0 0 0 
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Table V: Colony count from soil site 654.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 250 500 500 500 500 5 0 0 0 0 0 
10 500 500 500 500 500 10 0 0 0 4 5 
15 500 500 500 500 500 15 0 0 0 0 0 
20 500 500 500 500 500 20 0 0 0 1 2 
25 500 500 500 500 500 25 0 0 0 1 1 
30 74 150 500 500 500 30 0 0 0 0 0 
0% 
37 18 500 500 500 500 
5% 
37 0 0 0 0 0 
5 0 1 2 2 2 5 0 0 0 0 0 
10 2 6 8 10 13 10 0 0 0 0 0 
15 4 10 12 13 17 15 0 0 0 0 1 
20 17 500 500 500 500 20 0 0 0 0 0 
25 3 500 500 500 500 25 0 0 0 0 0 
30 7 13 13 13 13 30 0 0 0 0 0 
2% 
37 1 2 2 2 2 
6% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 2 5 7 10 0 0 0 0 0 
15 1 2 4 4 5 15 0 0 0 0 0 
20 1 5 6 6 6 20 0 0 0 0 0 
25 0 5 5 5 5 25 0 0 0 0 0 
30 0 0 0 0 1 30 0 0 0 0 0 
3% 
37 1 1 1 1 1 
7% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 3 6 6 10 0 0 0 0 0 
15 2 2 4 3 3 15 0 0 0 0 2 
20 0 1 1 1 3 20 0 0 0 0 0 
25 0 2 6 6 7 25 0 0 0 0 0 
30 0 3 3 4 4 30 0 0 0 0 0 
4% 
37 0 0 0 0 0 
8% 
37 0 0 0 0 0 
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Table VI: Colony count from soil site 701.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 0 500 500 500 500 5 0 0 0 0 102 
10 500 500 500 500 500 10 0 0 0 0 113 
15 500 500 500 500 500 15 0 0 0 0 101 
20 500 500 500 500 500 20 0 67 107 110 110 
25 500 500 500 500 500 25 77 90 92 95 100 
30 65 300 500 500 500 30 67 105 107 110 113 
0% 
37 35 200 300 500 500 
5% 
37 0 0 0 0 2 
5 0 0 37 76 76 5 0 0 0 0 32 
10 0 0 40 46 49 10 0 0 0 0 93 
15 14 19 41 41 43 15 0 0 0 0 77 
20 6 12 12 14 14 20 0 60 92 93 93 
25 19 20 31 32 32 25 62 87 91 92 93 
30 0 6 18 20 20 30 39 95 97 100 107 
2% 
37 1 1 7 8 8 
6% 
37 0 0 0 0 1 
5 0 0 20 57 60 5 0 0 0 0 0 
10 0 0 30 73 74 10 0 0 0 0 3 
15 8 26 35 49 51 15 0 0 0 0 30 
20 28 38 43 56 57 20 0 35 73 73 73 
25 7 21 22 31 31 25 7 60 62 67 67 
30 0 26 27 31 31 30 28 69 75 79 64 
3% 
37 0 0 0 0 0 
7% 
37 0 0 0 0 0 
5 0 0 40 50 50 5 0 0 0 0 0 
10 0 0 40 64 65 10 0 0 0 0 0 
15 0 21 47 70 70 15 0 0 0 0 0 
20 20 40 43 60 60 20 0 0 0 10 11 
25 7 30 60 76 76 25 0 31 40 49 49 
30 0 31 31 47 47 30 0 38 40 42 47 
4% 
37 0 0 0 0 0 
8% 
37 0 0 0 0 0 
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Table VII: Colony count from soil site 702.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 5 6 500 500 500 5 0 0 0 0 0 
10 200 500 500 500 500 10 0 0 0 0 68 
15 300 500 500 500 500 15 0 0 0 0 84 
20 300 500 500 500 500 20 0 0 12 52 67 
25 400 500 500 500 500 25 0 0 10 22 29 
30 50 500 500 500 500 30 0 0 5 7 7 
0% 
37 3 250 500 500 500 
5% 
37 0 0 0 0 0 
5 0 0 0 0 8 5 0 0 0 0 0 
10 0 0 0 3 7 10 0 0 0 0 35 
15 6 7 18 45 45 15 0 0 0 0 3 
20 15 47 50 50 58 20 0 0 9 42 59 
25 12 28 30 32 35 25 0 0 7 9 20 
30 50 5 10 11 11 30 0 0 0 0 0 
2% 
37 1 1 1 6 9 
6% 
37 0 0 0 0 0 
5 0 0 0 0 9 5 0 0 0 0 0 
10 0 0 0 54 62 10 0 0 0 0 0 
15 0 8 32 52 70 15 0 0 0 0 66 
20 2 37 42 55 71 20 0 0 7 40 49 
25 5 15 26 29 29 25 0 0 0 1 0 
30 4 4 14 19 14 30 0 0 0 0 0 
3% 
37 0 0 0 0 0 
7% 
37 0 0 0 0 0 
5 0 0 0 0 27 5 0 0 0 0 0 
10 0 0 0 53 70 10 0 0 0 0 0 
15 0 7 40 54 90 15 0 0 0 0 17 
20 2 29 30 32 55 20 0 0 0 1 1 
25 4 28 32 46 57 25 0 0 0 0 0 
30 3 15 20 20 20 30 0 0 0 0 0 
4% 
37 0 0 0 0 0 
8% 
37 0 0 0 0 0 
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Table VIII: Colony count from soil site 770.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 69 500 500 500 500 5 0 0 0 0 0 
10 132 500 500 500 500 10 0 0 0 0 68 
15 300 500 500 500 500 15 0 0 0 0 84 
20 300 500 500 500 500 20 0 6 12 52 67 
25 300 500 500 500 500 25 0 4 10 22 29 
30 300 500 500 500 500 30 0 5 5 7 7 
0% 
37 300 500 500 500 500 
5% 
37 0 0 0 0 0 
5 0 0 0 1 1 5 0 0 0 0 0 
10 0 0 1 2 2 10 0 0 0 0 35 
15 4 10 500 500 500 15 0 0 0 0 3 
20 152 500 500 500 500 20 0 0 9 42 59 
25 4 9 500 500 500 25 0 5 7 9 20 
30 3 7 500 500 500 30 0 0 0 0 0 
2% 
37 0 0 2 4 4 
6% 
37 0 0 0 0 0 
5 0 0 0 1 1 5 0 0 0 0 0 
10 0 0 2 3 3 10 0 0 0 0 0 
15 0 2 5 5 5 15 0 0 0 0 66 
20 1 4 500 500 500 20 0 0 7 40 49 
25 1 5 157 500 500 25 0 0 0 1 0 
30 0 4 4 4 4 30 0 0 0 0 0 
3% 
37 0 0 0 1 1 
7% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 0 0 0 10 0 0 0 0 0 
15 0 1 1 1 1 15 0 0 0 0 17 
20 1 1 1 4 4 20 0 0 0 1 1 
25 0 0 2 3 3 25 0 0 0 0 0 
30 0 0 4 4 4 30 0 0 0 0 0 
4% 
37 0 0 0 0 0 
8% 
37 0 0 0 0 0 
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Table IX: Colony count from soil site 901.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 500 500 500 500 500 5 0 0 0 0 0 
10 500 500 500 500 500 10 0 0 0 0 0 
15 500 500 500 500 500 15 0 0 0 50 50 
20 500 500 500 500 500 20 0 46 50 50 50 
25 500 500 500 500 500 25 0 0 49 49 49 
30 500 500 500 500 500 30 0 2 2 2 2 
0% 
37 500 500 500 500 500 
5% 
37 0 0 0 0 0 
5 0 50 50 500 500 5 0 0 0 0 0 
10 0 200 200 500 500 10 0 0 0 4 4 
15 0 150 200 500 500 15 0 21 22 23 23 
20 3 250 250 250 250 20 0 39 40 39 39 
25 27 500 500 500 500 25 0 21 40 40 40 
30 16 51 54 500 500 30 0 27 14 14 14 
2% 
37 0 0 0 500 500 
6% 
37 0 0 0 0 0 
5 0 0 0 33 33 5 0 0 0 0 0 
10 0 0 0 50 50 10 0 0 0 0 0 
15 0 29 29 42 42 15 0 0 0 0 0 
20 1 26 42 42 42 20 0 0 0 0 0 
25 14 23 33 32 32 25 0 0 0 4 4 
30 16 17 17 17 17 30 0 0 0 0 0 
3% 
37 0 0 0 1 1 
7% 
37 0 0 0 0 0 
5 0 0 0 28 28 5 0 0 0 0 0 
10 0 0 0 41 41 10 0 0 0 0 0 
15 9 75 75 63 63 15 0 0 1 4 4 
20 28 58 64 63 63 20 0 0 9 9 9 
25 58 77 77 77 77 25 0 0 3 3 3 
30 79 11 101 104 104 30 0 0 0 0 0 
4% 
37 8 9 1 10 10 
8% 
37 0 0 0 0 0 
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Table X: Colony count from soil site 902.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 500 500 500 500 500 5 0 0 0 0 0 
10 500 500 500 500 500 10 0 0 0 0 0 
15 500 500 500 500 500 15 0 2 7 38 38 
20 500 500 500 500 500 20 0 11 14 14 14 
25 500 500 500 500 500 25 0 7 4 7 7 
30 500 500 500 500 500 30 0 2 7 7 7 
0% 
37 500 500 500 500 500 
5% 
37 0 0 0 0 0 
5 0 0 0 13 13 5 0 0 0 1 1 
10 0 10 10 38 38 10 0 0 0 6 6 
15 3 45 500 500 500 15 0 18 21 21 21 
20 13 115 125 120 120 20 0 7 9 11 11 
25 24 40 70 500 500 25 0 9 11 11 11 
30 27 50 50 50 50 30 0 4 9 9 9 
2% 
37 0 1 1 1 1 
6% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 0 13 13 10 0 0 0 0 0 
15 0 12 82 87 87 15 0 0 7 7 7 
20 0 57 87 87 87 20 0 1 2 5 5 
25 2 10 58 58 58 25 0 0 3 3 3 
30 7 12 13 25 25 30 0 0 0 0 0 
3% 
37 0 0 0 0 0 
7% 
37 0 0 0 0 0 
5 0 0 0 0 0 5 0 0 0 0 0 
10 0 0 0 15 15 10 0 0 0 1 1 
15 0 22 62 75 75 15 0 2 2 4 4 
20 0 22 52 62 62 20 0 0 0 0 0 
25 4 17 17 19 19 25 0 0 1 1 1 
30 0 9 9 9 9 30 0 0 0 0 0 
4% 
37 0 0 0 0 0 
8% 
37 0 0 0 0 0 
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Table XI: Colony count from soil site 903.  
NO. of colonies on the 
observation days 
NO. of colonies on the 
observation days Phenol 
treatment Temp 
3 7 14 21 28 
Phenol 
treatment Temp 
3 7 14 21 28 
5 80 500 500 500 500 5 0 0 0 4 4 
10 500 500 500 500 500 10 0 0 0 14 14 
15 500 500 500 500 500 15 0 3 4 6 6 
20 500 500 500 500 500 20 0 10 10 10 10 
25 500 500 500 500 500 25 0 9 11 9 9 
30 500 500 500 500 500 30 2 4 10 16 16 
0% 
37 500 500 500 500 500 
5% 
37 0 3 5 5 5 
5 0 0 0 500 500 5 0 0 0 0 0 
10 0 8 8 500 500 10 0 0 0 0 0 
15 0 500 500 500 500 15 0 0 0 0 0 
20 5 500 500 500 500 20 0 0 0 1 1 
25 3 500 500 500 500 25 0 0 3 3 3 
30 2 500 500 500 500 30 0 1 1 2 2 
2% 
37 2 5 500 500 500 
6% 
37 1 1 3 3 3 
5 0 0 0 21 21 5 0 0 0 0 0 
10 0 0 0 33 33 10 0 0 0 0 0 
15 0 25 26 34 34 15 0 2 3 4 4 
20 0 18 19 21 21 20 0 5 6 7 7 
25 1 8 9 11 11 25 0 2 2 4 4 
30 1 2 4 5 5 30 0 5 13 13 13 
3% 
37 1 3 3 4 4 
7% 
37 0 2 3 3 3 
5 0 0 0 26 26 5 0 0 0 0 0 
10 0 0 0 22 22 10 0 0 0 0 0 
15 0 8 8 17 17 15 0 0 1 7 7 
20 0 14 17 20 20 20 0 8 8 8 8 
25 3 16 17 17 17 25 0 1 6 6 6 
30 3 15 8 8 8 30 0 4 9 9 9 
4% 
37 1 3 3 4 4 
8% 
37 1 2 2 2 2 
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Appendix III 
 
The effect of temperature and cultivation 
period on growth of Pseudeurotium zonatum, 
Chaetomium globosum and Chaetomium 
trigonosporum 
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Figure I: Effect of temperature and cultivation period on growth of P. zonatum on MYPA and SDA 
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Figure II: Effect of temperature and cultivation period on growth of C. globosum on MYPA and SDA 
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Figure III: Effect of temperature and cultivation period on growth of C. trigonosporum on MYPA and SDA. 
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